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                   Somatic embryogenesis receptor like kinases, 
                            structure, function and signaling 
Rumyana Karlova and Sacco de Vries
Modifi ed version of this chapter is published in Science STKE 2006, pe36
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General  Introduction
Plants are constantly challenged by changes in temperature, light, nutrient conditions, and 
exposure to pathogens and by other fl uctuations in their environment. Plants also lack extra-
cellular antibodies and specifi c cells that defend against pathogen attack. For example spe-
cialized cell types (macrophages, neutrophils, and dendritic cells), which as part of a circula-
tory blood system are the key players of the animal immune system, are not found in plants. 
Nevertheless, plants have developed remarkable strategies to detect and adapt to environment 
cues by the use of a wide array of receptors at the surface level of each single cell (Nurnberger 
et al., 2004; Torii, 2004). Transmembrane receptor kinases (RKs) mediate signal transduc-
tion pathways leading to cell proliferation, growth and differentiation in animals as well 
as in plants. Unlike animal RKs almost all plant RKs phosphorylate serine/threonine resi-
dues, where as animal kinases are predominantly ligand activated tyrosin kinases (Shiu and 
Bleecker, 2001). The Plant RKs are classifi ed into several groups based on the structure of the 
extracellular domains. The largest super family of plant RKs with more than 222 members in 
Arabidopsis contain extracellular leucine-rich repeat (LRR) motifs (Shiu and Bleecker, 2001). 
Initial steps in a general signal transduction cascade include perception of the external sig-
nal (ligand) or sets of signals that bind to the perception domain which than leads to protein 
conformational changes of the receptor (for example due to phosphorylation) and changing 
the interaction partner. This is followed by transmission of secondary signals through the 
plasma membrane and introduction of specifi c phosphorylation and dephosphorylation cas-
cades (Citri and Yarden, 2006). Eventually the signal is transmitted to the nucleus, where the 
expression of specifi c genes is affected. The attenuation of the signaling cascade primarily 
is controlled by receptor dephosphorylation and eventually receptor degradation. Coupled to 
this degradation pathway is receptor internalization which is considered the most effective 
process that robustly attenuates signaling. The receptors are targeted to the proteasome for 
degradation via the endosomal traffi cking pathway. The plant receptor class that is the focus 
of this chapter is the SOMATIC EMBRYOGENESIS RECEPTOR LIKE KINASES. 
Structure and homology classifi cation
The proteins of the SERK family consist of a signal peptide followed by a Leu- rich domain 
of 45 amino acids fi tting the Leu-zipper (LZ) pattrn Lx6Lx6Lx6L (Hecht et al., 2001) and 
Figure 1. The LLR domain is composed of fi ve units. LRRs have been found in a variety of 
proteins with diverse functions from yeast to fl ies, humans, and plants, and are implicated 
in protein-protein interactions. The plant extracytoplasmic LLR motif has the consensus se-
quence L--L--L--L-L--N-L-G-IP--, where the dashes represent nonconserved residues (Torii, 
2004). Although the majority of plant LRRs does not posses any introns, single LRR units of 
some LRR-RLKs like SERK, ERECTA and SYMRK/NORK, are intercepted by introns at 
the identical positions, between nucle-otides 2 and 3 of the codon for the fi rst leucine under-
lined in Figure 1 A. In most LRR receptor kinases, the transmembrane domain immediately 
follows the LLR domain. However, in AtSERK1 as in DcSERK, a Pro-rich region containing 
a repeated SPP motif separates these domains. 
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A 
     BRI1                               a--a--L--L-LS-N-aSG-IP- -          25
     FLS2                               a--L--L--L-L--N-LTG- IP- -          28
     SERK                               L- -a--L--L-L-NN-LSTPIP- -         5
     ERECTA                          LG-L--L--L-L--N-L-G-IP- -          20
B
BRI1 FLS2 SERK
LRR
kinase
loop-out island SPP motifTM leucine zipper
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Figure 1. (A). Alignments of the LRR consensus sequence for a plant extracellular LRR- RLKs. 
Symbol -, Nonconserved amino acid; a, aliphatic amino acid. Numbers on the right indicate the total 
number of repeats, including both compleat and incomplete repeats. At the left are the protein names. 
The bolded leucine indicates the position of the introns, located between codons 2 and 3. (B). Struc-
tural composition of plant LRR-RLKs adopted from Torii (2004). N-terminal signal peptides are not 
included. Domains represented are listed below the diagram. LRR, Leucine-rich repeat; TM, trans-
membrane; SPP, serine-proline-prolene.
This motif has been suggested to act as a hinge providing fl exibility to the extracellular part 
of the receptor or as a region for interaction with the cell wall   (Schmidt et al., 1997; Hecht 
et al., 2001). As shown on Figure 1 B, SERKs contain only 5 LRRs in contrast to two of their 
main ligand binding receptors, BRI1 and FLS2 (Li et al., 2002; Nam and Li, 2002; Chinchilla 
et al., 2007). BRI1 has 24 LRRs, with LRR21 being an unusual methionine-rich repeat, inter-
rupted with the ligand binding island domain and 28 LRRs for FLS2 (Vert et al., 2005; Dun-
ning et al., 2007). Direct binding of BL (biosynthetic brassinosteroid) was demonstrated with 
native and recombinant BRI1 protein (Kinoshita et al., 2005). Moreover, recombinant protein 
consisting of the island domain and the neighboring C-terminal LRR repeat were suffi cient 
to bind radioactive BL with an affi nity comparable to that observed for full-length BRI1 from 
plants. In addition to BRI1, three highly similar homologs have been characterized (Cano-
Delgado et al., 2004). Two of them, BRL1 and BRL3 display high BL-binding affi nity. FLS2 
was shown to bind bacterial fl agellin or the fl agellin-derived fl g22 peptide through a pre-
sumed physical interaction with the FLS2 extracellular domain. Site-directed randomizing 
mutagenesis of solvent-exposed LRR residues across LRRs 9 to 15 identifi ed mutations that 
disrupt fl g22 binding and showed that fl agellin perception is dependent on a limited number 
of tightly constrained residues of LRRs 9 to 15 (Dunning et al., 2007).   
The intracellular region of SERKs and their  main receptors BRI1 and FLS2, contains the 11 
subdomains characteristic of the catalytic core of Ser/Thr protein kinases (Stone and Walk-
er, 1995). The kinase domain ranges from 250-300 amino acid residues, corresponding to 
about 30 kD. All the sub-domains contain a characteristic pattern of conserved residues. 
The smaller N-terminal lobe containing sub-domain I-IV is primarily involved in anchoring 
and orienting the ATP molecules. The larger C-terminal lobe containing sub domains VI-IX 
is largely responsible for binding the substrates and initiating phosphotransfer (Hanks and 
Quinn, 1991; Hanks and Hunter, 1995). The juxtamembrane and C-terminal regions, that 
show less sequence conservation are believed to generate docking sites for specifi c kinase 
substrates rather than a more general response to kinase activation (Pawson, 2004). This 
was not the case for the C-terminal tail of BRI1, that was found to inhibit the kinase activ-
ity of the receptor and to be relieved upon ligand binding to the extracellular domain (Wang 
et al., 2005a). Depending on the amino acid residues that are phosphorylated, the receptor 
kinases have been classifi ed into two families; those that phosphorylate on tyrosine residues 
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and those that phosphorylate on serine and/or threonine residues. The exception from this 
classifi cation are proteins like SERK1 of which the kinase domain can trans- phosphorylate 
on Ser, Thr and Tyr residues and represents a dual specifi city kinase (Shah et al., 2001a). As 
found for the SERK family, the kinase domain sequence of various plant receptor kinases 
is highly conserved, yet their phosphorylation peptides are highly variable as well as their 
modes of phosphorylation. For example the disease-resistant RLK Xa21 from rice contains a 
kinase domain that phosphorylates in an intramolecular manner (Liu et al., 2002). In contrast, 
the Arabidopsis SERK1 and Lotus japonicus SYMBIOSIS RECEPTOR KINASE (SYMRK) 
are reported to autophosphorylate intermolecularly (Shah et al., 2001a; Yoshida and Parni-
ske, 2005). Although there is no crystal structure established for the kinase domain of plant 
RLKs, biochemical experiments have provided detailed information on the mechanism of 
phosphorylation catalyzed by these kinases. It was shown for the SERK1 kinase domain, that 
mainly autophosphorylates on threonine residues, that the reaction is Mg2+ dependent and 
inhibited by Mn2+, where for BRI1 Mg2+ was also important for the activity but Mn2+ did 
not have an inhibition effect (Oh et al., 2000). A lysine to glutamic acid substitution (K330E) 
in the ATP binding pocket of SERK1-KD abolishes all kinase activity and an active SERK1 
kinase can phosphorylate inactive SERK1K330E proteins suggesting an intermolecular 
mechanism of autophosphorylation. Comparable substitutions in another member of this re-
ceptor family, SERK3, that is identical to BRI1-Associated Receptor Kinase 1 (BAK1), also 
abolishes the kinase activity (Li et al., 2002). Replacing Thr-468 in the activation loop with 
alanine completely obliterated the ability of SERK1 to autophosphorylate (Shah et al., 2001a). 
Kinase activity was also shown for the other members of the family, SERK4 and SERK5 and 
is discussed in Chapter 4. Autophosphorylation activity was shown also for FLS2, which was 
found to hetero-dimerize with SERK3 (Gomez-Gomez et al., 2001; Chinchilla et al., 2007). 
In the activation loop of the SERK proteins, there are 4 conserved threonines representing 
Thr-459, Thr-462, Thr-463 and Thr-468 in SERK1 protein. These residues were identifi ed to 
be phosphorylated also in vivo in BRI1 and are functionally equivalent to Thr-1039, Ser-1042, 
Ser/Thr-1044/45 in BRI1 (Wang et al., 2005b). 
 Based on their sequence homology with SERK1, more LRR-RLKs were identifi ed as 
shown in Figure 2 with 54% to 32% sequence identities. From these receptors, most of which 
also contain 5 LRRs in the extracellular domain, only fi ve members had an SPP domain in 
front of the transmembrane domain, and thus defi ne the SERK family (Figure 2). 
Biological function of SERKs 
Steroid hormone signal transduction  
Steroid hormones play key roles in growth and development of multicellular eukaryotes. Plant 
steroid hormones are called brassinosteroids (BRs) and regulate cellular expansion, differ-
entiation, and proliferation. BRs are involved in diverse processes, such as stem elongation, 
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vascular differentiation, male fertility, timing of senescence and fl owering, leaf development, 
and resistance to biotic and abiotic stresses (Li and Chory, 1997; Clouse and Sasse, 1998; 
SERK1
SERK2
SERK3
SERK4
SERK5
LLR-RLK At5g10290
LLR-RLK At5g65240
LLR-RLK At5g63710
NIK3
NIK1
  NIK2
NIK2
LLR-RLK At4g30520
LLR-RLK At2g23950
LLR-RLK At5g45780
LLR-RLK At5g62710
LLR-RLK At1g31420
LLR-RLK At2g35620
LLR-RLK At5g48380
78%
53%
48%
32%
Figure 2. Arabidopsis LRR-RLKs and their phylogenetic relationships with SERK family. 
Amino acid sequence of the proteins were aligned using Clustal W (Thompson et al., 1994).
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; Altmann, 1999). Unlike animal steroids that are perceived by nuclear receptors, plant ster-
oids are perceived by transmembrane receptor kinases that initiate a phosphorylation-me-
diated signaling cascade to transduce the steroid signal. BRs bind to a subdomain within 
the extracellular leucine-rich repeats (LRRs) of the plasma membrane receptor kinase BRI1 
(BRASSINOSTEROID-INSENSITIVE 1), as well as to two of its close relatives BRL1 (BRI1-
Like 1) and BRL3 (Cano-Delgado et al., 2004; Zhou et al., 2004; Kinoshita et al., 2005). Both 
genetic and biochemical approaches have begun to provide further details of the various 
components of the BR signal transduction pathway.
On the basis of genetic screens and yeast-based protein-protein interaction screens, a sec-
ond LRR receptor–like kinase (RLK) designated BAK1 (BRI1 ASSOCIATED KINASE 1) 
was identifi ed (Li et al., 2002; Nam and Li, 2002) that most likely does not bind BR itself 
(Kinoshita et al., 2005). Two elegant studies of the in vivo phosphorylation properties of 
BRI1 revealed that after binding of BR to the BRI1 receptor, homodimerization was required 
(Wang et al., 2005a) to promote hetero-oligomerization with BAK1 (Wang et al., 2005b), 
which may result in a tetrameric receptor complex (Figure 3). Auto- or trans-phosphoryla-
tion of the C terminus of BRI1 is instrumental in enhancing the kinase activity of BRI1, as 
well as promoting its affi nity for the co-receptor BAK1 (Wang et al., 2005b; Wang et al., 
2005a; Wang et al., 2008). BAK1 is identical to the third member of the SERK family. After 
hetero-oligomerization, BAK1 (SERK3) accelerated internalization by endocytosis of BRI1 
(Russinova et al., 2004). In planta as well as in protoplasts the localization and turnover of 
BRI1 appear independent from the presence of the ligand (Russinova et al., 2004; Geldner 
et al., 2007). However, increasing endosomal localization of BRI1 enhances activation of the 
signaling pathway and genomic responses, dtected by an increase in dephosphorylation of 
one of the targets of BR signaling, BES1 (BRI1 EMS SUPPRESSOR 1) (Geldner et al., 2007). 
These data suggest that BRI1 can use the endosomes as signaling compartments like has been 
shown for other receptors, for example TGF-β (Panopoulou et al., 2002). Another member of 
the SERK family, SERK1, is also able to interact with BRI1 and appears to modulate BRI1 
signaling in a manner similar to that observed for BAK1 (chapter 2). The emerging picture 
suggests that SERK and BRI receptors exist as homodimers in the absence of ligands and 
form ligand-induced tetrameric complexes, analogous to the receptor complexes of mamma-
lian transforming growth factor–β (TGF-β) receptors. Precise combinatorial interactions in 
the tetrameric TGF-β receptor complex allow differential ligand binding or differential sign-
aling in response to the same ligand (Feng and Derynck, 1997). Whether this also applies to 
the BRI1-SERK complexes is not known. BRI1 also interacts with TRIP-1, a cytosolic protein 
that is homologous to a TGF-β receptor interacting partner (Ehsan et al., 2005). 
On the basis of genetic screens, other downstream components of BR signaling have been 
identifi ed. BIN2 (BR INSENSITIVE 2) is a glycogen synthase kinase 3 (GSK3) homolog. 
Genetic and biochemical evidence suggested that BIN2 is a negative regulator of BR signal-
ing and functions by phosphorylating and thereby inactivating two nuclear proteins, BZR1 
(BRASSINAZOLE RESISTANT 1) and BES1. 
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BRI1
BAK1SERK1
Receptor
recycling fast
No signaling
BKI1
OH
HO
HO
HO
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BKI1
BKI1
?
BIN2
BSU1
BES1 BES1
P
BZR1 BES1
P
Signaling II
Signaling I
Signaling II
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internalization
Nucleus
A
B
Brassinosteroid
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Cell division
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Figure 3. Model of the BR signal transduction pathway. The plasma membrane-localized receptor 
kinase BRI1 is the major BR receptor. (A) Without BR, BRI1 and its co-receptors BAK1 or SERK1, or 
both, recycle through endosomes. The kinase activity of BRI1 is kept in a basal state by both its own 
C- terminal domain and by an interaction with BKI1. (B) BR binding to the extracellular domain of 
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BRI1 induces a conformational change of the kinase domain, leading to the phosphorylation of BRI1 
and dissociation of BKI1 from the plasma membrane. Following the activation of BRI1, together with 
BAK1 or SERK1, a multimeric complex is formed. This complex may consist of different members 
of both BRI and SERK families; only one possible confi guration is shown. This activation leads to 
dephosphorylation of the nuclear proteins BES1 and BZR1 by inhibiting the negative regulator BIN2. 
BES1 and BZR1 then homodimerize and bind to DNA to regulate BR-responsive genes. In the absence 
of BR, the kinase BIN2 phosphorylates BES1 and BZR1. BSU1 is a nuclear phosphatase involved in 
the dephosphorylation of BES1. The entire hetero-oligomeric receptor complex can be internalized by 
endocytosis. It is not certain whether internalization of the receptor complex requires BR or whether 
the receptor complex is capable of propagating the BR signal following internalization.
Both are required for BR-regulated gene expression in a mechanism proposed to be analogous 
to that of Wnt signaling in fruit fl y and vertebrates (Choe et al., 2002; Li and Nam, 2002; Yin 
et al., 2002; He et al., 2005). When over-expressed in Arabidopsis plants as fusion proteins 
with the green fl uorescent protein (GFP), BES1 and BZR1 are rapidly dephosphorylated af-
ter treatment with BR (He et al., 2002; Yin et al., 2002), probably by the phosphatase BSU1 
(BRI1 SUPPRESSOR PROTEIN 1), a nuclear protein (Mora-Garcia et al., 2004) (Figure 3). 
Vert and Chory (Vert and Chory, 2006) showed that BR signaling differs from the previously 
proposed canonical Wnt signaling mechanism in which the GSK3β protein is inactivated 
in the presence of the ligand, leading to accumulation and nuclear translocation of the now 
dephosphorylated β-catenin (Staal et al., 2002). Individual loss-of-function alleles of BIN2 
and two of its closest homologs revealed no effect on BR signaling, but the triple knockout 
displayed constitutive BR responses and strong resistance to the BR biosynthetic inhibitor 
brassinazole, suggesting that GSK3 kinases act redundantly to negatively regulate BR signal-
ing. Furthermore, BIN2-GFP was localized in the nucleus, in the cytosol, and at the plasma 
membrane. In contrast, a GFP fusion with bin2 containing the E263K mutation that produced 
the original gain-of-function phenotype was found mostly localized to the nucleus. After 
expressing the mutant bin2 protein fused to a nuclear localization signal, severe dwarf phe-
notypes resembling the genetic defects observed in the absence of synthesis or perception of 
BRs were observed. These results showed that BIN2 activity is required inside the nucleus 
and not in the cytoplasm. The conversion of BES1 proteins from the dephosphorylated to the 
phosphorylated state was consistent with the observed dwarf phenotypes. After expression 
in transgenic plants the BES1-GFP protein was constitutively nuclear, which further supports 
the model that BIN2-mediated phosphorylation of BES1 is exclusively nuclear. Neither pro-
tein stabilization nor nuclear translocation of BES1 is apparently required for BR signaling, 
emphasizing the importance of phosphorylation in regulating BES1 activity. Finally, BIN2-
mediated phosphorylation of BES1 resulted in a complete loss of its DNA-binding activity 
to downstream target promoters, and its ability to multimerize was also clearly decreased. 
These results indicate that rather then regulating the nuclear translocation and accumulation 
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of BES1, BIN2 acts in the nucleus to regulate the genomic response to BRs through phos-
phorylation of BES1, which blocks the transcriptional activity of BES1. Recently a different 
model was proposed for BIN2 and BZR1 model of action by (Gampala et al., 2007; Ryu et al., 
2007). These authors showed that BZR1 functions as a nucleocytoplasmic shuttling protein 
and BIN2 induces the nuclear export of BZR1 by modulating BZR1 interaction with the 14-
3-3 proteins. BR-activated phosphatase mediated rapid nuclear localization of BZR1. It was 
proposed that the spatial redistribution of BZR1 is critical for proper BR signaling in plant 
growth and development. In these studies protein over-expression in protoplasts are used, 
which could only partially mimic the natural signaling process in planta.    
Wang and Chory described another negative regulator of BR signaling, BKI1 (BRI1 KINASE 
INHIBITOR 1) (Wang and Chory, 2006). BKI1 interacts directly with the kinase domain of 
BRI1, as did transthyretin-like (TTL) protein (Nam and Li, 2004), both of which were identi-
fi ed by yeast two-hybrid screening. The C-terminal domain of BKI1 was both necessary and 
suffi cient to bind the BRI1 kinase domain and the interaction was highly specifi c, because 
BKI1 did not interact with TTL, BIN2, or the kinase domain of other RLKs. Immunoprecipi-
tation experiments confi rmed that BRI1 interacted with a BKI1-FLAG fusion in vivo, and 
with the use of promoter–β-glucuronidase (GUS) fusions, BKI1 was shown to be coexpressed 
with BRI1 in a number of plant tissues (Friedrichsen et al., 2000; Nam and Li, 2004; Wang 
and Chory, 2006). RNA interference (RNAi) lines of BKI1 showed that BKI1 represses BR-
related growth, whereas over-expression of BKI1 resulted in dwarf plants resembling plants 
harboring weak alleles of bri1. As could be predicted from the phenotype, dephosphorylated 
BES1 in the BKI1 over-expression lines was almost undetectable, suggesting that BRI1 sig-
naling was suppressed by BKI1 over-expression. The BKI1-YFP (yellow fl uorescent protein) 
fusion was localized both at the plasma membrane and the cytosol. Within 5 min of BR appli-
cation, the plasma localization of BKI1 was shifted completely to the cytosol. No BR-induced 
dissociation of BKI1-YFP from the plasma membrane was observed in a bri1 kinase–inactive 
mutant background (Friedrichsen et al., 2000), suggesting that the kinase activity of BRI1 is 
required for BKI1-YFP relocalization. On the basis of these fi ndings, a new model is proposed 
where in the absence of BRs, BRI1 homodimers are kept localized at the plasma membrane 
in association with BKI1 proteins. This may in fact keep BRI1 from association with its 
co-receptors, such as BAK1 or SERK1 (Figure 3). These new fi ndings are summarized in a 
model based on various previous ones and shows that BR binding to the extracellular domain 
of BRI1 induces receptor phosphorylation and activation, as well as its dissociation from 
BKI1. In the absence of BRs, BIN2 negatively regulates BR signaling by phosphorylating 
the transcriptional regulators BES1 and BZR1. In the presence of BRs, BIN2 is inhibited 
by an unknown mechanism, leading to dephosphorylation of BES1 and BZR1, which then 
homodimerize or cooperate with other transcription factors, which allows DNA binding and 
regulation of BR-responsive genes (Yin et al., 2005; Vert and Chory, 2006).
This new signaling paradigm raises several interesting questions. The fi rst is the stoichiom-
etry and conformation of the BR receptor complex in the plasma membrane in the absence 
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and presence of BRs. To what extent are the proposed tetrameric complexes preformed, or are 
these tetrameric complexes only assembled upon ligand application? Both homodimeric and 
heterodimeric confi gurations appear to coexist in heterologous plant cells (Russinova et al., 
2004). A second question is whether the complex is the same in all cells where the receptors 
are expressed or whether there are a multiple forms composed of different family members. 
This is important for determining whether the proteins so far identifi ed are capable of inte-
grating or separating the different cellular and developmental effects of BRs.
A third question concerns the role of the co-receptors in BR signaling. One hypothesis, which 
is modeled on TGF-β signaling, suggests that BR binding activates BRI1, which can then 
phosphorylate BAK1 to propagate BR signaling (Li et al., 2002; Karlova et al., 2006). This 
hypothesis is supported by Wang et al. (Wang et al., 2005b), who showed that BR treatment 
not only stimulates the phosphorylation of both BRI1 and BAK1, but also enhances their 
physical interaction in transgenic plants coexpressing tagged BRI1 and BAK1. Thus, down-
stream components intermediate between BRI1 and BIN2 may interact with BAK1 rather 
then BRI1 itself. However, using the SERK1 protein as bait to identify interacting proteins, 
we did not identify any known components of BR signaling other than the BRI1 and BAK1 
receptors (Karlova et al., 2006; and chapter 2). Instead, we found components of the plant 
variant of the VCP/p97 complex of yeast and mammals (Aker et al., 2006; Karlova et al., 
2006; Aker et al., 2007) and two putative targets in the form of the transcriptional regulator 
AGL15 and a Zn-fi nger protein. An alternative hypothesis, which is based on the epidermal 
growth factor (EGF) receptor model, suggests that BRI1-BAK1 dimerization is essential for 
the activation of both receptor kinases by trans-phosphorylation (Nam and Li, 2002) and 
may represent the fi rst bifurcation in the pathway in which both BRI1 and BAK1 participate 
in downstream signaling. Recently Wang at al., (Wang et al., 2008) provided a proof for this 
model by showing a sequential trans-phosphorylation for BRI1 and its co-receptor BAK1. In 
this model BRI1 kinase function is initially activated to a basal level by BR binding to BRI1 
in the absence of BAK1. The activated BRI1 then associates with BAK1 and trans-phosphor-
ylates it on kinase domain residues. BRI1-activated BAK1 subsequently trans-phosphorylates 
specifi c juxtamembrane and C-terminal residues in BRI1, thereby increasing BRI1 kinase 
activity and substrate phosphorylation, leading to enhanced BR signaling and increased plant 
growth.
A fi nal question concerns the role of endocytosis in BR-mediated signaling. Although animal 
EGF and TGF receptors remain capable of downstream signaling after internalization, so far 
the ligand triggered endocytosis has only been shown for the plant receptor FLS2 (Robatzek 
et al., 2006), which is involved in innate immunity and bacterial fl agellin perception. BAK1 is 
reported to enhance endocytosis of BRI1 (Russinova et al., 2004). It is also unknown whether 
the BRI1-BAK1 complex may have functions that are independent of kinase activity. For 
example, the kinase activity of another plant receptor, CRINKLY4, is not instrumental for its 
biological activity (Gifford et al., 2005). If this is a general feature of plant receptors, proper-
ties other than the catalytic activity of BRI1 and BAK1 could also be essential for signaling.
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In conclusion, it appears that although plant signaling pathways have many components in 
common with their animal counterparts, their individual properties may be quite different 
and may help to fully explain how the problem of perceiving and responding to steroid hor-
mones as essential signal molecules has been tackled in different species. 
Plant disease resistance pathway trough FLS2-SERK3 receptor 
Plants, like animals, have the capacity to detect phathogens in a broad combinatorial way by 
detecting several general elicitors. Examples are fl agellin (the main component of the bacte-
rial fl agellum, chitin (fungal carbohydrate polymer), pilin (proteins that are part of the pilus 
structures in bacteria), and ergosterol (the main sterol of the higher fungi) (Afzal et al., 2008). 
The plants response to general elicitors includes the production of ROS (reactive oxygen spe-
cies) and ethylene and activation of the partial defense response genes. Genetic analysis in 
Arabidopsis has shown that FLS2, an LRR-RLK, is essential for fl agellin perception (Gomez-
Gomez and Boller, 2000). FLS2 was shown to be essential for the fl g22-mediated activa-
tion of defense mechanisms through the mitogen-activated protein kinase (MAPK) cascade 
(Asai et al., 2002). Recently, using chemical crosslinking and immunoprecipitation, FLS2 
was shown to bind fl g22 and determine the specifi city of fl agellin perception (Chinchilla et 
al., 2006).  Functionally, FLS2 is similar to animal Toll-like receptor 5 (TLR5), which also 
recognizes fl agellin through its LRR domain (Andersen-Nissen et al., 2007) and belongs to 
a family of evolutionarily conserved membrane receptors. These receptors are demonstrated 
to recognize a diverse set of microbial molecules, collectively termed pathogen-associated 
molecular patterns ‘PAMPs’, which are absent from the host, making these receptors ideal for 
distinguishing self from non-self (Akira and Takeda, 2004). Unlike BRI1 (Russinova et al., 
2004) and several toll-like receptors, Arabidopsis FLS2 does not undergo homodimerization 
either before or after fl g22 treatment (Ali et al., 2007). Recently, it was shown that FLS2 local-
izes to the plasma membranes and also to intracellular vesicles (Robatzek et al., 2006). FLS2 
was found to undergo rapid endocytosis in ligand-dependent manner leading to degradation. 
Two independent groups (Chinchilla et al., 2007; Heese et al., 2007) recently have shown that 
FLS2 rapidly becomes complexed with BAK1 (SERK3) in a ligand dependent manner, sug-
gesting that BAK1 is a partner of FLS2 in PAMP signaling similar to being a partner of BRI1 
in BR signaling. Plants carrying bak1 mutations show a decrease in the response to PAMPs, 
which is not due to reduced sensitivity to brassinosteroids. However, bak1- mutant plants did 
not reduce fl agellin binding, suggesting that BAK1 is not involved in fl agellin perception 
(Chinchilla et al., 2007). Thus, BAK1 seems to regulate the function of both receptors, BRI1 
and FLS2, at a step after ligand binding. Recent fi ndings also show that bak1 mutants have 
altered susceptibility to microbial pathogens such as oomycetes and true fungi (Kemmerling 
et al., 2007), indicating that BAK1 might regulate plant resistant responses other then FLS2 
and EFR. Interestingly, compared to the wild type plants, bak1-3 mutants showed markedly 
reduced endocytosis of FLS2 (Chinchilla et al., 2007). However, bak1 mutants clearly retain 
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partial sensitivity to fl agellin and elongation factor Tu (EF-Tu). One possible explanation for 
this is that a closely related protein might substitute for BAK1, like SERK1 in case of BRI1-
mediated signaling. However, non of the other single mutants from the SERK family, serk1, 
serk2, serk4 and serk5 showed an effect in fl g22 and elf18 responses (Chinchilla et al., 2007) 
or were susceptible to Alternaria brassicicola (Albrecht et al., 2008). The only exception be-
ing that a serk4 mutant allele enhances the bak1 (serk3) susceptibility towards Alternaria 
brassicicola.  Interestingly, in rice the OsSERK1 gene was found to act in two signaling 
pathways as positive regulator; somatic embryogenesis as well as the host defense response 
against fungal infection (Hu et al., 2005). Recently Shan et al., (Shan et al., 2008) showed that 
bacterial effectors like AvrPto and AvrPtoB target the common signaling partner, BAK1 to 
disrupt multiple PAMP receptor-signaling complexes and impede plant immunity. Remark-
ably, AvrPto and AvrPtoB are suffi cient to interfere with the bacterial-induced formation of 
FLS2-BAK1 receptor-signaling complex in plant leaves. Moreover the interaction between 
AvrPto and BAK1 also reduced the association between BRI1 and BAK1 in the presence or 
absence of BL, consistent with the BR-insensitive phenotypes observed in transgenic plants 
over expressing AvrPto protein (Shan et al., 2008). 
Cell death signaling pathway mediated trough SERK3 and SERK4 
Developmentally controlled programmed cell death is critical for normal plant growth and de-
velopment, as well as being part of a defense mechanism against numerous biotic and abiotic 
stresses. Recently two of the SERK proteins were shown to play a role in a cell death control. 
Although SERK3 and SERK4 share high sequence homology and a BAK1 null allele, bak1-4 
showed a subtle bri1-like phenotype, the SERK4 null allele bkk1 did not exhibit any defective 
phenotypes (He et al., 2007; Albrecht et al., 2008). However the double-null mutant bak1-4 
bkk1-1, illustrated extremely dwarfed phenotypes, yet completely distinct from typical bri1 
null mutants. bak1-4 bkk1-1 double mutants exhibit a seedling lethal phenotype due to con-
stitutive defense-gene expression, callose deposition, reactive oxygen species accumulation, 
and spontaneous cell death even under aseptic conditions. This indicates that SERK3 and 
SERK4 negatively regulate a BR-independent defense-related cell-death pathway. Albrecht et 
al., (Albrecht et al., 2008) extended these studies and showed that from the SERK family only 
SERK3 and SERK4 are partially redundant in cell death control. The authors demonstrated 
that a combination of weaker alleles of both SERK3 SERK4 genes no longer shows seedling 
lethality but exhibits reduced growth and more severe pathogen induced cell death than in the 
serk3-1 single mutant lines. None of the double or triple mutant combination of the SERKs 
genes show any additional effect on growth or cell death responses compared to serk3-1 
single or serk3-1 serk4-1 double mutants. It would be interesting to fi nd the composition of 
the different receptor protein complexes in plants, that are exposed to pathogen attacks or BR 
or fl g22 ligands to further understand how SERK3 protein play a role in separate signaling 
pathways.    
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Signaling pathways mediated trough SERK1 receptor
The SERK1 gene was fi rst identifi ed in carrot as a marker for single cells competent to form 
somatic embryos (SE) (Schmidt et al., 1997; Hecht et al., 2001). In Arabidopsis ectopic ex-
pression of SERK1 increases somatic embryogenesis in culture (Hecht et al., 2001), sug-
gesting that SERK1 mediated signaling is required for acquisition of embryogenic compe-
tence in somatic cells. Cells acquiring embryogenic competence in Arabidopsis are derived 
from procambium cells that express the SERK1 gene in the vascular tissue of the hypocotyl 
(Kwaaitaal and de Vries, 2007). Orthologs of the SERK genes were discovered in several 
plant specie, where the gene was also found to be a marker for embrygenic potential, like 
sunfl ower  (Thomas et al., 2004) and rice (Hu et al., 2005). Putative SERK genes were also 
identifi ed in Medicago truncatula (Nolan et al., 2003) and maize (Baudino et al., 2001) and 
show a predominant expression during somatic embryogenesis and shoot organogenesis. 
These results suggest that SERK genes may constitute a small gene family and are function-
ally conserved in plants with a specifi c role in somatic embryogenesis. Another gene that 
was shown to increase SE formation, when over-expressed is the MADS box transcription 
factor AGL15 (Harding et al., 2003). Recently AGL15 was shown to act redundantly with its 
homolog, AGL18 in two processes: somatic embryogenesis (Thakare et al., 2008) and in the 
control of fl owering time (Adamczyk et al., 2007). Both SERK1 and AGL15 (Hecht et al., 
2001; Nolan et al., 2003; Zhu and Perry, 2005; Kwaaitaal and de Vries, 2007) and MtSERK1 
(Nolan et al., 2003) genes expression is increase in response to auxin treatment (Hecht et al., 
2001; Zhu and Perry, 2005; Kwaaitaal and de Vries, 2007). It was shown in protoplasts that 
about 15 % of the SERK1 receptor kinase is present in a predimerized state  by Fluorescence 
Cross Correlation Spectroscopy (FCCS) (Hink et al., 2008). SERK1 dimerization and cor-
rect targeting depends on the extracellular LZ domain and N-linked glycosylation of the 
LLR domains (Shah et al., 2001b). Several downstream partners interacting with the SERK1 
kinase domain have been isolated. The Kinase Associated Protein Phospatase (KAPP), the 
AAA-ATPase Cell Division Cycle (CDC) 48 and the 14-3-3 protein GF14λ (Shah et al., 2002; 
Rienties et al., 2005). SERK1 and KAPP bind in a phosphorylation-dependent manner and 
KAPP dephosphorylates SERK1 and possibly negatively regulates SERK1 signaling (Shah et 
al., 2002). Co-expression of fl uorescently tagged KAPP and SERK1 in protoplasts resulted in 
internalization of the two proteins, where the interaction could be measured by FRET. This 
suggested that KAPP function is linked to inactivation of the SERK1 receptor by dephospho-
rylation and internalization and possible degradation in the vacuole (Shah et al., 2002). The 
closest homolog of SERK1 in the SERK family is SERK2 (Figure 2) and both genes show a 
complex expression pattern throughout development. Both are expressed in anther primordia 
up to the second parietal division. After this point, expression ceases in the sporocytes and is 
continued in the tapetum and middle layer precursors (Albrecht et al., 2005; Kwaaitaal et al., 
2005). Single knockout mutants of SERK1 and SERK2 show no obvious phenotypes. Double 
mutants of SERK1 and SERK2 are completely male sterile due to a failure in tapetum speci-
fi cation. Fertility can be restored by a single copy of either gene. The SERK1 and SERK2 
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proteins can form homodimers or heterodimers in vivo, suggesting they are interchangeable 
in the SERK1/SERK2 signaling complex (Albrecht et al., 2005). In vitro studies showed that 
serk1-1 truncated protein had lost its autophosphorylation activity. By contrast to the serk1-1 
serk2-1 double mutant, the strong bri1-201 mutant, which is also male sterile, does produce 
pollen and the anther phenotype of the serk1-1 serk2-1 could not be rescued by the bes1-D 
mutant construct (Albrecht et al., 2008). These data indicate that similar to serk3 serk4 dwarf 
phenotype, serk1 serk2 male sterility phenotypes are not related to BRI1-mediated BR signal-
ing. 
In summary members of the SERK family have in part redundant functions, can act as co-
receptors with different main receptors and individual members can act in different signaling 
pathways. Although the different SERK members are expressed in all tissues during develop-
ment and share a large overlapping pattern of expression (Albrecht et al., 2005; Kwaaitaal et 
al., 2005; Kwaaitaal and de Vries, 2007) these receptors have different functions. SERK1 and 
SERK2 are fully interchangeable in male sterility (Albrecht et al., 2005). SERK1 and SERK3 
have additive effects in BR signaling (Albrecht et al., 2008) and SERK3 (BAK1) and SERK4 
(BKK1) are redundant in mediating cell death (He et al., 2007). SERK3 alone also controls 
innate immunity (Kemmerling et al., 2007) and it is involved in fl agellin perception by being 
a co-receptor of FLS2 (Chinchilla et al., 2007; Heese et al., 2007). SERK4 mutant allele en-
hances the serk3 susceptibility towards Alternaria brassicicola (Albrecht et al., 2008). These 
data support the hypothesis for heterotetrameric receptor complex formation of two ligand-
binding receptors and two co-receptors. Different specifi cities could then be attributed to a 
specifi c combination of main and co-receptors in analogy to the  mammalian ERBB (eryth-
roblastosis oncogene B) receptors (Citri and Yarden, 2006). 
Scope of the thesis:
Plants have developed remarkable strategies to detect and adapt to environmental cues by 
the use of a wide array of receptors at the cell surface. Plant transmembrane receptors are 
prime components of many signaling cascades and thus are involved in cell fate, growth, 
differentiation and defense against pathogen attacks. One amazing properties of the plants 
is their ability to regenerate very fast. Single somatic plant cells in culture can be induced to 
shift their fate towards totipotency by application of exogenous auxins. The acquisition of the 
totipotent state coincides with the expression of the Somatic Embryogenesis Receptor Kinase 
(SERK). The main focus of this study is to unravel the signaling pathways in which the SERK 
proteins are involved.
In Chapter 2, the composition of the SERK1 signaling complex in vivo was investigated. Two 
other LRR-RLKs, the brassinosteroid insensitive 1 (BRI1) receptor and its co-receptor the 
SERK3 (BAK1) protein were identifi ed as interacting partners. In addition the kinase associ-
ated protein phosphatase (KAPP), CDC48A and 14-3-3ν were found. Finally, the MADS-box 
transcription factor AGL15 and an uncharacterised zinc-fi nger protein, member of the CON-
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STANS (CO) family were identifi ed as part of the SERK1 complex. The role of the SERK1 
receptor in BR signaling was also established. Collectively our results suggest that apart from 
SERK3 (BAK1) also SERK1 is involved in the brassinosteroid signaling pathway.
In Chapter 3, using a modifi ed and improved method for isolation of transmembrane recep-
tor complexes, the interacting partners of SERK3 and BRI1 were identifi ed. It appears that 
SERK1 and SERK3 share a similar, but not identical protein complex composition, in line 
with their genetically determined functions. 
In Chapter 4 the autophosphorylation activity of the kinase domains of the fi ve SERK mem-
bers was compared and the phosphorylated residues were identifi ed by LC-MS/MS. Differ-
ences in the activity that range from a high activity of SERK1, intermediate activities for 
SERK2 and SERK3 to the low activity of SERK4 and SERK5 proteins were noted. In the 
SERK1 kinase, residue Ser-562 was found to control the full authophosphorylation  activity. 
In vivo SERK1 phosphorylation was induced by brassinosteroids and seven in vivo phos-
phorylation sites were identifi ed. The trans-phosphorylation sites in BRI1 and SERK1 were 
detected and the importance of the kinase activity for the interaction between SERK1 and 
BRI1 was investigated.    
In Chapter 5 the role in the SERK1 protein complex of AGL15, 14-3-3ν and BRI1 proteins 
was investigated. The steroid hormone brassinolide, perceived by the BRI1 receptor and its 
co-receptor SERK1 was shown to be instrumental in changing the differentiated cell fate 
towards embryogenic competence in Arabidopsis explants. AGL15 was also involved in this 
process and was found to be a positive regulator of both somatic embryogenesis and brassi-
nosteroid signaling.  Upon BL-dependent nuclear translocation, mediated by the adaptor pro-
tein 14-3-3ν, the AGL15 protein was shown to be able to bind to the promoter elements of 
the BRI1 and SERK1 genes and most likely is a positive regulator of the expression of both 
genes. 
In Chapter 6, a summarizing discussion of the research presented in this thesis is provided. 
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Abstract
The Arabidopsis thaliana Somatic Embryogenesis Receptor Kinase 1 (SERK1) is a leucine-
rich repeat receptor-like kinase (LRR-RLK) involved in the acquisition of embryogenic com-
petence and in male sporogenesis. To determine the composition of the SERK1 signaling 
complex in vivo we generated plants expressing the SERK1 protein fused to the cyan fl uo-
rescent protein under control of the SERK1 promoter. The membrane receptor complex was 
immunoprecipitated from seedlings and the co-immunoprecipitating proteins were identifi ed 
using Liquid Chromatography / Matrix Assisted Laser Desorption Ionization-Time of Flight 
/ Mass Spectrometry (LC/MALDI-TOF/MS) of the trypsin-released peptides. This approach 
identifi ed two other LRR-RLKs, the brassinosteroid insensitive 1 (BRI1) receptor and its 
co-receptor the SERK3 or BRI1-associated kinase 1 (BAK1) protein. In addition the kinase 
associated protein phosphatase (KAPP), AtCDC48A and 14-3-3nu were found. Finally, the 
MADS-box transcription factor AGL15 and an uncharacterised zinc-fi nger protein, member 
of the CONSTANS (CO) family were identifi ed as part of the SERK1 complex. Using Blue 
Native Gel Electrophoresis we show that SERK1 and SERK3 are part of BRI1 containing 
multiple protein complexes with a relative mass between 300 and 500 kDa. The SERK1 
mutant allele serk1-1 enhances the phenotype of the weak BRI1 allele bri1-119. Collectively, 
these results suggest that apart from SERK3 also SERK1 is involved in the brassinolide sig-
naling pathway.
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Introduction
Membrane-located leucine-rich repeat receptor like kinases (LRR-RLKs) play important 
roles in plant signaling pathways. For example, the Arabidopsis CLAVATA1 (CLV 1), BRI1, 
ERECTA, rice Xa21, HAESA-RLK5 and FLS2 genes were shown to function in shoot mer-
istem maintenance, hormone perception, organ elongation, disease resistance, abscission and 
fl agellin signaling respectively (reviewed in (Torii, 2004). Extensive genetic and biochemi-
cal studies have been undertaken to identify additional components of different signaling 
pathways. For example negative and positive regulators of brassinosteroid (BR) signaling 
were identifi ed as the GSK-3/Shaggy-like kinase called Brassinosteroid Insensitive 2 (BIN2), 
(Li and Nam, 2002) and the nuclear-localized Ser/Thr phospatase bri1 Suppressor 1 family 
(Mora-Garcia et al., 2004), respectively. Their potential substrates are the nuclear proteins 
BRASSINAZOLE RESISTANT1 (BZR1) (Wang et al., 2002b) and bri1- EMS-SUPPRES-
SOR1 (BES1) (Yin et al., 2002). 
We have previously identifi ed the Arabidopsis Somatic Embryogenesis Receptor-like Kinase 
1, an LRR-RLK that marks formation of embryogenic cells in culture and is expressed in 
ovule primordia and in both male and female gametophytes. In sporophytic tissues SERK1 
has a complex expression pattern, with expression being highest in the vascular tissue of all 
organs (Hecht et al., 2001; Kwaaitaal, 2005; Albrecht, 2005). Ectopic expression of SERK1 
does not result in an obvious phenotype in Arabidopsis plants but increases somatic embryo 
formation in culture (Hecht et al., 2001). SERK1 is a member of a small family of fi ve related 
RLKs all of which have 5 LRRs and a typical serine-proline rich juxtamembrane region 
(Hecht et al., 2001). The SERK1 knock-out alleles serk1-1 and serk1-2 did not have a mor-
phological phenotype but in combination with a serk2 null mutant resulted in complete male 
sterile plants (Albrecht, 2005; Colcombet, 2005). SERK3 or BRI1-ASSOCIATED RECEP-
TOR KINASE 1 (BAK1) is part of the BR receptor complex and is proposed to function as 
a co-receptor of the BRASSINOSTEROID INSENSITIVE 1 (BRI1) protein (Li et al., 2002; 
Nam and Li, 2002). Recently we showed that in living plant cells BRI1 and SERK3 interac-
tion occurred in restricted areas of the membrane and recycled upon internalisation by endo-
cytosis (Russinova et al., 2004).
SERK1 was shown to interact with the Kinase Associated Protein Phosphatase (KAPP) that 
is postulated to play a role in receptor internalization (Shah et al., 2002). Employing a yeast 
two-hybrid screen, two additional SERK1 interacting proteins, AtCDC48A and 14-3-3λ were 
found (Rienties et al., 2005). These interactions suggested analogy with the mammalian 
CDC48 homologue p97/VCP complex, where p97/VCP can be phosphorylated by the JAK-2 
kinase and dephosphorylated by the phosphatase PTPH1 that associates with a 14-3-3 pro-
tein (Zhang et al., 1997; Zhang et al., 1999).  KAPP has also been reported to interact with 
other LRR-RLKs such as HAESA; WALL-ASSOCIATED KINASE1 (WAK1); FLS2 and 
CLAVATA1 (reviewed in (Becraft, 2002). Transgenic studies indicate that KAPP functions 
as a negative regulator of CLV1 and FLS2 signaling (Williams et al., 1997; Stone et al., 1998; 
Gomez-Gomez et al., 2001).
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 Identifi cation of proteins can now be performed at high sensitivity by specifi c proteolytic di-
gestion and determination of the peptide masses by Mass Spectrometry (MS). This technique 
has been used for a systematic study of multiprotein complexes. For the epidermal growth 
factor receptor (EGFR), a human receptor tyrosin kinase, immunoprecipitation combined 
with matrix-assisted laser desorption/ionisation MS (MALDI) was used to identify compo-
nents of the EGFR signaling complex (Pandey et al., 2000). For only a few plant RLKs the 
signaling complex has been defi ned. One example is the 105 kDa CLV1 receptor that is found 
in two distinct protein complexes of 450 and 185 kDa. The larger 450 kDa complex requires 
functional CLV1 and CLV3 proteins for assembly and includes KAPP and a Rho GTPase-
related protein (Trotochaud et al., 1999). 
In this study we have determined the composition of the SERK1 complex/es in vivo. We 
combined immunoprecipitation of CFP-tagged SERK1 with a rapid Liquid Chromatography 
(LC)-MALDI-MS based protein identifi cation. Using this method we confi rmed the presence 
in the SERK1 signaling complex of AtCDC48A (Rienties et al., 2005) and KAPP (Shah et al., 
2002). Additional proteins were found such as another member of the 14-3-3 family, 14-3-3nu, 
SERK3 (BAK1) and BRI1, the MADS-box transcription factor AGL15 and an uncharacter-
ised zinc-fi nger protein. In particular the interaction between SERK1 and BRI1 was con-
fi rmed by a genetic experiment and Fluorescence Lifetime Imaging Microscopy (FLIM) to 
determine Förster Resonance Energy Transfer (FRET) between fl uorescently tagged recep-
tors. Our data show that the method used here can distinguish between individual isoforms of 
related members of the same protein family, confi rms and extends previous screens carried 
out using the more commonly applied yeast two hybrid method to fi nd interacting partners.
Materials and Methods
Plant materials and growth conditions
Arabidopsis thaliana ecotype Columbia was used as the wild type. Seeds were surface steri-
lized and sown on germination medium (½ Murashige and Skoog (MS) salt and vitamins 
medium (Duchefa, Haarlem, The Netherlands) supplemented with 0.8 % (w/v) agar (Daishin) 
and 2 % (w/v) sucrose). Seeds were kept for 2 days at 4oC and then transferred to a growth 
chamber. Seedlings were grown at 22oC under 16 h light/ 8 h dark periods for 7 days. Arabi-
dopsis plants expressing the SERK1 receptor fused to cyan fl uorescent protein (CFP) under 
its native promoter were similar to the SERK1-yellow fl uorescent protein (YFP) expressing 
plants described previously by Kwaaitaal et al. (2005). The BRI1-GFP transgenic plants used 
for immunoprecipitation and BAK1-GFP plants used for BN-PAGE were described before 
(Russinova et al., 2004).  bri1-4 strong allele (nr 3953 obtained from Frans Tax – Arabidopsis 
stock center) were previously described by Noguchi et al., 1999.
Generation of bri1-119 serk1-1, bri1-119 serk3 and bri1-119 serk2-2 double mutants
The bri1-119 mutant was obtained from the Arabidopsis Biological Resource Center (Ohio 
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State University, Columbus, stock CS399, ecotype Enkheim-2) and was previously described 
by (Noguchi et al., 1999) and (Friedrichsen et al., 2000). The SERK1 and SERK3 knockout 
lines, serk1-1 and serk3, were obtained from the SIGnAL TDNA-Express collection (Alonso 
et al., 2003) as insertion lines SALK_544330 and SALK_034523.56.00 respectively and the 
serk2-2 insertion line (nr 119-G03) from the SAIL lines, previously described by Albrecht et 
al., 2005 in Columbia background. bri1-119 serk1-1 and bri1-119 serk2-2 were generated by 
crossing bri1-119 with serk1-1 or serk2-2, bri1-119 serk3 was generated by crossing bri1-119 
with serk3. In each case, the F1 was allowed to self-fertilize, and candidate double F2 plants 
were genotyped phenotypically and by PCR.
Transient expression in protoplasts and Fluorescence Lifetime Imaging Microscopy 
(FLIM)  
The full-length SERK1, SERK3 and BRI1-CFP and YFP fusion constructs were previously 
described (Shah et al., 2001b, Russinova et al., 2004). FLIM was performed using a Bio-
rad Radiance 2100 MP system in combination with a Nikon TE 300 inverted microscope 
as described before (Russinova et al., 2004). From the intensity images obtained, complete 
fl uorescence lifetime decays were calculated per pixel and fi tted using a double exponential 
decay model. The fl uorescence lifetime of one component was fi xed to the value found for 
SERK1-CFP (2.5 ns). 
Protein extraction, SDS-PAGE and Western Blot analysis
To prepare total protein extracts, plant material was ground in liquid nitrogen and thawed in 
extraction buffer containing 50 mM Tris pH 7.5, 150 mM NaCl and 0.5% Triton X-100, and 
a protease inhibitor cocktail according to the manufactures instructions (Roche, Germany). 
Samples were incubated on ice for 30 min. The suspension was centrifuged at 200g (Beck-
man-Microfuge 18 centrifuge) at 4 oC for 3 minutes. The concentration of extracted proteins 
was determined with the Biorad Protein assay (Biorad). After boiling 30 μg of total protein 
for 5 min in sample buffer containing 100mM Tris HCl at pH 6.8, 4% SDS, 0.2% bromophe-
nol blue, 20% glycerol and 100mM dithiothreitol (DTT) the proteins were separated on 8% or 
12% SDS polyacrylamide gels (Laemmli, 1970) and transferred onto nitrocellulose (Schleich-
er & Schuell, Germany) by wet electroblotting (Mini-Protean II system; Biorad). Proteins 
were analysed by immunoblotting with anti-GFP (IgG fraction, 1500 x diluted, Molecular 
Probes, The Netherlands) and a polyclonal antibody generated against the GST-SERK1 ki-
nase domain fusion protein (3000 x diluted, Rienties et al., 2005). Anti-BRI1 specifi c anti-
bodies were kindly provided by Joanne Chory, (the Salk Institute for Biological Studies, La 
Jolla, California USA and used at 1000 x dilution), anti-CDC48A antibodies (Rancour et al., 
2002) were kindly provided by Sebastian Bednarek, (University of Wisconsin, Department 
of Biochemistry, Madison, USA and used at 1000 x dilution), and-14-3-3 antibodies that have 
been previously described (Rienties et al., 2005). Bound primary antibodies were detected 
with horseradish peroxidase-conjugated IgG purifi ed donkey anti-rabbit at 10000 x dilution 
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(Rockland Laboratories) or goat anti-chicken at 5000 x dilution (Rockland Laboratories) sec-
ondary antibodies and visualized using reagents for chemiluminescent detection (ECL Plus 
reagent, Amersham Biosciences, England).
Blue Native Gel Electrophoresis
Preparation of microsomes and Blue Native Gel electrophoresis were performed as described 
(Rivas et al., 2002). Microsomes from 7d old seedlings from wild type plants or transgenic 
plants expressing the SERK1 promoter-SERK1-CFP construct were solubilized in extrac-
tion buffer supplemented with 750mM aminocaproic acid and incubated for 30 min on ice. 
Aliquots of supernatants were incubated with 0.5% Coomassie Brilliant Blue G 250, 5% v/v 
glycerol and loaded on gel. Blue native PAGE then was performed following according to 
(Schagger and von Jagow, 1991) on a 5 to 15% gradient polyacrylamide gel. Albumin bovine 
monomer (66 kD), albumin bovine dimer (132 kD), urease trimer (272 kD) and urease hex-
amer (545 kD) from Sigma, were used as marker proteins.
Immunoprecipitations
Routinely we used 4 plates (9 cm) with about 400 seven days old seedlings (100 per plate) 
to prepare a protein extract suitable for immunoprecipitation. Ten millilitres of total plant 
protein extract (1mg.ml-1) in extraction buffer (isolated as described above) were incubated 
for 1 hour at 4°C with 100μl 50% v/v protein A-Sepharose CL-4B beads slurry (Amersham 
Biosciences), in 50mM Tris, 150mM NaCl, pH 7.5. After centrifugation at 200g (Beckman-
Microfuge 18 Centrifuge) for 2 min at 4°C, the supernatant was incubated with 7μl of anti-
GFP, anti-BRI1, anti-14-3-3, anti-CDC48A or rabbit preimmune serum. After incubation with 
gentle mixing for 1 h at 4°C, 200μl of fresh 50% slurry of Protein A beads was added and 
incubation continued for 4 h.  Protein A beads were pelleted by centrifugation at 200g for 1 
min and the supernatant was removed. The beads were washed three times with 1 ml wash 
buffer (50 mM Tris pH 7.5, 150 mM NaCl) and once with 10mM NH4HCO3, pH 8. Before 
the last wash step the beads together with the wash buffer were moved to a new tube. After 
centrifugation, the wash buffer was removed and the beads were used in this form directly for 
digestion with trypsin and subsequent MALDI-TOF/MS analysis.
For immunodetection, the proteins were eluted from the beads by adding SDS sample buffer 
and boiling for 5 min at 95 °C. In case of co-immunoprecipitation of SERK1-CFP with rabbit 
anti-GFP antibodies and detection with rabbit anti 14-3-3 antibodies no DTT was included 
in the SDS sample buffer. This prevents separation of the heavy and the light chain of the 
antibodies and improved the resolution of the blots since the detection system also recognized 
immunoglobulins of which the light chain overlaps with the 14-3-3 proteins.
 
Protein Digestion 
Proteins bound to protein A beads in 50μl 10mM NH4HCO3 were incubated with 100ng 
trypsin (Sequencing Grade, Boehringer Mannheim, Germany). After overnight incubation 
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with gentle shaking at room temperature, the pH was decreased to 2 by adding trifl uoro-ace-
tic acid (TFA) in water up to 0.4% v/v. 
Liquid Chromatography and MALDI-TOF Mass Spectrometry Analysis
Fifty microliters of peptide sample was injected into a 100x 0.25 mm Prontosil 3 μm C18H 
column (prepared in house) and eluted at a fl ow of 4 μl/min with 5% v/v acetonitril in water 
containing 0.05% TFA. A gradient from 5% to 20% v/v acetonitril in water containing 0.05% 
v/v TFA was applied in 90 s, followed by a slower linear increase to 40% v/v acetonitril in 
water containing 0.05% v/v TFA in another 4 min. (Alliance 2690 running at 0.25 ml/min 
equipped with a fl ow splitter, Waters, the Netherlands). Samples were directly collected onto 
a sample plate (MTP AnchorChip 200/384, Bruker Daltonics, Germany) in fractions of 15 s 
taking into account the system gradient delay time and column volume before starting col-
lecting. After air-drying, 1μl of a 20x diluted α-cyano-4-hydroxy-cinnamic acid solution was 
added to each spot. This solution was prepared by diluting a saturated α-cyano-4-hydroxy-
cinnamic acid solution (prepared in 50% v/v acetonitril, 49% v/v water, 1% v/v TFA) 20 
times into the same solution. Sample spots were recrystallized by applying 1.5 μl of 60% v/v 
ethanol, 30% v/v acetone, 10% v/v water and 0.1% v/v TFA to all samples and allowing them 
to air-dry. Mass spectra were measured with Bruker Ultrafl ex MALDI-TOF/MS equipped 
with a refl ectron (Bruker Daltonics, Germany) in positive mode with a high precision method. 
Spectra were measured after external quadratic calibration with a peptide standard mixture 
containing 9 peptides in the mass range between 757 and 3146 Da (Bruker Daltonics, Ger-
many). In general, spectra were summed for about 500 – 1000 laser pulses (20 Hz, N2-laser at 
337 nm) and internally recalibrated with Protein A derived peptides and/or trypsin autolysis 
peaks when present. All m/z values also present in the control peptide sample were subse-
quently removed from the m/z list obtained for the immunoprecipitated SERK1 protein com-
plex. Remaining m/z values were checked for sodium and/or potassium adducts (difference 
of 22.990 and 38.946 Da respectively). When found, these m/z values were deleted too. For 
identifi cation of SERK1 the program GPMAW (http://welcome.to/gpmaw/) was used to de-
termine which m/z values correspond to tryptic peptides from the predicted protein sequence 
of SERK1. These selected m/z values were used as input for the MASCOT program to search 
either the Arabidopsis database or all entries, without selecting a taxonomy. Posttranslational 
modifi cations phosphorylation (of serine, threonine and tyrosin) and oxidation of methionines 
were allowed and a peptide m/z tolerance of 100 ppm was used. After identifi cation, the m/z 
values that matched the SERK1 protein were removed from the list before searching for other 
proteins.  Alternatively, the searches were performed with the complete m/z list directly using 
the MASCOT search engine (http://www.matrixscience.com) (Perkins et al., 1999). 
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Results
Immunoprecipitation and detection of SERK1-CFP protein 
In order to purify and detect the SERK1 protein and its interacting partners directly from 
seedlings, C-terminal SERK1-CFP fusion proteins were stably expressed in Arabidopsis wild 
type plants under control of the SERK1 promoter as described by (Kwaaitaal et al., 2005). 
The expression pattern of SERK1-CFP was identical to the expression pattern of a previ-
ously characterized SERK1-YFP protein (Kwaaitaal et al., 2005). Similar to SERK1-YFP ex-
pressing plants no unusual phenotype was observed, while introduction of the same SERK1 
promoter-SERK1-CFP construct as used here in the SERK1 knock-out mutant background 
restored the male sterility phenotype of the double serk1-1 serk2-2 mutant (Albrecht et al., 
2005). This confi rms that the fusion protein did not interfere with its endogenous counterpart 
and was fully functional. Total proteins extracted from 7 day old SERK1-CFP expressing 
seedlings were separated on SDS-PAGE and after blotting on a membrane, the fusion pro-
teins were detected with anti-GFP antibody (Figure 1, lane 1). The same protein extract was 
detected with anti-GST-SERK1 kinase antibodies, that recognize endogenous SERK1 as well 
as the SERK1-CFP fusion proteins, confi rming the specifi city of the anti-GFP antibodies 
(Figure 1, lane 2). After immunoprecipitation an aliquot was analysed with anti-GFP anti-
body to confi rm that SERK1-CFP was indeed recovered in the immunoprecipitation. A band 
of 100 kDa was recognized only in protein extracts of the transgenic line (Figure 1 lane 4) 
and not in extracts of wild type seedlings (Figure 1, lane 3). 
Figure 1. Detection of SERK1 and SERK1-CFP from wild type and transgenic plants.Total protein 
extracts from SERK1-CFP transformed seedlings and wild type seedlings were immunoprecipitated 
(IP) with anti-GFP antibodies. Thirty μg of total protein extracted from SERK1-CFP seedlings (lane 1 
and 2) and the IP products from SERK1-CFP seedlings (lane 4) and wild type (lane 3) were separated 
on a 10% SDS-PAGE gel. The blots were incubated with anti GFP antibodies (lanes 1, 3 and 4) or with 
anti-GST-SERK1 kinase antibodies (lane 2). The size of the marker proteins is indicated by arrows.
1 2 3 4 
100 kD 
75 kD 
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LC/MALDI-TOF/MS identifi cation of SERK1 and its interacting partners in vivo
To identify proteins that bind to SERK1 as extracted from SERK1-CFP expressing seedlings 
we subjected the immunoprecipitated proteins (bound to the protein A-Sepharose beads) to 
trypsin digestion. To reduce the infl uence of ion suppression effects in MALDI-TOF/MS 
measurements and obtain more peptide peaks, separation of the tryptic peptides by reverse 
phase column chromatography was performed before subjection to MALDI-TOF/MS meas-
urements. As a negative control, samples obtained from an immunoprecipitated protein ex-
tract from wild type seedlings with anti GFP antibody were analysed in the same way by 
LC/MALDI-TOF/MS.
A representative LC/MALDI-TOF/MS spectrum, recorded for fraction 9 from the 24 LC 
fractions obtained after trypsin digestion of the immunoprecipitated SERK1 complex is 
shown in Figure 2A. In Figure 2B a spectrum recorded for fraction 9 of the trypsin-digested 
immunoprecipitated negative control extract is shown. All mass over charge (m/z) values 
also present in the negative control, that is values belonging to Protein A, GFP antibodies 
and proteins aspecifi cally immunoprecipitated by the GFP antibodies were removed from the 
m/z list. The remaining values were then compared with the predicted tryptic peptide masses 
for the Arabidopsis proteome as described in Materials and Methods. The upper panels of 
Figure 2C, 2D, 2E and 2F show four representative spectra, expanded from the spectrum 
shown in Figure 2A, that led to the identifi cation of the SERK1 interacting partner 14-3-3nu. 
Both peaks with m/z of 1492.7 (Figure 2C) and 1611.8 (Figure 2E) are predicted with one 
phosphorylated residue present. The peak with m/z value of 1531.8 (Figure 2D) has the same 
predicted peptide sequence as the one predicted for m/z of 1611.8 (Figure 2E), but without 
phosphorylation of the serine residue. The same peptide sequence but now extended due to 2 
missed tryptic cleavage sites is predicted for the peak with a m/z value of 1716.8 (Figure 2F). 
All lower panels of Figure 2C-F show the corresponding expanded spectra recorded for the 
negative control sample shown in Figure 2B. The combined results of comparable analysis 
carried out for the list of remaining m/z values were used to compile the list of identifi ed 
proteins as presented in Table 1. As expected the SERK1 protein was identifi ed to be part of 
the complex. This identifi cation was based on 13 tryptic peptide matches and a Mascot score 
of 84. All of the peptides found covered the kinase domain of SERK1 and are located on the 
exterior of the protein including the phosphorylated peptides based on structural model for 
SERK1 protein (Shah et al., 2001a). None of the peptides were matching the sequence of the 
extracellular domain, which may be due to post-translational modifi cation by glycosylation 
(Shah et al., 2001b) or the presence of two disulfi de bounds between the four cysteines present, 
making trypsin digestion more diffi cult. One peptide could be identifi ed in which oxidation 
of methionine had occurred, while three other peptides were identifi ed that were modifi ed by 
phosphorylation. The second receptor in the SERK1 complex was identifi ed as the SERK3 or 
BAK1 protein. LC/MALDI-TOF/MS fi ngerprint analysis revealed tryptic peptide m/z values 
from both SERK1 and SERK3, but because of the high homology in their protein sequences 
(78%) 8 out of 13 of the predicted m/z values are matching with the sequence of both proteins. 
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Five peptides unique for SERK3 were identifi ed, 3 without and 2 with modifi cation by phos-
phorylation. By inspecting the model of the SERK1 protein structure four of the fi ve SERK3-
specifi c peptides identifi ed are from a region also yielding peptides used for identifi cation of 
the SERK1 protein. This fi nding corroborates the identifi cation of SERK1 and SERK3. For 
SERK2, which is 90% homologous to SERK1 on the protein level, fi ve m/z values are identi-
cal for both proteins. No m/z values unique for SERK2 were found. The third receptor found 
in the SERK1 complex was the BRASSINOSTEROID INSENSITIVE 1 (BRI1) receptor (Li 
and Chory, 1997) identifi ed on the basis of 17 peptides, most of them covering the kinase 
domain. Most of the peptides identifi ed with phosphorylations were also found as non-phos-
phorylated or as oxidized peptides, which provide additional evidence for identifi cation as the 
BRI1 protein. Since SERK3 (BAK1) is reported to be the co-receptor of BRI1 (Li et al., 2002; 
Nam and Li, 2002), the presence of both these receptors suggests that there is a direct link be-
tween SERK1 activity and brassinolide signaling. In addition to SERK1, SERK3 and BRI1, 
several proteins were found that were previously reported to be interacting with SERK1 and 
therefore were expected to be present in the SERK1 immunoprecipitated complex. One of 
them is the Arabidopsis kinase associated protein phosphatase (KAPP). KAPP was shown to 
interact only with a catalytically active kinase domain of SERK1, involving Thr-468 (Shah 
et al., 2001a). In a yeast two-hybrid screen two other proteins were found to interact with the 
kinase domain of SERK1, CDC48A and 14-3-3λ (Rienties et al., 2005). MALDI-TOF/MS 
fi ngerprint analysis indeed revealed tryptic peptides derived from CDC48A (Table 1). In our 
search 14-3-3nu, rather then 14-3-3λ was identifi ed with a high score after searching even with 
the complete m/z list. Apparently only these two members of the large Arabidopsis family 
of 14-3-3 proteins can interact with the SERK1 receptor. Finally, two unexpected proteins 
were found. The fi rst is the MADS box transcription factor AGL15 (Heck et al., 1995) and a putative 
CONSTANS-like B-box zinc fi nger protein (At2g33500). The zinc fi nger protein is annotated 
as one large 401 aa protein and also as a shorter protein of 186 aa. We only found peptides 
covering the shorter protein. To validate that the proteins as found above indeed interacted 
with the SERK1 protein, we treated control samples with SDS or with 0,5 M NaCl prior to 
co-immunoprecipitation in order to destroy protein-protein interactions. The resulting list of 
m/z values revealed only the presence of the SERK1 protein (results not shown). Finally, we 
employed our co-immunoprecipitation procedure to the GFP-tagged BRI1 receptor and to the 
GFP-tagged integral membrane protein PIN1. For BRI1, the resulting m/z lists did not reveal 
the presence of any of the SERK1 interacting proteins as listed in Table 1 (results not shown). 
We therefore conclude that the coimmunoprecipitation/LC/MALDI-TOF/MS procedure for 
identifying protein complexes in Arabidopsis as presented here is reliable and identifi es spe-
cifi c interacting partners.
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Protein name At number
 
  
 
 Protein size
(kD) 
Number of
peptides identified
Sequence
coverage (%)
Mascot Score
obtained
Conformation from
additional experiments
SERK1
SERK3
BRI1
KAPP
CDC48A
14-3-3nu
AGL15
Zinc finger
protein
At1g71830
At4g33430
At4g39400
At5g19280
At3g09840
At3g02520
At5g13790
At2g33500
13
13
17
18
14
12
7
11
15
17
9
25
19
23
37
45
84
96
76
102
80
110
62
195
69
68
130
65
89
30
30
21
IP
FRET
CoIP, FRET
FRET, Y2H
CoIP, Y2H, FRET
CoIP
ND
ND
Table 1.  SERK1-interacting proteins identified by MALDI-TOF-MS. The proteins identified in the 
SERK1complex all have a MASCOT score over 60 and were grouped according to postulated function. 
Interactions were confirmed using co-immunoprecipitation (CoIP), in case of SERK1 alone by immu-
noprecipitation (IP), yeast-twohybrid interaction  (Y2H), (Rienties et al., 2004) and by detection of FRET, 
which is indicative of protein proximity in transient protoplast transfection assays (Sha et al., 2002; 
Rienties et al., 2004; Aker et al., 2006 and this study). ND is not determined.
BRI1, SERK3, CDC48A and 14-3-3nu interact in vivo with SERK1  
To confi rm our results obtained by LC/MALDI-TOF/MS we employed co-immunoprecipi-
tation and FLIM based analysis to detect the interaction between SERK1 and its interact-
ing partners in vivo. CFP-tagged SERK1 protein was immunoprecipitated with anti-GFP 
antibodies and the precipitated proteins were detected using anti BRI1 antibodies. A band 
with the expected mobility of BRI1 was visualized (Figure 3A, lane 1), that was absent in an 
immunoprecipitation of wild type plants with the GFP antibody (Figure 3A, lane 2). BRI1 
antibodies recognize endogenous BRI1 as well as BRI1-GFP fusion proteins, and can pre-
cipitate BRI1 from a total plant protein extract (Figure 3B, lane 1-3). BRI1 antibodies are 
specifi c for BRI1, since they do not detect a band with the expected mobility for BRI1 in 
the protein extract from strong bri1-4 allele homozygous plants (data not shown). Recipro-
cal co-immunoprecipitation with anti BRI1 antibodies revealed the presence of SERK1-CFP 
in the co-immunoprecipitated proteins (Figure 3C, lane 1). Previously we have shown that 
FRET can be detected between the cyan and yellow fl uorescent GFP variants (CFP and YFP) 
of SERK3 and BRI1 when transiently expressed in cowpea protoplasts. Co-expression of 
BRI1 and SERK3 results in a change of the steady-state distribution of both receptors due to 
accelerated endocytosis (Russinova et al., 2004). To determine whether the SERK1 protein 
can form heterodimers with either BRI1 or SERK3 in the plasma membrane we employed 
a similar transient assay in protoplasts to detect FRET by FLIM. In Figure 3D, we show the 
fl uorescence intensity images of protoplasts transfected with SERK1-CFP alone (Figure 3 D-
I) , SERK1-CFP together with BRI1-YFP (Figure 3 D-II) and of SERK1-YFP together with 
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Figure 2. LC/MALDI-TOF/MS obtained after trypsin digestion of SERK1-GFP immunoprecipi-
tated complex.
(A). MALDI-TOF/MS spectra from SERK1-CFP immunoprecipitated complex (upper panel, fraction 
number 9 out of 24) compared to corresponding spectra (fraction number 9) from the control IP per-
formed with wild type plants (B). The spectra were obtained after LC separation from the trypsin-di-
gested proteins after IP. The X-axis represents m/z (mass over charge) values. The Y-axis represents 
the intensity of the peaks in arbitrary units. (C), (D), (E), (F). Four representative spectra expanded 
from A (upper panels) and B (lower panels), which led to identifi cation of one of the SERK1 interact-
ing partners 14-3-3nu are shown. The corresponding predicted peptides are also shown. The peaks are 
present only in the spectra from SERK1-CFP immunoprecipitation (upper panel) and not in the control 
(lower panel). 
SERK3-CFP (Figure 3 D-III). The corresponding fl uorescence lifetime images are compared 
in Figure 3 D-IV to VI. The results presented in Figure 3 D-V show that SERK1 and BRI1 
heterodimerize in small patches in the plasma membrane as indicated by the signifi cant re-
duction in the average lifetime (τ) from 2.5 to 2.1ns of the donor (SERK1-CFP) molecules in 
those areas indicated by an arrow. A similar phenomenon was described for the SERK3/BRI1 
heterodimers (Russinova et al., 2004). SERK1-YFP also formed heterodimers with SERK3-
CFP protein in the plasma membrane as shown by the green coloured plasma membrane in 
Figure 3 D-VI that corresponds to an average lifetime of 1.9 ns for the donor (SERK3-CFP) 
molecules. Thus, the co-localization in the plasma membrane and the ability to form het-
erodimers in plant protoplasts strongly suggest that SERK1, SERK3 and BRI1 proteins can 
be part of the same complex in intact plant membranes. To confi rm the in vivo interaction 
of CDC48A with SERK1, we co-immunoprecipitated SERK1 from Arabidopsis tissue-cul-
tured cells with anti GST-SERK1 kinase antibodies (Rienties et al., 2005). The precipitated 
proteins were analysed by immunoblotting using anti CDC48-antibodies (Rancour et al., 
2002). A band with the expected mobility for monomeric CDC48A was detected in the total 
protein extract (Figure 4A, lane 1), and in the immunoprecipitated sample (Figure 4A, lane 
3), showing that AtCDC48A indeed co-immunoprecipitates with SERK1. No CDC48A band 
was detected in the negative control using rabbit preimmune serum for immunoprecipitation 
(Figure 4A, lane 2). Similarly the presence of a 14-3-3 protein in the complex with SERK1 
in vivo was verifi ed by co-immunoprecipitation with GFP antibodies of CFP-tagged SERK1 
followed by immunodetection with anti 14-3-3 antibodies (Figure 4B, lane 1). No 14-3-3 band 
was detected in the negative control using wild type seedlings for immunoprecipitation (Fig-
ure 4B, lane2). The 14-3-3 antiserum can recognize in vitro produced 14-3-3nu protein (data 
not shown) as well as 14-3-3λ, confi rming that SERK1 can interact with both 14-3-3λ (Rien-
ties et al., 2005) and 14-3-3nu isoforms (this study). A summary of the experiments providing 
additional evidence for the presence of proteins in the SERK1 complex is shown in Table 1.
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Figure 3. Direct interaction of SERK1 with BRI1 and SERK3 
(A). Total protein extract from SERK1-CFP transgenic seedlings was immunoprecipitated using anti-
GFP antibodies (lane 1). As a negative control proteins extracted from wild type plants were precipitat-
ed using anti GFP antibodies (lane 2). (B) Total protein extracts from BRI1-GFP transgenic seedlings 
(lane 1) and wild type (lane2) and immunoprecipitated products from wild type seedlings (lane 3) were 
separated on 8% SDS-PAGE gel and were detected using anti BRI1-antibodies. (C) Protein extract 
from SERK1-CFP transgenic plants was precipitated using anti BRI1-antibodies (lane 1). As a negative 
control protein extract from wild type plants was precipitate with the same antibodies (lane2). The re-
sulting immunoprecipitates were separated on 8% SDS-PAGE, transferred to a membrane, and probed 
with anti-GFP for detection of SERK1-CFP fusion proteins (C) or anti-BRI1 antibodies for detection of 
BRI1 protein (A and B). Arrows indicate the size of the marker proteins. (D) FRET between SERK1, 
SERK3 and BRI1 imaged by FLIM on cowpea protoplasts transiently expressing SERK1-CFP (I and 
IV), BRI1-YFP/SERK1-CFP (II and V) and SERK3-CFP/SERK1-YFP (III and VI) for 16 hours. The 
fl uorescence intensity images representing a steady state of the donor SERK1-CFP or SERK3-CFP 
fl uorescence are presented in (I), (II) and (III) respectively. The mean fl uorescence lifetime values (τ) 
and the lifetime distribution for the images in (I), (II) and (III) are presented as pseudocolour images 
in (IV), (V) and (VI). The arrowhead points to an area with a short lifetime, indicative for FRET. 
Note the colour bar where dark blue colour is used to display a τ -of 2.5 ns (no interaction) and light 
green (τ)- of 1.9 ns (interaction). The red to dark orange colour corresponding to a τ-of 1.5 ns is due to 
autofl uorescence effects.
SERK1 Genetically Interacts with BRI1 
Analysis of the single T-DNA insertion mutant serk1-1, an allele that produces a kinase-dead 
receptor protein, did not reveal a morphological plant phenotype as well as serk2-2 (Albrecht 
et al., 2005). We therefore crossed the serk1-1 allele into the weak BRI1 mutant allele bri1-119. 
This allele contains the G644D missense mutation in the island domain of BRI1 (Fredrichsen 
et al. 2000). At the seedling level 7-day old bri1-119 mutants exhibit mild morphological char-
acteristics of the bri1 phenotype such as small seedlings, short petiols and round, dark green, 
inwardly curved true leaves (Figure 5A). Bri1-119 plants developed smaller, compact rosettes 
(Figure 5D) as compared to the wild type. The weak bri1-119 allele is a semi-fertile dwarf that 
has less reduced stature (Figure 5D) when compared to severe bri1 alleles (Noguchi et al., 
1999). The serk1-1 mutation clearly enhanced all BRI1 associated phenotypes, especially the 
length of the petioles and excessive inward curling now seen in double mutant (bri1-119 serk1-
1) of 7d old seedlings (Figure 5B), as well as a reduction in size of the rosette (Figure 5E). The 
stature of the double bri1-119 serk1-1 mutant was also reduced (Figure 5H). For comparison, 
we also introduced the serk3 mutation (Russinova et al., 2004), an allele of the BAK1 co-re-
ceptor, into the bri1-119 mutant. The resulting bri1-119 serk3 double mutant had even smaller 
rosette (Figure 5F) and grew with a severely reduced stature (Figure 5I) resembling strong 
bri1 alleles, indicating that serk3 mutation had even stronger effect on the bri1-119 mutation 
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than serk1-1. In comparison with serk1-1 and serk-3 bri1-119 double mutants serk2-2 mutant 
allele (Albrecht et al., 2005) had no effect on bri1-119 mutation, showing that the effect of the 
double serk1-1 and serk3 bri1-119 mutants is not infl uenced from the two different ecotypes 
used (Columbia for serk1-1, serk2-2 and serk3 and Enkheim-2 for bri1-119). These results 
provide genetic evidence that SERK1 is involved in BRI1 signaling and confi rm the role of 
the SERK3 (BAK1) gene as a BRI1 co-receptor. 
Figure 4. SERK1 interacts in vivo with AtCDC48A and 14-3-3(A). Co-immunoprecipitation of 
SERK1 and AtCDC48A. Total protein extract was isolated from Arabidopsis tissue cell culture and 
directly analysed by SDS-PAGE and immunodetected with anti-CDC48 antibody (lane 1) or immuno-
precipitated with anti- SERK1-kinase antibody (lane 3) or preimmune sera (lane 2) and detected with 
anti AtCDC48 antibody. (B). Co-immunoprecipitation of SERK1 and 14-3-3. Total protein extract was 
isolated from SERK1-CFP transgenic plants (lane 1) or wild type plants (lane 2) and precipitated with 
GFP antibody. Precipitated proteins were immunodetected with anti 14-3-3 antibodies. The size of the 
marker proteins is indicated by arrows.
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Identifi cation of a Membrane-Associated SERK1-Containing Complex using Blue Na-
tive PAGE 
In previous studies, we have shown that SERK1 is located at the membrane in protoplasts 
and in plants (Russinova et al., 2004; Kwaaitaal, 2005), and can directly interact in vitro 
and in vivo with KAPP and 14-3-3λ , and in vitro with CDC48A (Shah et al., 2002; Rienties 
et al., 2005). Our results presented here confi rm the previously observed interactions and 
showed that SERK1 can be present in a complex with several other proteins. It is not clear if 
the SERK1 complex harbors all of the proteins listed in Table 1 at the same time or that we 
immunoprecipitated multiple forms of the SERK1 complex. Different forms could exist in 
different cell types or in different subcellular locations such as plasma membrane or after in-
ternalization (Russinova et al., 2004). To determine the size of the SERK1 complex in planta, 
microsomal preparations from SERK1-CFP and BAK1-GFP expressing seedlings and wild 
type seedlings were solubilized with Triton X-100 and subjected to blue native (BN) PAGE. 
In this technique, coomassie dyes and aminocaproic acid are employed to induce a charge 
shift and improve the solubilization of membrane-associated proteins (Rivas et al., 2002). 
To detect SERK1 within the potential protein complex, single lanes of the BN-PAGE were 
cut and mounted on a denaturing SDS gel. After electrophoresis the gel was subjected to im-
munoblot analysis using anti-GFP-antibody or anti-GST-SERK1 kinase antibody. Using the 
mass standards about 85 % of the protein complex containing SERK1 was determined to have 
a mean relative mass of 350 kDa. The remaining 15% appears to exist as complex with a mean 
mass of 450 kDa. The maximum size is approximately 500 kDa (Figure 6A). This variability 
in protein complex size is also seen when the tagged- SERK1-CFP complex is detected by 
anti-GFP antibodies (Figure 6B). About 90 % of the CFP-tagged complex has a mean mass 
of 400 kDa and 10 % has a mass of about 500 kDa. Although there is a clear difference in the 
mean size of the complex with and without the CFP tag we cannot precisely estimate if this 
difference is 25 kDa (one molecule of CFP protein) or 50 kDa (two molecules of CFP protein). 
The results show that there is one abundant “core” complex for SERK1 of about 350 kDa. We 
fi rst examined whether BRI1 was part of the “core” SERK1 complex. A microsomal fraction 
prepared from SERK1-CFP transgenic plants was therefore examined for the presence of 
BRI1 proteins. BRI1 was found in complex with the same size range of 400 to 500 kDa (Fig-
ure 6C1) as the SERK1-CFP proteins. In contrast to SERK1, most of the BRI1 protein was 
found as probably a homodimeric form of approximately 250 kDa (Figure 6C2). The occur-
rence of potential BRI1 homodimers is consistent with our observation of BRI1 homodimeri-
zation observed in protoplast (Russinova et al., 2004) and was recently shown in plants (Wang 
et al., 2005a). The observed smaller and higher forms of BRI1 are probably due to recognition 
of differentially processed forms (Figure 6C). The distribution of BAK1 in the microsomes 
prepared from BAK1-GFP transgenic plants was then studied by BN-PAGE. BAK1-GFP was 
found in complex(es) with the same size range as the SERK1-CFP proteins (Figure 6D). 
These data suggest that BRI1, SERK1 and SERK3 are indeed present in the main 350 kDa 
“core” complex and are also present in complexes of higher molecular mass. No signal was 
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detected when solubilized microsomes from wild type seedlings were analyzed for the pres-
ence of GFP, confi rming that the observed signal in Figure 6B and 6D are indeed derived 
from microsomal SERK1-CFP or BAK1-GFP proteins (Figure 6E). Collectively, the results 
obtained from the BN-PAGE suggest that the “core” SERK1 complex of approximately 350 
kDa as well as the larger complexes consist of the membrane receptors SERK1, SERK3 and 
BRI1. Assuming that all proteins listed in Table 1 are present as monomers, a predicted size 
of about 500 kDa is obtained. Although this is about the maximum size of the SERK1complex 
as estimated by BN-PAGE, it exceeds the size of the predominant complex of 350 kDa. 
In summary, we propose that in Arabidopsis seedlings a “core” SERK1 membrane complex 
consists of SERK1, BRI1 and SERK3. Collectively this would account to approximately 270 
kDa when all proteins are present as monomer or between 350 and 400 kDa in a more con-
ventional tetrameric arrangement. This is clearly in range of the observed sizes of BN-PAGE 
gels. KAPP is only interacting with the active SERK1 receptor (Shah et al., 2002) and could 
represent one of the lesser abundant higher Mr forms. 
Discussion
In this work we have used a combination of co-immunoprecipitation based on the GFP vari-
ant CFP as a protein tag and LC/MALDI-TOF/MS to identify proteins associated with the 
membrane receptor SERK1. Based on our data with other membrane proteins from Arabi-
dopsis this technique appears to be of general use. When compared with other techniques to 
identify interacting proteins such as in vitro pull-down assays and yeast two-hybrid screen 
the main advantage is that the immunoprecipitation combined with LC/MALDI-TOF/MS al-
lows protein complex isolation under native conditions, therefore allows functional studies in 
which the activity or post-translational modifi cation of one or several proteins in the complex 
can be examined (Drewes and Bouwmeester, 2003). Another advantage is that the CFP tag 
allows directly following all subcellular localisations of the fusion proteins. This allows pre-
dictions concerning the nature of the proteins recovered, especially in the case of membrane 
receptors undergoing recycling (Russinova et al., 2004). Other tags have been employed such 
as tandem affi nity purifi cation (TAP) tags for plant protein complex isolation in a transient 
expression system or in stably transformed transgenic lines, using the caulifl ower mosaic 
virus 35S promoter (Rohila et al., 2004; Rubio et al., 2005). Our procedure differs in several 
aspects; we have used an endogenous promoter-based construct and only employed CFP as a 
protein tag, thereby minimising potential biological problems arising from the use of strong 
constitutive promoters. Also, we have used integral membrane protein as bait rather then 
soluble proteins so far employed.
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bri1-119 bri1-119 serk1-1 bri1-119 serk3
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Figure 5. SERK1, SERK3 and BRI1 function together. serk1-1 and serk3 mutations enhance the 
weak bri1-119 mutation. 7-day old seedlings are shown in A, B and C. 3-weeks old plants are shown in 
D, E and F and 6-weeks old plants in G, H and I. (A, D and G) bri1-119, (B, E and H) bri1-119 serk1-1 
and (C, F and I) bri1-119 serk3 mutations. Note the increase in the curliness of the fi rst true leaves and 
reduction in the petiole length in the double mutant seedlings as well as the reduced rosette width of 
the double mutant plants.
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Figure 6. BN-PAGE of solubilized WT and SERK1-CFP microsomes. 
Microsomes were isolated from wild type plants (A, E) and SERK1-CFP  (B and C) or BAK1-GFP (D) 
expressing transgenic plants and subjected to BN- PAGE in the fi rst dimension and SDS-PAGE in the 
second dimension. Proteins were immunodetected using anti SERK1-kinase antibodies (A) or anti GFP 
antibodies (B, D and E) or anti BRI1 antibodies (C). C1 is part of the membrane exposed for 3h and C2 
is part of the same membrane exposed for 3min. The molecular masses of standard proteins used are 
indicated at the top (BN-PAGE) and on the right (SDS-PAGE). Arrowheads in (A) indicate the positions 
of main SERK1 complex sizes of 350 and lower amount of 450 kDa and in (B) the positions of the main 
SERK1-CFP complex of 400 and the lower amount of 500 kDa. Arrowheads in (C) indicate the posi-
tion of the main BRI1 complexes of 250, 350 and 450 kDa (C) and in (D) indicate the main BAK1-GFP 
complexes ranging from 350 kDa to 450 kDa.
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SERK1 and brassinosteroid signaling
A highly interesting fi nding was to identify two members of the brassinosteroid (BR) sign-
aling pathway, the main BR receptor BRI1 (Li and Chory, 1997) and its co-receptor BAK1 
(SERK3) (Li et al., 2002; Nam and Li, 2002) as components of the SERK1 complex. This im-
plies that SERK1 is a so far unrecognized element of BR signaling. Recently we showed that 
the SERK3 receptor may have a role in internalisation of the BRI1 protein after heterodim-
erisation and that BRI1 can also form homodimers in the plasma membrane (Russinova et al., 
2004). Further biochemical evidence comes from the fi nding that BRI1 and SERK1 as well 
as SERK1 and SERK3 can interact in the plasma membrane of protoplasts (this study). FRET 
studies between SERK1-CFP and SERK1-YFP have shown that only 15% of SERK1 exists 
as homodimers on the plasma membrane of protoplast cells (Shah et al., 2001b). Our results 
showed that both SERK1 and SERK3 heterodimerize with the BRI1 receptor suggesting that 
both co-receptors can have a comparable activity in terms of BRI1 signaling and/or internali-
zation. Another piece of evidence is that a bak1 null allele shows less severe phenotypes than 
bri1 loss-of-function alleles indicating that partially redundant activity could be attributed to 
different SERK family members (Li et al., 2002; Nam and Li, 2002). Genetic analysis of the 
serk1-1 bri1-119 double mutants suggests that SERK1-BRI1 interactions indeed affect BRI1-
mediated signaling in planta, but to a lesser extend than SERK3-BRI1 interactions. Notably, 
none of the proposed downstream components of BRI1, such as BES1, BZR1, or BIN2 (Yin et 
al., 2002; Wang et al., 2002b; Li and Nam, 2002) were detected in the SERK1 complex.
It is unlikely that all proteins (as identifi ed by MALDI-TOF/MS) listed in Table 1 are present 
in a complex together with SERK1 at the same time. Especially since proteins such as recep-
tors and CDC48A (Rancour et al., 2002; Rancour et al., 2004) are known to shuttle between 
mono and multimeric forms and can change their interaction properties upon activation and 
relocalization, multiple forms of the same complex are to be expected. An indication for the 
presence of different complexes is the localization of SERK1 in the plasma membrane as well 
as in internalised membrane compartments (Russinova et al., 2004; Kwaaitaal, 2005 ).      
It was proposed that BRI1 forms heterodimers with SERK3 to initiate brassinosteroid signal-
ing upon BR binding (Nam and Li, 2002; Li et al., 2002). This was recently confi rmed in an 
elegant demonstration of the in vivo phosphorylation properties of the BRI1 receptor (Wang et 
al., 2005b). In that work it was clearly shown that the interaction between the BAK1 (SERK3) 
proteins and BRI1 is brassinolide dependent. Since we did not apply exogenous ligands be-
fore isolation of the SERK1 complex, it is likely that only a small fraction of the complexes 
we isolated are actively signalling via the SERK1 protein. This seems to be supported by the 
fact that most of the BRI1 receptors were found to be unassociated with SERK1 in seedlings. 
Although our results do not allows us to precisely predict the composition, it is likely to as-
sume that SERK1, SERK3 and BRI1 receptors can form tetrameric complexes in analogy 
to the functional complex of TGF- β receptors. Each type of TGF- β receptor is also present 
as a ligand-independent dimer on the cell surface. TGFβ binding to the TβRII homodimers 
promotes the formation of (TβRI)2/(TβRII)2 heterodimers where TβRI is phosphorylated by 
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the constitutively active TβRII and becomes activated to propagate the TGFβ signal. Combi-
natorial interactions in the tetrameric receptor complex allow differential ligand binding or 
differential signaling in response to the same ligand. One receptor combination often binds 
different ligands, and patterns of ligand and receptor expression dictate which receptor-ligand 
combination are activated (Feng and Derynck, 1997). This so-called tetrameric model was 
also recently proposed for BRI1 and BAK1 (SERK3) (Wang et al., 2005a).  
Other SERK1 complex components  
The presence of the PP2C phosphatase KAPP, the 14-3-3nu protein and CDC48A in the SERK1 
complex confi rm previously obtained results using yeast two hybrid screening and in vitro 
interaction studies (Rienties et al., 2005). Collectively, these proteins appear to be involved 
in dephosphorylation, protein interaction and membrane interaction and protein degradation 
respectively. It is likely that these proteins represent receptor maintenance or traffi cking func-
tions. Previously it was shown that SERK1 could interact with 14-3-3λ (Rienties et al., 2005). 
Our results presented here suggest that in seedlings the receptor preferentially interacts with 
14-3-3nu and perhaps in siliques with 14-3-3λ, given the origin of the Arabidopsis cDNA li-
brary from young silique tissue that was used for yeast two-hybrid screening. The kinase do-
main of SERK1 is able to trans-phosphorylate and bind in vitro to CDC48A, 14-3-3λ as well 
as KAPP (Rienties et al., 2005). In vitro, the interactions are all phosphorylation-dependent. 
In vivo, it was shown that SERK1 interacts with KAPP only in intracellular vesicles and was 
proposed to play a role in receptor internalisation as well as in dephosphorylation (Shah et 
al., 2002). For two other LRR-RLKs, CLV1 (Williams et al., 1997) and FLS2 (Gomez-Gomez 
et al., 2001) it has been show that KAPP functions as a negative regulator, and may have the 
same role in controlling signaling trough the SERK1 receptor.  
CDC48 protein assembles mainly in hexameric forms (Rancour et al., 2002). In Arabidopsis 
suspension-cultured cells, soluble (cytosolic) CDC48A protein was found in high molecular 
order protein of 640 kDa. Recently it was proposed that CDC48A interacts with PUX1 as a 
monomer and may have a function in regulating plant growth (Rancour et al., 2004) and also 
in the plant endoplasmic reticulum-associated protein degradation (ERAD) system (Muller 
et al., 2005). 
Plant 14-3-3 proteins have also been found to be associated with G-box transcription factors 
(Lu et al., 1992). Five Arabidopsis thaliana 14-3-3s, including 14-3-3λ have been shown to 
interact with other transcription factors (Pan et al., 1999) and current models propose that the 
interaction with members of the 14-3-3 family is “client-driven” (Paul et al., 2005).
Two transcription factors were found to be associated with the SERK1 complex, AGL15 and 
a putative CONSTANS-like B-box zinc fi nger protein. Most likely these two proteins do not 
interact directly with the receptor, but require 14-3-3 proteins as adaptor proteins. It has been 
shown that 14-3-3 proteins can also promote the cytoplasmic localization or, conversely, the 
nuclear localization of transcription factors (reviewed in (Muslin and Xing, 2000). One of 
the other MADS box transcription factors, AGL24, was shown to directly interact with the 
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kinase domain of the Arabidopsis Meristematic Receptor-Like Kinase (RLK-MRLK) and 
to be phosphorylated by the kinase domain of the receptor in vitro (Fujita et al., 2003). The 
AGL15 protein was shown to accumulate in nuclei but to be also present in the cytoplasm 
(Perry et al., 1996). SERK1 and AGL15 are highly expressed during embryogenic cell for-
mation in culture and during early embryogenesis. As found for SERK1 (Hecht et al., 2001), 
AGL15 promotes somatic embryo production from SAM in liquid culture when ectopically 
over-expressed (Harding et al., 2003; Perry et al., 1996).  Interestingly, AGL15 over-express-
ing tissues also had elevated expression of SERK1 (Harding et al., 2003). It was shown that 
AGL15 could bind directly to the promoter regions of different targets (Wang et al., 2002a). 
The authors described that after chromatin immunoprecipitation they obtained DNA frag-
ments containing cis regulatory elements targeted by AGL15, which may contribute to the 
regulation of the SERK gene by directly binding to its promoter. These data and our fi ndings 
suggest that SERK1 and AGL15 can be involved in the same signaling pathway.
The other putative transcription factor found in the SERK1 complex belongs to a large family 
of CONSTANS (CO)-like zinc fi nger transcription factors, where the zinc fi nger region regu-
lates protein-protein interactions as found for several animal transcription factors (reviewed 
in (Griffi ths et al., 2003). Recently it was shown that CO protein accumulation is regulated by 
photoreceptors in photoperiodic fl owering (Valverde et al., 2004). 
In conclusion, we propose that in Arabidopsis seedlings signaling mediated by the SERK1 re-
ceptor combines elements of the BL pathway with a short signal transduction chain where the 
plasma membrane receptor is in a complex with its cognate transcriptional regulators such 
as AGL15. Further studies are needed to evaluate this model and to map the phosphorylation 
sites that are responsible for the activation of receptor kinases and recruitment of downstream 
signaling components. 
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Introduction
Membrane located plant receptor like kinases (RLKs) play important role in plant signaling 
pathways. There are more than 600 RLKs in Arabidopsis but for only a few the function 
is known. One of the best studied plant receptors is the LRR-RLK BRASSINOSTEROID-
INSENSITIVE1 (BRI1), the main receptor in brassinosteroid (BR) signaling. Brassinosteroids 
are plant steroid hormones which are involved in diverse processes such as stem elongation, 
vascular differentiation, male fertility, timing of senescence and fl owering, leaf development, 
and resistance to biotic and abiotic stresses (Li and Chory, 1997; Clouse and Sasse, 1998; 
Altmann, 1999).Biochemical studies have shown that BRI1 can bind BRs directly (Kinoshita 
et al., 2005) and can form heterodimers in vivo with SERK1 (Karlova et al., 2006), SERK3 
(BAK1) (Li et al., 2002; Nam and Li, 2002) as well as with SERK4 (BKK1) (He et al., 2007). 
Recently it was shown that the phosphorylation status of the co-receptors of BRI1- SERK1 
(Karlova et al., 2008 in press), BAK1 (Wang et al., 2005b) and BKK1 (He et al., 2007) is 
increased upon BR stimulation. Other negative and positive regulators of BR signaling 
were identifi ed as the GSK-3/Shaggy-like kinase- BRASSINOSTEROID-INSENSITIVE2 
(BIN2) (Li and Nam, 2002) and Ser/Thr phosphatase bri1 Suppressor1-BSU1 (Mora-Garcia 
et al., 2004), respectively and based on genetic studies their potential substrates are the 
BRASSINOZOLE-RESISTANT1 (BZR1) (Wang et al., 2002) and bri1-EMS-SUPPRESSOR1 
(BES1) (Yin et al., 2002). BRI1 has been shown to interact at the plasma membrane with BKI1, 
which is a negative regulator of BR signaling (Wang and Chory, 2006). The WD-domain 
protein TRIP-1 has been also shown to interact in vivo with BRI1 in analogy to the TGF-β RII 
receptor kinase in mammals, which could also interact with a WD-40 repeat protein (Ehsan 
et al., 2005). Recently scaffold/adaptor proteins like 14-3-3s were shown to be involved in BR 
signaling by playing a role in the cytoplasmic translocation of BZR1 upon BIN2-mediated 
phosphorylation (Ryu et al., 2007). Despite this progress in identifying proteins involved in 
BR signaling, there is still a big gap in our understanding of BR signal transduction between 
BR perception at the cell surface and subsequent inactivation of BIN2 in the cytoplasm. 
Therefore, identifi cation of the in vivo status and composition of BRI1 and BAK1 protein 
complexes is an important step for the complete understanding of BR signaling.  
Three members of the SERK family SERK1 (Karlova et al., 2006), SERK3 (Li et al., 2002; 
Nam and Li, 2002) and SERK4 (He et al., 2007) were shown to interact in vivo with BRI1. 
SERK1 and SERK3 can also trans-phosphorylate the kinase domain of BRI1 or to be trans-
phosphorylated by BRI1 and participate in BR signaling. The redundancy between SERK3 
and SERK4 in regulating BR signaling was proposed (He et al., 2007). Members of the SERK 
family can act as co-receptors with different main receptors and individual members can act 
in different signaling pathways. SERK1 was found to act redundantly with SERK2 in tapetum 
specifi cation and male sterility (Albrecht et al., 2005). SERK1 was found to be in one complex 
together with SERK3 and BRI1. Using blue native gel electrophoresis we showed that SERK1 
and SERK3 are part of BRI1-containing protein complexes with relative masses between 
300 and 500 kD. SERK3 was recently implicated to be involved in plant innate immunity 
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responses (Heese et al., 2007; Kemmerling et al., 2007) and as a component of the fl agellin-
perceiving FLS2 receptor complex (Chinchilla et al., 2007). SERK3 also has a redundant 
function with SERK4 in negatively regulating a BR-independent cell death pathway (He et 
al., 2007). Unraveling the composition of the protein complexes in which SERK receptor are 
involved will shed light on how this receptor can function in different signaling pathways.  
 In order to identify the composition of the protein complexes of transmembrane plant 
receptors we have develop a fast single step purifi cation method based on GFP tag as a 
bait protein (Karlova et al., 2006). Using this method we have now identifi ed a number of 
interacting partners for BRI1 and SERK3 with or without exogenous application of BRs.  
Materials and Methods
Plant materials and growth conditions
Arabidopsis thaliana ecotype Columbia was used as the wild type. Seeds were surface 
sterilized and sown on germination medium (½ Murashige and Skoog (MS) salt and 
vitamins medium (Duchefa, Haarlem, The Netherlands) supplemented with 0.8 % (w/v) agar 
(Daishin) and 2 % (w/v) sucrose). Seeds were kept for 2 days at 4oC and then transferred to 
a growth chamber. Seedlings were grown at 22oC under 16 h light/ 8 h dark periods for 7 
days. Arabidopsis plants expressing the BRI1 or SERK3 (BAK1) receptor fused to green 
fl uorescent protein (GFP) under the control of the native promoters were described before 
(Russinova et al., 2004). The seedlings were induced for 1h with 100 nM epibrassinolide in 
liquid MS media on a rotary shake platform. 
Immunoprecipitations
To prepare total protein extracts, plant material was ground in liquid nitrogen and thawed 
in extraction buffer containing 50 mM Tris pH 7.5, 150 mM NaCl and 0.5% Triton X-100, 
supplemented with a protease inhibitor cocktail (Roche, Germany). Samples were incubated 
on ice for 30 min. The suspension was centrifuged at 200g (Beckman-Microfuge 18 centrifuge) 
at 4 oC for 3 minutes. The concentration of extracted proteins was determined with the Biorad 
Protein assay (Biorad). Routinely we used 4 plates (9 cm) with about 400 seven days old 
seedlings (100 per plate) to prepare a protein extract suitable for immunoprecipitation. Ten 
millilitres of total plant protein extract (1mg.ml-1) in extraction buffer (isolated as described 
above) were incubated for 2-3 hour at 4°C with 30 μl 50% v/v CNBr-activated Sepharose 
4B beads (GE Healthcare) cross linked to anti-GFP antibodies (Prodused by Eurogentech). 
CNBr-activated beads were prepared according to the manufacturers instructions. The beads 
were pelleted by centrifugation at 200g for 1 min and the supernatant was removed. After 
that the beads were washed three times with 1 ml wash buffer (50 mM Tris pH 7.5, 150 mM 
NaCl, 0.01% triton X-100) and twice with 10mM NH4HCO3, pH 8. Before the last wash step 
the beads together with the wash buffer were moved to a new tube. After centrifugation, the 
wash buffer was removed and the beads were used in this form directly for digestion with 
trypsin and subsequent MS/MS analysis.
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In-liquid protein treatment 
The protein reduction was performed by adding 2 μL 50 mM DTT in 50 mM NH4HCO3 and 
incubated for 1h. at 56 oC. Alkylation was performed with 2 μL 100mM iodacetamide in 50 
mM NH4HCO3 solution. To remove the excess of iodoacetamide 1 μL of 125 mM cystein 
dissolved in 50 mM NH4HCO3 was added followed by 1 μL of trypsin. 
In-gel protein treatment
All chemical products used were of analytical or HPLC grade quality. For MS analysis the 
protein gels were stained with Colloidal Coomassie staining kit (Invitrogen), according to the 
manufacturers’ instructions. The protein bands were excised and the gel parts cut into 1 mm 
pieces. In-gel digestion was performed as described by Shevchenko et al. (Shevchenko et al., 
1996) with the following modifi cations. Destaining was obtained by two washes with water 
and two times with 50 mM NH4HCO3/ CH3CN (1/1 mixture) for 15 min. at 37
 oC. Reduction 
was performed with 10 μL of 50 mM DTT (dithiotreitol) in 50 mM NH4HCO3 for 1h at 56
oC. 
Alkylation was performed with 10 μL of 100 mM iodacetamide in 50 mM NH4HCO3 for 1h. 
at room temperature in the dark. The gel pieces were washed three times with 100 μL 50 mM 
NH4HCO3 and dried in a vacuum centrifuge. For proteolytic digestion, the gel was treated 
over night with 1 μL (in 10 μL 50 mM NH4HCO3) trypsin (sequencing grade, Boehringer 
Mannheim, Germany) or endoproteinase Lys C (sequencing grade, Roche Mannheim, 
Germany) at room temperature. The gel fragments were removed by centrifugation and the 
proteolytic peptides were recovered in the supernatant fraction. A second extraction step of 
the peptides was performed using 15-20 μL 5% TFA (trifl uoro-acetic acid) in water followed 
by sonication for 1 min. A third gel extraction was done using 10-15 μL CH3CN/TFA/H2O 
(25/1/84 v/v/v) mixture and sonicated for 1 min. Finally all extracts were pooled together in 
μL and used as such for LC-MS/MS. (25/1/84 v/v/v) mixture and sonicated for 1 min. Finally 
all extracts were pooled together in μL and used as such for LC-MS/MS. 
Tandem mass spectrometric analysis and data analysis 
Peptides extracted from tryptic digests were subjected to LC-MS/MS analysis. The samples 
were analyzed by injecting 20 μL over a 0.10 mm x 32 mm Prontosil 300-3-C18H pre-
concentration column (Bischoff, Germany, prepared in house) at a fl ow of 4 μL/min for 10 
minutes or 6 μL/min for 5 minutes. Peptides were eluted from the pre-concentration column 
onto a Prontosil 300-3-C18H analytical column (0.10 mm x 200 mm) with an acetonitril 
gradient at a fl ow of 0.5 μL/min. The gradient consisted of an increase from 10 to 35% 
acetonitril in water with 1ml/L formic acid in 50 minutes followed by a fast increase in the 
percentage acetonitril to 80% (with 20% water and 1 ml/l formic acid in both the acetonitril 
and the water) in 3 minutes as a column cleaning step. Downstream of the column, an 
electrospray potential of 1.8 kV was applied via a platinum electrode that made direct contact 
with the eluent. Full scan positive mode MS spectra with 3 or 1 microscans were measured 
between m/z 350 and 1400 on a LCQ classic or LTQ-Orbitrap (Thermo Electron, San Jose, 
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CA, USA). MS/MS scans of the 3 (for LCQ) or 4 (for LTQ-Orbitrap) most abundant peaks in 
the MS scan were recorded in data dependent mode. 
Each run with all MS/MS spectra obtained was analyzed with Bioworks 3.3 (Thermo Electron). 
For the identifi cation of the proteins the searches were done with an A. thaliana database 
and allowing methionine oxidation and phosphorylation of serine, threonine and tyrosine as 
variable modifi cations and carboxamidomethylation of cysteines as fi xed modifi cation. The 
peptide identifi cations obtained were analyzed with Bioworks 3.3 with the following fi lter 
criteria: ΔCn > 0.08, Xcorr > 2 for charge state 1+ ,  Xcorr > 1.5 for charge state 2+ and Xcorr 
> 3.3 for charge state 3+  as described previously (Peng et al., 2003) and Xcorr > 4 for charge 
state 4+. 
In vitro auto- and trans-phosphorylation assays
14-3-3 λ, 14-3-3ν and BRI1-KD were cloned and expressed in pGEX-4T1 vector. Protein 
expression, GST purifi cation and the in vitro phosphorylation reaction with (γ-32P) ATP was 
done as described previously (Shah et al., 2001). After incubation for 30 min. at 30 oC, the 
reaction was quenched by adding Laemmli SDS-PAGE sample buffer, boiled at 95 oC for 
5 min. and separated on 10% SDS-PAGE. The gel was stained with Coomassie Brilliant 
Blue (CBB) to verify equal loading and then dried. The radioactivity was quantifi ed with 
PhosphoImager using the ImageQuant program (Molecular Dynamics). 
 
Results and Discussion
Immunoprecipitation and Detection of BRI1-GFP interacting partners in vivo
By using immunoprecipitation in combination with MS we previously identifi ed proteins 
interacting with SERK1-CFP in vivo. In this way SERK3 and BRI1 as well as 14-3-3ν, 
CDC48A and AGL15 were found to be present in the SERK1 protein complex (Karlova et al., 
2006). For the immunoprecipitation, protein A beads were used, which resulted in the presence 
of Protein A peptides after trypsin digestion in our precipitates. In order to avoid the presence 
of external peptides in our samples we optimized the procedure by crosslinking anti-GFP 
antibodies to CNBr-activated agarose beads (GE Healthcare). This resulted in better protein 
coverage of the precipitated receptor. For example for the BRI1 protein only 4 peptides were 
identifi ed by using Protein A beads, in comparison with 83 BRI1 peptides found, when using 
crosslinked agarose beads and the precipitated complexes were digested in liquid with trypsin 
and directly (without extra separation) subjected to LC-MS/MS. By using this procedure we 
could isolate about 2 μg of BRI1-GFP protein from the plant extract (Figure 1 A). The identity 
of this comassie stained band of around 160 kDa was confi rmed by western blotting (Figure 
1B) using anti GFP antibodies and by LC-MS/MS. From the BRI1 protein sequence 43% 
was recovered and the relative abundance representing the percentage of the peak areas was 
calculated to be 35 % (Table 1). In the SEQUEST softer there is a possibility to obtain semi-
quantitative information on peptides and proteins by calculating the peak areas of peptides 
identifi ed, representing the relative abundance of a protein, using the formula; (the sum of 
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peak areas for protein X, divided by the sum of peak areas of all protein identifi ed, times 
100%). All of the proteins, that were identifi ed in the negative control, sample consisting of 
proteins extracted from WT seedlings and precipitated with anti GFP antibodies, binding 
either aspecifi cally to the beads or to the anti GFP antibodies are listed in Table 3 and are 
subtracted from the list of the interacting protein (Table 1, 2 and 4). Not only BRI1 was 
identifi ed but also the fusion protein tag GFP with 13 peptides (39.9% sequence recovered). 
Interestingly, although the protein concentration of BRI1 should be equal to its fusion protein, 
for the GFP protein the relative abundance was only 2%. There are two possible explanations 
for this difference. One is that the GFP protein is more diffi cult to be digested by trypsin than 
BRI1 (although similar sequence recovery was observed for both proteins, Table 1).
Figure 1. A. Detection of BRI1-GFP protein on coomassie stained SDS gel from BRI1-GFP transgenic 
plants after immunoprecipitation (IP) with anti GFP antibodies. The size of detected proteins is 
indicated on the right. B. Detection of BRI1-GFP protein from BRI1-GFP transgenic plants, lane 1 
and wild type plants, lane 2 after immunoprecipitation with anti GFP antibodies. C. In vitro trans-
phosphorylation of 14-3-3λ, and 14-3-3υ by BRI1 kinase domain protein. The GST tag only of 14-
3-3λ was cleaved by trombin, which resulted in difference in the protein size between the two 14-3-
3 isoformes. Phosphoimage of 14-3-3λ (lane 1) and 14-3-3υ (lane 2) trans- phosphorylated by BRI1. 
Arrows indicate the position of 14-3-3 proteins.
Another possibility is that BRI1 is homodimerizing with the endogenous receptor protein 
in vivo in agreement with data of (Russinova et al., 2004; Wang et al., 2005a) and thereby 
the amount of precipitated BRI1 protein is higher than the amount of the GFP fusion protein 
alone. Similar difference was observed for BRI1 and GFP proteins precipitated from the 
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pools of seedlings stimulated with BL (biosynthetic brassinosteroid), Table 2. Compared to 
the relative protein amount of the precipitated BRI1-35%, the protein amounts of the identifi ed 
interacting partners is lower and ranges from 0.84 to 0.01%. This relative abundance of the 
identifi ed proteins after immunoprecipitation shows how much of the bait protein was isolated 
compared to the background proteins and it is useful to estimate for the following experiments 
how much from the bait proteins is needed in order to detect a specifi c interacting partner with 
very low abundance. Amongst these proteins 14-3-3s were identifi ed as interacting partners 
for BRI1 similar to what was found previously for SERK1 (Karlova et al., 2006). Recently 
14-3-3 proteins were shown to play a role in the brassinosteroid signaling by interacting with 
phosphorylated BZR1 transcription factor and leading to cytoplasmic retention of BZR1 (Ryu 
et al., 2007). Our data suggests direct interaction of 14-3-3s with BRI1. We next investigated 
if 14-3-3s are substrates of BRI1. As shown on fi gure 1C BRI1 can trans-phosphorylate two 
14-3-3 isoformes, 14-3-3υ and 14-3-3λ in vitro. Other interacting partners identifi ed for BRI1 
are the nodulin related protein (At1g13930) without a known function, a glycoprotein located 
to the plasma membrane with peptidase activity (At1g03220) and also an unknown cell wall 
protein (At5g25460) (Bayer et al., 2006). Another protein located in the cell wall was identifi ed 
in the BRI1 complex, gibberellin (GA)-responsive GASA1 protein (At1g75750). These cell 
wall proteins probably interact with the extracellular (LLR) domain of BRI1 receptor. GASA1 
encodes a small peptide of 98 residues of unknown function and accumulates markedly in 
siliques, about fi ve days after pollination and correlates with the peak of GA biosynthesis 
at this stage (Aubert et al., 1998). GASA1 was found to be up-regulated by GA and down 
regulated by BR (Bouquin et al., 2001). In our complex isolation experiments we could 
identify the GASA1 protein only in non BR treated pools of seedlings, which is consistent 
with the down regulation of this protein by BRs. GASA1 gene expression co-localized with 
BRI1 expression in 1-week- old seedlings in roots and vasculature (Raventos et al., 2000). We 
could also identify (only in the BRI1 receptor complex not induced with BRs) a WD-40 repeat 
protein, RACK1A (Receptor for Activated C Kinase 1). Previously TRIP-1 WD-40 repeat 
protein was shown to interact with BRI1 and to be also involved in brassinosteroid signaling 
based on the phenotype of antisense suppression of TRIP-1 in Arabidopsis plants (Jiang and 
Clouse, 2001) and was also shown to be transphosphorylated by BRI1 (Ehsan et al., 2005). 
The mammalian counterparts of serine-threonine receptor like kinases are the transforming 
growth factor-beta (TGF-β) receptors. Based on heterodimerization of BRI1 with its co-
receptors SERK1, SERK3 a tetrameric complex formation model was proposed for BRI1 
in analogy with TGF-β receptors (Karlova et al., 2006). WD-40 domain proteins similar 
to TRIP-1 were shown to be interacting partners of TGF-β receptors (Choy and Derynck, 
1998). TRIP-1 was found to inhibit the signal transduction of the activated TGF-β receptor 
complex, where the Arabidopsis TRIP-1 was proposed to positively regulate BRI1 signaling 
(Jiang and Clouse, 2001). WD-40 repeats, were fi rst recognized in the β-subunit of hetero-
trimeric G proteins (Fong et al., 1986) and have been involved in diverse functions, such 
as transcriptional regulation, RNA processing, signal transduction, cell cycle progression, 
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and vesicular traffi cking (Neer et al., 1994). These proteins are often found in multi-subunit 
protein complexes, and it has been proposed that WD-40 repeats are important for protein-
protein interactions. RACK1A was found to be ubiquitously expressed in Arabidopsis and 
loss-of-function mutations in RACK1A result in defects in seed germination, leaf production 
and fl owering. rack1a mutant displayed reduced sensitivity to gibberellin and brassinosteroids 
in seed germination, hypersensitivity to abscisic acid in seed germination and early seedling 
development, and reduced sensitivity to auxin in adventitious and lateral root formation. 
Another link to brassinosteroid signalling is that in etiolated seedlings, the hypocotyls of 
rack1a mutants were shorter than those of the wild type (Chen et al., 2006). These results 
indicate that RACK1A is involved in multiple hormone responses and signal transduction 
pathways. Other proteins involved in protein degradation like ubiquitin or polyubiquitin and 
26S proteosome were identifi ed only in the BRI protein complex isolated from seedlings not 
induced with BRs. In both pool downs, treated and non treated with BRs  we could identifi ed 
as specifi c interacting partners of BRI1, the small Ras GTP binding proteins, three ADP-
ribosylation factors (ARFs, At1g23490 or At1g10630 or At3g62290). Because of the high 
homology we could not distinguish between the three isoforms. ARFs are in general require 
for effi cient membrane traffi cking. Association of the GTPase with guanine nucleotide 
exchange factors (GEFs), catalize the conversion of the small GTP-binding protein to their 
GTP-bound “active” conformation (Matheson et al., 2007). In plants it was suggested that 
ARF1 is involved in retrograde protein transport from Golgi to ER by interaction with COPI 
vesicle coat protein component. Plant ARF1 is localized not only on Golgi apparatus with 
coatomers but also on additional structures that lack coatomers, which might be involved 
in protein transport to the vacuole (Matheson et al., 2007). BRI1 was shown to internalize 
and colocalize in vesicles in the protoplast system as well as in BFA bodies in plant cells 
(Russinova et al., 2004; Geldner et al., 2007). Most likely BRI1 interacts with these ARFs in 
these internal membrane vesicles. Although SERK1 (Karlova et al., 2006) as well as SERK3 
(Li et al., 2002; Nam and Li, 2002) were shown to interact with BRI1 we did not fi nd peptides 
for these receptors with the fi lter settings we used. One possible explanation could be that 
only very low amount of BRI1 protein is in a complex with these receptors and they probably 
are below the detection limit. This is in line with our previous observations that BRI1 receptor 
is mainly present as a homodimer on the membrane and only around 5% is in a higher order 
complex coinciding with SERK1 and SERK3. The co-receptors were only observed in higher 
molecular size complexes and not as a monomers or dimers (Karlova et al., 2006).    
Finally it appears remarkable that none of the other genetically identifi ed BRI1 interacting 
proteins as BKI1 (Wang and Chory, 2006), BIN2 (Li and Nam, 2002), BZR1 (He et al., 2005) 
etc were found. Apparently non of these proteins is interacting stably enough or long enough 
to appear in our list of BRI1 complex partners.  
Immunoprecipitation and Detection of SERK3-GFP interacting partners in vivo
Previously it was shown that SERK3 is part of brassinosteroid signalling pathway and is a co-
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receptor of BRI1 (Li et al., 2002; Nam and Li, 2002). BAK1 was reported to be also involved 
in resistance against bacterial pathogens by interacting with fl agellin-sensitive 2 (FLS2) and 
elongation factor Tu (EFR) receptors (Chinchilla et al., 2007). BAK1 and FLS2 form a complex 
in vivo, in a ligand-dependent fashion, within the fi rst minutes of stimulation with the ligand 
fagellin (Chinchilla et al., 2007). In order to identify interacting partners of SERK3 we use 
the same immunoprecipitation technique in combination with mass spectrometry as described 
above for BRI1. The proteins identifi ed to be present in SERK3-GFP complex are listed in 
Table 4. SERK3 was identifi ed with 38 peptides recovering 33 % of the protein sequence. No 
unique peptides were found for SERK1 or SERK4/5. Two other LRR-RLKs were identifi ed, 
At1g27190 and At3g28450 with 44.5% and 20% sequence recovery respectively (Table 4). 
These two receptors share 54% sequence identity with each other and 27% with SERK3 
(Figure 2) and consist of 5 LRR, a single transmembrane domain and a serine/threonine 
kinase domain but are lacking the Ser-Pro rich domain before the transmembrane domain, 
which is characteristic for the SERK family members (Hecht et al., 2001). 
Figure 2. Phylogenic relationship of RLKs identifi ed in SERK3 receptor complex. Amino acid 
sequence of the proteins were aligned using Clustal W (Thompson et al., 1994).
Interestingly we could observe the same receptors to be present also in the SERK1 protein 
complex, using this time the same improved technique as used for BRI1 (data not shown), 
which could point to the possibility that SERK1 and SERK3 are part of several multireceptor 
complexes or that exchange occurs between these related receptors and SERK3/SERK1, in 
similarity with TGF-β receptors in mammals. Combinatorial interactions within a family 
building up a tetrameric receptor complex would allow differential ligand binding or differential 
signaling in response to the same ligand. Patterns of ligand and receptor expression can 
then help to determine which receptor-ligand combination is activated (Feng and Derynck, 
1997). SERK3 apparently has multiple functions and was found also to play a role in negative 
regulation of a cell death pathway independent of its role in brassinosteroid signaling (He et 
al., 2007). The double mutant bak1 bkk1 (serk4) exhibits a seedling-lethality phenotype due 
to constitutive defense-gene expression, reactive oxygen species (ROS) accumulation, and 
27%
54%
At1g27190
At3g28450
SERK3
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spontaneous cell death even under sterile growing conditions. Interestingly we identifi ed the 
BAG1 (Bcl-2-associated athanogene) protein in SERK3 receptor complex. BAG proteins are 
evolutionarily conserved, and consist of a family of multifunctional proteins that promote cell 
survival. They are distinguished by a common conserved region located near the C terminus 
termed the BAG domain (BD) involved in interaction with Hsp70 proteins. Some of them, 
like AtBAG1, contain a ubiquitin-like domain at the N terminus (Doukhanina et al., 2006). 
BAG proteins may operate as bridging molecules that recruit molecular chaperones to target 
proteins or via the ubiquitin-like domain control protein turnover rates. Alternatively BAG1 
protein can mediate binding to other proteins, including the 26S proteosome (Takayama and 
Reed, 2001). Mammalian BAG proteins have been reported to associate with and regulate the 
activity of steroid hormone receptors and to associate with the tumour necrosis factor (TNF) 
receptor that regulates signal transduction events preventing cell death (Takayama and Reed, 
2001). The plant BAG proteins were also shown to have a function in cell protection under 
stress and inhibition of plant programmed cell death (PCD) that shares features associated 
with apoptosis (Doukhanina et al., 2006). This supports the idea that some mechanisms for 
PCD regulation are conserved between plants and animals. Similar to the SERK1 receptor 
complex, the CDC48A protein was also identifi ed in the SERK3 protein complex. CDC48A 
in Arabidopsis was shown to play role in protein degradation of incorrectly folded proteins 
(Muller et al., 2005). As found for BRI1 we identifi ed in SERK3 complex element of the 26S 
proteosome, the 14-3-3 chi isoform as well as ARF1 (Table 1, 2 and 4). The identifi cation of 
small Ras related GTPase in both complexes could indicate that there are similar mechanisms 
in vesicle traffi cking of both BRI1 and SERK3 receptors. This is in line with the fact that the 
two receptors can co-localize together in vesicles and also can physically interact with each 
other in endosomes (Russinova et al., 2004; Geldner et al., 2007). 
In summary, by isolating the protein complexes of SERK3 and BRI1 and identifying their 
protein composition, several novel interacting partners were observed, that were shown 
to be involved in different functions, that range from vesicle traffi cking (ARFs) to protein 
degradation (CDC48 and 26S proteosome), regulation of apoptosis (BAG1) and protein-
protein interactions like 14-3-3s. Finding all these proteins to be associated with single 
receptors indicates that most probably we are isolating multiple receptor complexes, either at 
different stages of formation, or playing different roles in different signalling pathways. The 
composition of SERK1 and SERK3 protein complexes was found to be quite similar, both 
receptors interact with 14-3-3s, CDC48A and two other RLKs. This could be explained by 
the fact that they can share common functions like in brassinosteroid signalling (Karlova et 
al., 2006).
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 Table 1. Identifi cation of the proteins interacting specifi cally with BRI1 using Bioworks 3.3 
software. All the proteins present in the negative control were removed from the list of the 
BRI1 interacting partners.  
 
   Protein               TAIR          N of peptides              % protein           % Peak area 
   Name                 number       observed                      coverage 
 
 BRI1             At4g39400 83                      42.9                  34.75 
 
 GFP     P42212       13                      39.9                  2.13  
 
 Vacuol          At1g20260 2  6.1         0.02 
 ATP ase
 
 Nodulin        At1g13930 3                        25.2              0.01   
 related 
 
 Small GTP-   At1g23490 2                        14.15              0.01 
 ase                or  At1g10630  2                        13.8 
                      or At3g62290    
 
 Ubiquitin       At4g05320       4                        17.7                  0.84  
 or PoliU 
                                                                                    
  GASA1        At1g75750       2                        11.2                  0.01 
 
 Glycoprotein At1g03220       2                        5.7                    0.01 
 
 26S               At1g53750       2                        6.8                    0.0 
 proteosome 
 
 14-3-3           At5g38480                 3                        11.3                  0.0 
 psi                               
 
 cell wall
 protein          At5g25460       
3                        11.65                0.02 
 
RACK1A     At1g18080                 2                         11.3 0.0
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Table 2. Identifi cation of the proteins interacting specifi cally with BRI1 immunoprecipitated 
from seedlings induced with 100nM BL for 1h, using Bioworks 3.3 software. All the proteins 
present in the negative control were removed from the list of the BRI1 interacting partners.  
Table 3. Identifi cation of proteins present in the negative control using Bioworks 3.3 
software.
                                                                                     
Protein               TAIR          N of peptides          % protein        % Peak area 
name                 number       observed                 coverage 
 BRI1             At4g39400 66            38.4                  26.5
 GFP              P42212       17            39                     5.5 
 Vacuol          At1g20260 2 6.1  0.02
 ATP-ase 
  Small GTP -   At1g23490  2              14.5             0.01
 ase                or  At1g10630  2              19.9                  0.01
                      or At5g14670   2             19.5                  0.01
 Glycoprotein At1g03220       2             5.7                   0.02
14-3-3 psi     At5g38480                 3             11.3                 0.03
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   Protein        TAIR       N of peptides    % protein           
   Name       number     observed           coverage 
RUBISCO    At2g39730     23                   53%
12S seed storage At5g44120     19                   34%
protein
Malate Dehydrogenase 
genase At2g22780     13                   55.6
Cupin          At4g28520     17                   48.2 
Homocystein methyl At5g17920      10                  19.6
Transferase
Glyceraldehyde-3 At3g04120      10                   33.4
Phosphate Dehydroge-
nase
ATP syntase Atcg00480 7  25.3
calcium - binding  protein  At1g12900      7                    25.3
Chlorophyl 7                     38.5  
membrane 30kd protein  At1g65260 6                  25.4
beta-Glucosidase             At3g09260      6                    26.1
Keratine                7                     19
Photosystem 2                 At2g34420  6                    27
Fructose- Biphosphate At3g52930      5                     29.6
aldolase
Prohibitin                        At5g40770 5                     34.6
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 Protein name                       TAIR         N of peptides % protein           
coverage
Elongation factor           At5g60390 8               14.4
1-alpha
EPSIN-like                             At1g03050 4                 13.8
Jasmonate inducible protein At3g16460 3                6.9 
MATH domain protein         At5g26280    3             17.7
Glutamine synthetase     At5g35630   3                14.1
Glutamine rich protein   At1g10270   3                4.7
60S ribosomal protein    At2g01250   3               19.8
  WHIRLY2                          At1g71260   3                 15.9
Catalase                          At4g35090    2                 7.5
Carbonic anhydrase 2     At5g14740   2                12.7
Luminal-binding protein 2  At5g42020 2               4.6
  ribosome                       At4g31700   2               17.5
Ribonucleoprotein 1      At4g14300   2               7.7
Glycolate oxidase                   At3g14130   2                13.9
Probable peroxisomal    At3g14420 2              9.8
(S)-2-hydroxy-acid 
oxidase 2 
GloEL protein; chaperonin    At3g13470    2                4.1
Putative DNA binding 
 protein AT4g27000  2             11.4
MATH domain              At5g26280   2               13.4
Cytosolic invertase 1 At1g35580   2               7.6
Oxygen-evolving           At5g66570  2               12.6
enhancer protein  
DNA binding                 At1g76010   2  11.7
Heat shock protein 70    At5g49910  2             3.9
number
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Table 4. Identifi cation of proteins interacting with BAK1 using Bioworks 3.3 software.  All 
the proteins present in the negative control were removed from the list of the BAK1 interacting 
partners.  
 
             
    
Protein name  TAIR 
                       number    
     Number           %protein        % Peak    
of peptides   coverage         area
BAK1             At3g28450  38           33.3           6.15
   RLK         At1g27190  25           44.5           2.46
   RLK   At3g28450   9             20            0.18  
14-3-3 chi        At4g09000  4             15.3            0.00
Putative 26S
 proteosome      At5g20000  2             5.7               0.01
Ras related  or At3g46060   2             12.96               0.01
ARA3         or At5g59840 2 10.5
ARF1              At1g10630 2               10.5
Pentatrico-
peptide            At5g11310  3 4.4                   0.01
CDC48C At3g09840 2  3.7                   0.01  
BAG regulatorAt5g52060 2          10.5                0.01
of apoptosis 
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 Identifi cation of in vitro phosphorylation sites in the Arabidopsis thaliana
                                  Somatic Embryogenesis Receptor-like Kinases
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Abstract
The Arabidopsis thaliana Somatic Embryogenesis Receptor-like Kinase (SERK) family con-
sists of fi ve leucine-rich repeat receptor-like kinases (LRR-RLKs) with diverse functions 
such as Brassinosteroid Insensitive 1 (BRI1) -mediated brassinosteroid perception, develop-
ment and innate immunity. The autophosphorylation activity of the kinase domains of the fi ve 
SERK proteins was compared and the phosphorylated residues were identifi ed by LC-MS/
MS. Differences in autophosphorylation that ranged from high activity of SERK1, intermedi-
ate activities for SERK2 and SERK3 to low activity for SERK5 were noted. In the SERK1 
kinase the C-terminally located residue Ser-562 controls full autophosphorylation activity. 
Activation loop phosphorylation, including that of residue Thr-462 previously shown to be 
required for SERK1 kinase activity, was not affected. In vivo SERK1 phosphorylation was 
induced by brassinosteroids. Immunoprecipitation of CFP-tagged SERK1 from plant extracts 
followed by tandem mass spectrometry identifi ed Ser-303, Thr-337, Thr-459, Thr-462, Thr-
463, Thr-468 and Ser-612 or Thr-613 or Tyr-614 as in vivo phosphorylation sites of SERK1. 
Trans-phosphorylation of SERK1 by the kinase domain of the main brassinosteroid receptor 
BRI1 occurred only on Ser-299 and Thr-462. This suggests both intra- and intermolecular 
control of SERK1 kinase activity. Conversely, BRI1 was trans-phosphorylated by the kinase 
domain of SERK1 on Ser-887. BRI1 kinase activity was not required for interaction with the 
SERK1 receptor in a pull down assay. 
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Introduction
Plant genomes contain a large number of genes encoding predicted transmembrane receptor 
like kinases (RLKs) with a structure similar to animal receptor kinases (Shiu and Bleecker, 
2003, Shiu et al., 2004). Membrane-located leucine-rich repeat receptor like kinases (LRR-
RLKs) play important roles in plant signaling pathways (reviewed in (Torii, 2004). Plant 
RLKs consist of an extracellular domain, a single transmembrane-spanning domain and 
a cytosolic kinase domain that resembles those of serine/threonine receptor kinases of the 
transforming growth factor β (TGF β) family in metazoa. 
We have previously identifi ed the Arabidopsis Somatic Embryogenesis Receptor-like 
Kinase 1, an LRR-RLK that marks formation of embryogenic cells in tissue culture. Ectopic 
expression of SERK1 does not result in an obvious phenotype in Arabidopsis plants, but 
increases somatic embryo formation in culture (Hecht et al., 2001). SERK1 is a member of 
a small family of fi ve related RLKs all of which have 5 LRRs and a typical serine-proline 
rich juxtamembrane region (Hecht et al., 2001). The C-terminal kinase catalytic domain is 
also conserved and has all of the 11 subdomains as described for serine/threonine protein 
kinases (Shah et al., 2001b). The GST-SERK1-KD (kinase domain) fusion protein mainly 
autophosphorylates on threonine residues and the reaction is Mg2+ dependent and inhibited by 
Mn2+. A lysine to glutamic acid substitution (K330E) in the ATP binding pocket of SERK1-
KD abolishes all kinase activity and an active SERK1 kinase can phosphorylate inactive 
SERK1K330E proteins, suggesting an intermolecular mechanism of autophosphorylation. A 
comparable substitution in another member of this receptor family, SERK3 that is identical 
to BRI1-Associated Receptor Kinase 1 (BAK1), also abolishes the kinase activity (Li et 
al., 2002). Replacing Thr-468 in the activation loop with alanine completely obliterated the 
ability of SERK1 to autophosphorylate. Trans-phosphorylation by SERK1 on myelin basic 
protein and casein showed tyrosine, serine and threonine as targets, demonstrating that 
SERK1 is a dual specifi city kinase (Shah et al., 2001a). The SERK1 knock-out alleles serk1-1 
and serk1-2 do not result in a morphological phenotype but in combination with the SERK2 
mutant alleles serk2-1 or serk2-2 result in complete male sterility (Albrecht et al., 2005; 
Colcombet, 2005). Recently we have shown that hetero-oligomerization can occur between 
SERK family members (Russinova et al., 2004, Albrecht et al., 2005) and with the major 
brassinosteroid receptor BRI1 in living plant cells (Karlova et al., 2006). It was also shown 
that SERK3 (BAK1) as well as SERK1 are part of the BR receptor complex and are proposed 
to function as co-receptors of the BRI1 ligand-binding receptor (Li et al., 2002; Nam and Li, 
2002; Karlova et al., 2006). SERK3 was recently implicated to be involved in plant innate 
immunity responses (Kemmerling et al., 2007; Heese et al., 2007) and as a component of the 
fl agellin-perceiving FLS2 receptor complex (Chinchilla et al., 2007). BAK1 was also shown 
to have a redundant function with SERK4 (also called BAK1-Like Kinase 1 or BKK1) in 
positively regulating a BR-mediated plant growth pathway, and negatively regulating a BR-
independent cell death pathway (He et al., 2007). It has also been shown that the interaction 
and phosphorylation of the BRI1 and BAK1 receptors is dependent on the presence of BRs 
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(Wang et al., 2005b; Wang et al., 2005a). Site-directed mutagenesis studies suggested that 
autophosphorylation of BRI1 in the juxtamembrane (JM) or C-terminal regions plays a role 
in recognition and/or phosphorylation of downstream targets (Albrecht et al.). The C-terminal 
tail of the BRI1 intracellular domain also plays a critical role in negatively regulating the 
kinase activity (Wang et al., 2005a). BAK1 and BRI1 can trans-phosphorylate each other, 
and the autophosphorylation activity of BAK1 is stimulated by BRI1 (Li et al., 2002). The 
proposed current model is that BR binding to the extracellular domain of BRI1 induces 
receptor phosphorylation and activation (Wang et al., 2005a; Karlova and de Vries, 2006). 
Which sites are trans-phosphorylated within the receptor pair and involved in their activation 
remains to be determined.    
Mass spectrometry (MS) represents an effi cient tool to perform such an analysis and has been 
used to identify the phosphorylation sites of several RLKs using liquid chromatography-
tandem mass spectrometry (LC-MS/MS) of tryptic peptides from plasma membrane proteins 
(Nuhse et al., 2004). The kinase domains of numerous plant RLKs have been expressed as 
recombinant proteins and they do indeed behave as functional kinases and are capable of 
autophosphorylation on serine and threonine residues in vitro (Stone et al., 1998; van der 
Knaap et al., 1999; Fujita et al., 2003; Wang et al., 2005b). Only for a few plant receptors, 
including BRI1 and BAK1, the autophosphorylation sites have been identifi ed (Oh et al., 
2000; Wang et al., 2005b). After BR treatment the BRI1 receptor autophosphorylates at 6 
residues that were identifi ed in vivo and corresponded to the same residues as previously 
identifi ed from the in vitro produced BRI1 protein. 
Members of the SERK family have in part redundant functions, can act as co-receptors with 
different main receptors and individual members can act in different signalling pathways. 
Here we investigated the in vitro autophosphorylation properties of all SERK proteins in 
order to determine whether any link exists between particular phosphorylated residues 
and the observed biological activity. SERK1 is the most active kinase, resulting in 24 
autophosphorylated residues. SERK1, SERK2 and SERK3 (BAK1) proteins were all found 
to be phosphorylated at the same threonines in the activation loop of the kinase domain, 
while fast degradation was responsible for SERK4 (BKK1) and SERK5 showing lower 
autophosphorylation activity in vitro. However, SERK1 and SERK2 are fully interchangeable 
in male sterility and require kinase activity (Albrecht et al., in preparation), SERK1 and 
SERK3 have additive effects in BR signaling (Karlova et al., 2006) and SERK3 (BAK1) and 
SERK4 (BKK1) are redundant in mediating cell death (Heese et al., 2007). The functional 
signifi cance for the in vitro kinase activity of specifi c Ser and Thr residues of SERK1 was 
examined. We identifi ed phosphorylated sites of SERK1 by using LC/MS/MS analysis of 
immunoprecipitated SERK1-CFP protein to show that the receptor is also phosphorylated on 
specifi c Ser and Thr residues in vivo. We also assessed the trans-phosphorylation between 
BRI1 and SERK1 and addressed the dependence of BRI1 and SERK1 association on the 
kinase activity of BRI1.             
71
SERKs phosphorylation status
Materials and Methods
Bacterial strains and growth conditions
For cloning and expression of recombinant proteins E. coli DH5α (Clontech Laboratories, 
Palo Alto, USA) and E. coli BL21 (DE3) pLysS (Novagen, R&D Systems Europe, Albingdon, 
Oxford, United Kingdom) were used. All E. coli strains were grown and maintained in LB 
medium supplemented with 100 μg/mL ampicillin at 37oC. 
Cloning, over-expression, and purifi cation of cytosolic kinase domains (KD) of  SERK 
proteins. 
The SERK1-KD and SERK1-KDK330E constructs used were described before (Shah et al., 
2001a), BRI1-KD and BRI1-KDK911E were kindly provided by John Walker (Division 
of Biological Sciences, University of Missouri-Columbia, Columbia, MO 65211 USA) 
and described before (Li et al., 2002). PCR fragments encoding the intracellular region 
corresponding to the kinase catalytic domain and the juxtamembrane linker of SERK2 (residue 
282-629) and SERK3 (residue 248-616) were amplifi ed by using synthesised cDNA from 
10d old seedlings as a template with the following primers: 5’-CCGGAATTCGACCCTGA-
GGTTCACTTGG-3’ and 5’- CCG CTCGAGT TATCT TG GACCAGACA ACTC-
3’ for SERK2 and 5’-A A A A AGA AT TCGACCACT TCT T TGATGTACC-
3’ and 5’-T T T T TCTCGAGT TATCT TG GACCCGAG G -3’  for SE R K 3. 
SERK4 (residue 261-621) was amplifi ed from cDNA (accession number 
AY056243) with primers 5’-AAAAAGAATTCGACCACTTCTTCGATGTACC-
3’ and 5’-TTTTTGCGGCCGCTTATCTTGGACCCGAGG-3’. SERK5 
(residues 242-601) was amplifi ed from cDNA (accession number U21915) 
with primers 5’-AAAAAGAATTCGGTCACTTTCTTGATGTAC-3’ and 5’- 
TTTTTGCGGCCGCTTATCTTGGCCCCGAGG-3’. The SERK2 and SERK3 PCR fragments 
(amplifi ed with proofreading-grade polymerase Pwo, Roche) were digested with EcoRI and 
XhoI and ligated into vector pGEX4T1. SERK4 and SERK5 PCR fragments were digested 
with EcoRI and NotI and ligated into pGEX4T1 vector as well.  Site-directed mutagenesis 
was carried out using the QuickChange Site-Directed Mutagenesis Kit (Strategene) and was 
used to create the SERK1-KDT541A, SERK1-KDS562A, SERK1-KDS570A, SERK1-KDT541A/S570A, 
SERK1-KDT559A/S562A, SERK1-KDT541A/S570A/T559A/S562A (SERK1-KDTSTS) constructs. All DNA 
constructs were verifi ed by sequencing before being transformed into E. coli strain BL21 
for protein expression. SERK2-KD and all of the SERK1-KD kinase mutants, SERK3-KD, 
SERK4-KD, BRI1-KD and BRI1-KDK911E were induced and purifi ed as described previously 
(Shah et al., 2001a; Li et al., 2002). 
In vitro auto- and trans-phosphorylation assays
In vitro phosphorylation of each kinase (1 μg) with [γ-32P]ATP was done as described previously 
(Shah et al., 2001a). After incubation for 30 min at 30 oC, the reaction was quenched by adding 
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Laemmli SDS-PAGE sample buffer, boiled at 95 oC for 5 min. and separated on 10% SDS-
PAGE. The gel was stained with Coomassie Brilliant Blue (CBB) to verify equal loading and 
then dried. The radioactivity was quantifi ed with a PhosphoImager using the ImageQuant 
program (Molecular Dynamics). For trans-phosphorylation assays the reaction conditions 
were the same as described for the autophosphorylation experiments. 
In vitro phosphorylation with ATP for MS analysis was performed as described above except 
that 3 μg of each kinase protein was used and  [γ-32P]ATP was replaced by 3 mM of cold 
ATP.
Immunoprecipitation and Immunoblot analysis
SERK1-CFP was immunoprecipitated from extracts of 7 d old seedlings with cross- linked 
to agarose beads anti-GFP antibodies (produced by Eurogentec). Immunoprecipitation was 
essentially as described before (Karlova et al., 2006), except that kinase inhibitors (50 mM NaF, 
1 mM Na3VO4 , 1 mM EDTA) and Phosphatase Inhibitor Cocktail (Sigma) were added during 
preparation of the plant extracts. Immunoprecipitated proteins were detected by immunoblot 
analysis on PVDF membrane with anti-GFP antibody (1: 1000) or anti-phosphothreonine 
antibody (Zymed laboratories, Invitrogen immunodetection) at 1:250. Blots were developed 
with horseradish peroxidase-linked secondary antibodies and the ECL chemiluminesence 
detection system (GE Healthcare). 
   
In vivo pull down assay
Plants were grown as described before (Karlova et al., 2006). To prepare total protein extracts, 
Arabidopsis 10 d old seedlings were ground in liquid nitrogen and thawed in extraction buffer 
containing 50 mM Tris pH 7.5, 150 mM NaCl and 0.5% Triton X-100, and a protease inhibitor 
cocktail according to the manufacturers instructions’ (Roche, Germany). Samples were 
incubated on ice for 30 min. The suspension was centrifuged at maximum speed (Beckman-
Microfuge 18 centrifuge) at 4 oC for 10 minutes. The extract was incubated with 30 μL of 
amylose resin (New England BioLabs) for 30 min at 4 oC and the resins were removed by 
centrifugation at 200g for 2 min. The supernatant was transferred to a new tube. For the 
identifi cation of BRI1-KDK911E interacting proteins, immobilized MBP-BRI1-KDK911E on 
amylose resin was incubated with the protein extract at 4 oC for 2 h at 0.3 mg BRI1-KDK911E 
per 10 mg of plant protein extract. Bound protein complexes were collected by centrifugation 
of the resins followed by washing two times with 1 ml of extraction buffer supplemented with 
0.05% Triton X100 and two times with 50 mM NH4HCO3. The proteins bound to the resin 
were then subjected to trypsin digestion and LC-MS/MS.  
In-gel protein treatment
All chemical products used were of analytical or HPLC grade quality. For MS analysis the 
protein gels were stained with Colloidal Coomassie staining kit (Invitrogen), according to the 
manufacturers’ instructions. The protein bands were excised and the gel slices cut into 1 mm 
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pieces. In-gel digestion was performed as described by Shevchenko et al. (Shevchenko et al., 
1996) with the following modifi cations. Destaining was obtained by two washes with water 
and two times with 50 mM NH4HCO3/ CH3CN (1/1 mixture) for 15 min. at 37
 oC. Reduction 
was performed with 10 μL of 50 mM DTT (dithiotreitol) in 50 mM NH4HCO3 for 1h at 56
oC. 
Alkylation was performed with 10 μL of 100 mM iodacetamide in 50 mM NH4HCO3 for 1h 
at room temperature in the dark. The gel pieces were washed three times with 100 μL 50 mM 
NH4HCO3 and dried in a vacuum centrifuge. For proteolytic digestion, the gel was treated 
over night with 1 μL (in 10 μL 50 mM NH4HCO3) trypsin (sequencing grade, Boehringer 
Mannheim, Germany) or endoproteinase Lys C (sequencing grade, Roche Mannheim, 
Germany) at room temperature. The gel fragments were removed by centrifugation and the 
proteolytic peptides were recovered in the supernatant fraction. A second extraction step of 
the peptides was performed using 15-20 μL 5% TFA (trifl uoro-acetic acid) in water followed 
by sonication for 1 min. A third gel extraction was done using 10-15 μL CH3CN/TFA/H2O 
(25/1/84 v/v/v) mixture and sonicated for 1 min. Finally all extracts were pulled together 30 
μL and used as such for LC-MS/MS. 
In-liquid protein treatment 
The protein reduction was performed by adding 2 μL 50 mM DTT in 50 mM NH4HCO3 and 
incubating for 1h. at 56 oC. Alkylation was performed with 2 μL 100 mM iodacetamide in 50 
mM NH4HCO3. To remove the excess of iodoacetamide 1 μL of 125 mM cysteine dissolved in 
50 mM NH4HCO3 was added, followed by 1 μL of trypsin or endoproteinase Lys C.
Tandem mass spectrometric analysis and data analysis 
Peptides extracted from tryptic or LysC digests of 3 μg of each kinase were subjected to LC-
MS/MS analysis. The samples were analyzed by injecting 20 μL over a 0.10 mm x 32 mm 
Prontosil 300-3-C18H pre-concentration column (Bischoff, Germany, prepared in house) at a 
fl ow of 4 μL/min for 10 minutes or 6 μL/min for 5 minutes. Peptides were eluted from the pre-
concentration column onto a Prontosil 300-3-C18H analytical column (0.10 mm x 200 mm) 
with an acetonitril gradient at a fl ow of 0.5 μL/min. The gradient consisted of an increase 
from 10 to 35% acetonitril in water with 1ml/L formic acid in 50 minutes followed by a fast 
increase in the percentage acetonitril to 80% (with 20% water and 1 ml/l formic acid in both 
the acetonitril and the water) in 3 minutes as a column cleaning step. Downstream of the 
column, an electrospray potential of 1.8 kV was applied via a platinum electrode that made 
direct contact with the eluent. Full scan positive mode MS spectra with 3 or 1 microscans 
were measured between m/z 350 and 1400 on a LCQ classic or a LTQ-Orbitrap (Thermo 
Electron, San Jose, CA, USA). MS/MS scans of the 3 (for LCQ) or 4 (for LTQ-Orbitrap) most 
abundant peaks in the MS scan were recorded in data-dependent mode. 
Each run with all MS/MS spectra obtained was analyzed with Bioworks 3.3 (Thermo 
Electron). For the identifi cation of the proteins the searches were done with an A. thaliana 
database or in case of the identifi cation of the mutant proteins a homemade local database 
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was used, containing the protein sequence of the mutated and wild type protein kinases. 
In all cases, the following proteins were added to the databases; maltose binding protein 
(P02928), GST, trypsin (bovine, P00760), trypsin (porcine, P00761), keratin K2C1 (human, 
P04264) and keratin K1CI (human, P35527). The searches were done allowing methionine 
oxidation and phosphorylation of serine, threonine and tyrosine as variable modifi cations 
and carboxamidomethylation of cysteines as fi xed modifi cation. The peptide identifi cations 
obtained were analyzed with Bioworks 3.3 with the following fi lter criteria: ΔCn > 0.08, 
Xcorr > 2 for charge state 1+ ,  Xcorr > 1.5 for charge state 2+ and Xcorr > 3.3 for charge state 
3+  as described previously (Peng et al., 2003) and Xcorr > 4 for charge state 4+. 
Results
Expression, purifi cation and autophosphorylation of the kinase domains of SERK1, 
SERK2, SERK3, SERK4 and SERK5
The kinase domains of SERK1, SERK2, SERK3, SERK4 and SERK5 were cloned into 
plasmid pGEX4T1 and transformed into E.coli BL21. Analysis of the GST fusion proteins by 
SDS-PAGE showed that the kinase domains were expressed in soluble form and migrated as a 
single band with the predicted molecular mass (Figure 1A). Exception was SERK4, where we 
observed fast degradation and the protein was running slightly higher than expected. Although 
we tried different conditions for expression only little amount of the SERK4 protein could be 
purifi ed. However this problem was solved when the SERK4 protein was expressed as a MBP 
fusion, but then no autophosphorylation activity could be detected any more (data not shown). 
The SERK receptors have a kinase domain homology between 87% and 95% at protein level 
(Hecht et al., 2001). To examine the autophosphorylation activity of the recombinant kinases, 
an in vitro phosphorylation assay was performed by incubating the fi ve different proteins in 
the presence of [γ-32P] ATP. The reaction products were then separated by SDS-PAGE and 
the labeled proteins were identifi ed by autoradiography using the ImageQuant program. The 
BRI1 protein was expressed both as a MBP or GST fusion protein and the tag used did not 
interfere with the kinase activity, where for SERK4 and SERK5 the MBP fusion proteins did 
not show autophosphorylation activity (data not shown). SERK1-KD, SERK2-KD, SERK3-
KD, SERK4-KD and SERK5-KD exhibit variable autophosphorylation activity (Figure 1B). 
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Figure 1. Autophosphorylation activity of the 5 SERK kinases.
A. Lane 1, cytoplasmic kinase domains of SERK1 (residue 269-626). Lane 2, SERK2 (residue 282-
629). Lane 3, SERK3 (residue 248-616). Lane 4, SERK4 (residue 261-621). Lane 5, SERK5 (residue 
242-601). The proteins were expressed, purifi ed on a glutathione-Sepharose 4B matrix, submitted to 
gel electrophoresis and stained with Colloidal Coomassie Blue. B. In vitro phosphorylation assays were 
performed with [γ-32P]ATP for 30 min. Proteins were analysed by SDS-PAGE and radioactive bands 
were revealed by autoradiography. The size of the marker proteins is shown on the right. 
Identifi cation of the in vitro phosphorylated residues in SERK 1, 2, 3, 4 and 5 kinase 
domains 
The fi ve kinase domains were autophosphorylated with non radioactive ATP, digested with 
trypsin and subjected to tandem mass spectrometric analysis. To obtain better sequence 
coverage of the proteins both trypsin and endoproteinase Lys C were used in combination 
with in liquid and in gel digestion. An example of the results obtained is shown in Figure 2 
and the combined results of all 5 SERK kinase domains are shown in Supplemental Figure 
1. Tryptic digests yielded between 60 and 80% coverage. Non-tryptic proteases such as LysC 
typically yielded only 10-25% coverage, resulting in identifi cation of an additional site in 
SERK1-KD, as well as confi rmation for several other sites already identifi ed from tryptic 
digests and also providing additional peptide coverage. Although a high sequence recovery 
was achieved for the fi ve SERK proteins, it is possible that some of the non-recovered regions 
containing serine, threonine or tyrosine residues could also be potential phosphorylation sites. 
As shown in Table 1, SERKs are phosphorylated on multiple serine and threonine residues 
and in case of SERK1-KD also three phosphorylated tyrosine residues were found. In our 
MS/MS conditions, phosphoserine and phosphothreonine containing peptides displayed 
signifi cant ion signals originating from neutral loss of phosphoric acid (-H3PO4, equal to –98 
Da), as shown in Figure 2. Since this loss is not being taken into account in the calculation 
of the cross correlation Xscores (XC) given by the software, XC scores of phosphopeptides 
are generally relatively low compared to the non-phosphorylated peptides. Therefore, the 
assignment of phosphorylated sites was verifi ed by manual inspection of the MS/MS spectra. 
Successive losses of two molecules of phosphoric acid were observed for y or b fragment ions 
in the case of doubly phosphorylated peptides. Most of the phosphorylated peptides assigned 
were also found as non phosphorylated residues. A peptide from SERK1-KD (Figure 2 A) 
was identifi ed with an Xscore of 4.7, while a peptide with the same sequence was identifi ed 
with one phosphorylated serine residue and an Xscore of 2.8 (Figure 2 B), and as a peptide 
with two phosphorylated residues with Xscore of 2.2 (Figure 2 C). In agreement with the 
autophosphorylation radioactive assay (Figure 1 B), SERK1-KD appears to be the most active 
amongst the family with at least 24 phosphorylated residues identifi ed (Table 1). To distinguish 
between the phosphorylated sites that are resulting from autophosphorylation activity and 
those due to E. coli kinases, we investigated the autophosphorylation profi le of the SERK1-
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KDK330E kinase-dead mutant (Shah et al., 2001a) and (Figure 4A, lane 6). As shown in Table 
1, three sites (Ser-303, Ser-386 and Thr-559) were identifi ed as being phosphorylated in the 
SERK1-KDK330E mutant kinase.
domain 
position 
in 
SERK1 
SERK1 SERK1K330E SERK1S562A SERK2 SERK3 SERK4 SERK5 
Juxtamem-
brane Ser-291  
Ser-299  Thr-302 
 I Ser-303 *  Ser-290 Ser-295 
II Thr-325  
II Thr-337 *
Thr-346  
Ser-352  
Ser-386   
Ser-394  
Ser-415      
Thr-402       
Tyr-456  
III 
 V 
       VII 
Thr-459 *  Thr-462 Thr-446   
Thr-462 *  Thr-465 Thr-449   
Thr-463 *  Thr-466 Thr-450   
Thr-468 * Thr-455 Thr-441 
VIII 
Tyr-476  
Ser-478  
Thr-479  
Ser-482 or Ser-483 
IX 
Ser-483 or Ser-482 
Thr-541  Ser-506 
X 
Tyr-543  
Thr-559   
Ser-562  
Ser-570 Possible 
Ser-601 Ser-604 or Thr-589
     XI               
Ser-606  or Ser-595
Ser-612 *
Thr-613 or*Tyr-614  
Thr-616 Ser-604   
Tyr-614 or*Thr-613  
    
Ser-622   
Ser-625 Ser-612   
C-terminal  
Tail 
Total number 
of sites 
26 3 7 
 
7 
 
 
8 
 
1 
 
2 
77
SERKs phosphorylation status
Table 1. Comparison of phosphorylated sites in SERK1-KD, SERK1-KDK330E, SERK1-KDS562A 
SERK2-KD, SERK3-KD, SERK4-KD and SERK5-KD. In the fi rst column the kinase domains in 
which the phosphorylation occurs are listed. In the second column the position of the phosphorylated 
residues in the SERK1 protein are shown. Asterisks represent phosphorylated sites for SERK1 identifi ed 
in vivo. In the third to nineth columns the grey boxes represent the phosphorylated residues, normalized 
to the corresponding positions in SERK1. Where text occurs in the boxes, this indicates whether the 
position differed from the one in SERK1 or that the precise phosphorylation site could be on either one 
of the residues given.
                    
For the wild type SERK1-KD protein the same residues were found to be phosphorylated 
(Table 1), suggesting that out of the 24 phosphorylation sites identifi ed, only 3 are due to 
bacterial trans-phosphorylation activity. However, comparable residues were not always 
phosphorylated in the proteins of the other SERK members (Table 1).
In contrast to SERK1-KD, in the most related kinase SERK2-KD only 7 phosphorylated sites 
were determined, 3 of which are in the activation loop one in the juxtamembrane region and 
3 sites in the C-terminal tail and represent the same sites identifi ed in SERK1. For SERK3 
four phosphorylated sites Ser-290 in kinase sub domain I and Thr-446, Thr-449 and Thr-455 
in the activation loop were previously identifi ed by Wang et al., 2005 (Wang et al., 2005b). 
We could confi rm these 3 autophosphorylation sites in the activation loop and identifi ed 
4 additional phosphorylated residues, one in the activation loop (Thr-450) and 3 in the C-
terminal tail (Thr-589 or Ser-595, S-602 and Ser-612) of the SERK3-KD. For SERK4 and 
SERK5 a lower autophosphorylation activity was observed (Figure 1 B). SERK4 fused to 
GST was degrading very rapidly and we could obtain only 47 % of the protein sequence after 
trypsin digestion. This was not the case when SERK4 was expressed as an MBP fusion, of 
which 63% of the protein sequence could be determined, but this fusion protein did not show 
any autophosphorylation activity so we identifi ed only one phosphorylated serine (Ser-295) 
(Figure 1 B and data not shown). This residue corresponds to Ser-303 in SERK1-KDK330E and 
most probably is a site trans-phosphorylated by E. coli kinases. For SERK5-KD, cDNA from 
the Arabidopsis ecotype Columbia was used and we could identify 2 phosphorylated sites, 
one of which is in the activation loop and corresponding to Thr-468 in SERK1, which was 
shown to play an important role in regulating SERK1 activity (Shah et al., 2001a). Despite 
the high sequence homology amongst the SERK family a surprisingly large variation in 
phosphorylation status of the kinase domains in vitro was found. 
Site directed mutagenesis of SERK1 phosphorylation sites identifi ed in the C-terminal 
kinase subdomains X and XI affects kinase activity
We chose to investigate the last subdomains of the kinase of SERK1 because of the serk1-1 
allele, in which the last 90 amino acids of the protein are missing, has no kinase activity left 
in vitro and confers male sterility in Arabidopsis plants together with serk2 mutant alleles 
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(Albrecht et al., 2005). The potential role for SERK1 kinase activity of identifi ed 
phosphorylation sites Ser-562, Thr-541, Ser-570 in the kinase subdomains X and XI was  
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Figure 2. LCQ MS/MS spectra identifying SERK1 in vitro phosphorylation sites.
MS/MS mass spectrum of the non-phosphorylated (A), mono-phosphorylated (B) and doubly-
phosphorylated (C) peptides. Fragment ions with relative abundance above 15%, which were measured, 
are shown. Neutral losses of phosphoric acid from the entire peptide or fragments are indicated. 
ssessed by site-directed mutagenesis. All three residues were mutated into alanine alone or in 
combination and the resulting proteins were expressed and assayed for autophosphorylation 
activity. The role for authophosphorylation activity of the phoshorylated sites in the activation 
loop Thr-459, Thr-462, Thr-463 and Thr-468 was described previously by Shah et al., 2001 
(Shah et al., 2001a). The mutation Ser-562-Ala nearly abolished the autophosphorylation 
activity of SERK1-KD. Substitutions at residues Thr-541 and Ser-570 alone did not, but in 
combination did result in a reduction in autophosphorylation activity (Figure 3 B). We next 
investigated the phosphorylation profi le of the SERK1-KDS562A mutant protein by LC-MS/
MS. As shown on Table 1 only 7 phosphorylated residues remained in the mutant protein. 
In comparison with phosphorylated residues in the wild type SERK1-KD protein these 7 
residues were identical. Four of these 5 phosphorylated sites in the SERK1-KDS562A mutant 
are in the activation loop of the kinase. Apparently activation loop phosphorylation is not 
suffi cient to regain the authophosphorylation activity of this mutant protein and suggest an 
important role of the SERK1-Ser-562 residue in regulating the overall kinase activity.
Figure 3. Effect of mutating specifi c Ser and Thr residues of the SERK1 cyoplasmic domain on 
autophosphorylation in vitro.   
A. Lane 1, SERK1-KD. Lane 2,  SERK1-KDT541A. Lane 3, SERK1-KDS562A. Lane 4, SERK1-
KDS570A. Lane 5, SERK1-KDT541A/S570A. Lane 6, SERK1-KDT559A/S562A. Lane 7, SERK1-
KDT541A/S570A/T559A/S562A. The proteins were expressed, purifi ed and loaded on 10% SDS-
PAGE in equal amounts and stained with Colloidal Coomassie. B. In vitro phosphorylation assays on 
the proteins in the same order as shown on A were performed with [γ-32P]ATP. The size of the marker 
proteins (in kDa) is shown on the right.
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Figure 4. SERK1 and BRI1 both trans-phosphorylate kinase domains. A. Lane 1, SERK1-
KD. Lane 2, SERK1-KD together with BRI1-KDK911E. Lane 3, BRI1-KD alone. Lane 4, BRI1-KD 
together with SERK1-KDK330E. Lane 5, BRI1-KDK911E alone and lane 6, SEK1-KDK330E alone. 
The proteins were loaded at equal concentrations and stained with Coomassie. B. The protein were 
incubated with [γ-32P]ATP. The size of the marker proteins (in kDa) is shown on the left. C. Exogenous 
application of BR increases the phosphorylation level of SERK1 in time. Liquid grown seedlings 
expressing SERK1-CFP were either treated or not with 100 nM BR for different time periods, after 
treatment with 1 μM BRZ. The levels of threonine phosphorylation were detected with anti-phospho 
threonine antibody (upper panel). Lower panel shows that equal amounts of SERK1-CFP proteins were 
used as depicted with anti-GFP antibody. 
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Identifi cation of residues in SERK1-KD and BRI1-KD that can be trans-
phosphorylated
We previously showed that not only SERK3 (BAK1) but also SERK1 interacts in vivo with 
BRI1 and is involved in the brassinosteroid pathway (Karlova et al., 2006). To determine 
whether SERK1 can be trans-phosphorylated by BRI1 or can trans-phosphorylate BRI1, 
we made use of enzymatically inactive forms of BRI1, BRI1-KDK911E (Shah et al., 2001a; 
Li et al., 2002) and SERK1-KDK330E proteins (Shah et al., 2001a; Li et al., 2002). Mixtures 
of mutant and wild-type proteins were tested for protein kinase activity (Figure 4 A). The 
results show that BRI1 and SERK1 can trans-phosphorylate each other in vitro, similar to 
results obtained for BRI1 and BAK1 (Li et al., 2002). We next identifi ed the SERK1-KD 
trans-phosphorylation sites by using LC-MS/MS. More than 80% sequence recovery was 
achieved after proteolytic in gel digestion. We could not detect any phosphorylated residues 
in the BRI1-KDK911E protein alone but in combination with active SERK1-KD proteins, only 
Ser-887 was found to be phosphorylated in the BRI1-KDK911E protein (Figure 5). It was shown 
by Wang et al., (Wang et al., 2005b) that Ser-887 is phosphorylated in vitro in the active BRI1 
protein and substitution with alanine did not affect the kinase activity of BRI1, but slightly 
increased trans-phosphorylation on a peptide substrate. For the SERK1-KDK330E mutant 
trans-phosphorylated by BRI1-KD, the same three sites that were trans-phosphorylated by 
E. coli kinases were identifi ed plus two additional ones, Ser-299 and Thr-462 were found 
to be phosphorylated (Figure 5). We conclude that these two sites are targets for BRI1-KD 
trans-phosphorylation in SERK1-KD. When Thr-462 was mutated to alanine the mutant 
protein SERK1-KDT462A had decreased activity compared with the wild type SERK1-KD, 
and both casein and MBP cannot be trans-phosphorylated by SERK1-KDT462A protein (Shah 
et al., 2001a). This suggests that the phosphorylation status of Thr-462 is essential for SERK1 
activity and suggest a direct link to trans-phosphorylation by BRI1. 
SERK1 is phosphorylated at Ser and Thr sites in vivo and the phosphorylation 
status is enhanced by BR
To test if the in vivo phosphorylation level of SERK1 was also regulated by exogenously 
applied brassinosteroids (BR), we grew SERK1-CFP expressing seedlings in liquid culture 
in the presence of brassinazole (BRZ; an inhibitor of brassinosteroid synthesis) for 3 days 
and then induced with 100 nM epibrassinolide for 0 to 90 min after which the SERK1-CFP 
protein was immunoprecipitated with anti-GFP antibodies. The depletion of endogenous BRs 
resulted in basal levels of threonine phosphorylation on SERK1 (Figure 4 C). After a 30 min 
treatment of these BRZ-pretreated seedlings with BR the phosphorylation status of SERK1 
in vivo was enhanced. These data show that SERK1 is involved in brassinosteroid signaling 
in a similar fashion as BAK1 and SERK4 (BKK1) (Albrecht et al., 2005). To identify in vivo 
phosphorylation sites, transgenic plants expressing SERK1-CFP (Karlova et., 2006), were 
grown in liquid culture for 7 d, treated for 3 d with 2 μM BRZ and then induced with BR for 
60 min. After immunoprecipitation (IP) with anti-GFP the IP was loaded on SDS-PAGE and 
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the SERK1-CFP band (around 0.2 μg) was excised, digested with trypsin, and subjected to 
MS/MS analysis. A high sequence recovery was achieved, 93% of the SERK1 cytoplasmic 
domain sequences and 7 phosphorylated sites were identifi ed; Ser-303 in kinase subdomain 
I, Thr-337 in kinase subdomain II, Thr-459, Thr-462, Thr-463 and Thr-468 in the activation 
loop, kinase subdomain VIII and Ser-612 or Thr-613 or Tyr-614 in the C-terminal tail (Table 
1, the in vivo sites identifi ed are marked with an asterisk). Interestingly the phosphorylated 
sites in the C-terminal tail were only observed in the pull of SERK1-CFP seedlings treated 
with BRZ and BR and not in the ones treated only with BZR. All of these sites, except for Thr-
337, were also identifi ed as in vitro autophosphorylation sites of the GST-SERK1 cytoplasmic 
domain (Table 1).               
SERK1 can interact with the inactive kinase domain of BRI1
We have demonstrated previously that SERK1 interacts in vivo with BRI1 (Karlova et al., 
2006). To test whether this interaction depends on the phosphorylation status of BRI1 we 
expressed and purifi ed the BRI1-KDK911E mutant protein. Arabidopsis total protein extract was 
then incubated with immobilized MBP alone or MBP-BRI1-KDK911E fusion protein. Proteins 
interacting specifi cally with BRI1-KDK911E were identifi ed by in liquid trypsin digestion and 
LC-MS/MS. As shown in Table 2, SERK1 was identifi ed with 4 specifi c peptides, which were 
not found in the control experiment with MBP alone. Similar results were previously obtained 
for SERK3 and BRI1 in vitro (Li et al., 2002) and suggested that protein kinase activity is not 
required for the interaction between the SERK and BRI1 receptors. 
Table 2. Identification of Arabidopsis SERK1 receptor interacting with MBP-BRI1K911E fusion 
protein. The peptides were identified by ion trap LC-MS/MS.
Peptide- SERK1                                             Charge State   XC-scorea     Ionsb
 
R.LADGTLVAVKR.L 2 1.9 12/20 
R.ELQVASDGFSNK.N 2 2.6 16/22 
R.GTIGHIAPEYLSTGK.S 2 3.38 17/28 
R.ERPPSQPPLDWPTR.K 2 2.48 11/26 
aBioworks 3.2 cross-correlation score (Xcorr) of the peptide is based on the fit of the ion trap MS/MS 
data to the theoretical distribution of ions produced for the peptide using a simple fragmentation model.
bThe total number of b and y ions (identified/theoretical).
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Figure 5. Sequence recovery after trypsin digestion and identifi cation of the phosphorylated 
residues by LC/MS/MS. The phosphorylated residues are shown in bold and with a star.  
SERK1-KDK330E : total sequence recovery= 80% 
DIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFS*NKNILGRGGFGKVYKGRLADGTLVAVE
RLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS*CLRERP
PSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD
YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVML
LDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCT*QGSPMERPKMSEVVRMLEG
DGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPRF 
BRI1-KDK911E ; total sequence recovery=86% 
REMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFAD
LLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIEKLIHVSGQGDREFMAEMETIGKIKHRN
LVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHN
CSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC
STKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLRISDVFDPELMKEDPALEIE
LLQHLKVAVACLDDRAWRRPTMVQVMAMFKEIQAGSGIDSQSTIRSIEDGGFSTIEMVDMSIK
EVPEGKL 
BRI1-KDK911E   trans-phosphorylated by SERK1-KD; total sequence recovery=86% 
REMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFAD
LLQATNGFHNDS*LIGSGGFGDVYKAILKDGSAVAIEKLIHVSGQGDREFMAEMETIGKIKHRN
LVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHN
CSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC
STKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLRISDVFDPELMKEDPALEIE
LLQHLKVAVACLDDRAWRRPTMVQVMAMFKEIQAGSGIDSQSTIRSIEDGGFSTIEMVDMSIK
EVPEGKL. 
SERK1-KDK330E  trans-phosphorylated by BRI1: total sequence recovery= 82% 
DIFFDVPAEEDPEVHLGQLKRFSLRELQVAS*DGFS*NKNILGRGGFGKVYKGRLADGTLVAV
ERLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS*CLRE
RPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM
DYKDTHVT*TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV
MLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCT*QGSPMERPKMSEVVRML
EGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPRF 
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Discussion 
SERK1 is a member of a small family of fi ve homologous LRR-RLKs (Hecht et al., 2001). 
Members of this family, such as SERK1 and SERK3, were shown to exhibit ATP-dependent 
autophosphorylation activity (Shah et al., 2001a; Li et al., 2002; Nam and Li, 2002). In this 
study we examined and compared the kinase activity of all fi ve members of the SERK 
family, and determined the position of numerous autophosphorylated residues by LC-MS/
MS. Differences in activity and in the number of autophosphorylated residues were found in 
vitro. 
As found for the SERK family, kinase domain sequences of various plant receptor kinases 
are highly conserved, yet their phosphorylation properties are variable. A suggestion was 
made to distinguish between active and non-active kinases based on the mutations in the 
RD kinase motif (He et al., 2007). However, in the case of the SERK family all kinases have 
this motif, yet diverge widely in autophosphorylation activity. SERK5-KD, (since we used 
cDNA obtained from Col) did have a mutation in this RD domain, Leu to Arg at position 
401, nevertheless the kinase remains active (Figure 1). Also the modes of phosphorylation in 
plant receptor kinases can be different. For example, the disease-resistant RLK Xa21 from 
rice contains a kinase domain that phosphorylates in an intramolecular manner (Liu et al., 
2002). In contrast, the Arabidopsis SERK1 and Lotus japonicus SYMBIOSIS RECEPTOR 
KINASE (SYMRK) are reported to autophosphorylate intermolecularly (Shah et al., 2001a; 
Yoshida and Parniske, 2005). Recently it was shown that two of the SERK members, 
SERK1 and SERK2, have a redundant function in tapetum specifi cation in anthers, while 
both the SERK1 and the SERK2 proteins are fully interchangeable genetically (Albrecht et 
al., 2005) and also need to be catalytically active (Albrecht et al., in preparation). Yet both 
proteins have a different auto-phosphorylation activity in vitro. SERK3 was also shown to 
be involved in different signaling pathways. Both SERK3 and SERK4 were recently shown 
to be required in preventing cell death in Arabidopsis (He et al., 2007), while SERK3 alone 
has multiple functions in BR mediated signalling (Li et al., 2002; Nam and Li, 2002) and in 
innate immunity (Kemmerling et al., 2007). Taken together, apparently the kinase activity 
or pattern of autophosphorylated residues identifi ed in vitro does not give a direct clue for 
the biological signifi cance of the kinase domains. A similar case was reported for the kinase 
activity of another plant receptor, CRINKLY4, that was shown to be not required for its 
biological activity (Gifford et al., 2005). 
In animal systems, upon ligand binding receptor oligomerization occurs followed by 
activation of the cytoplasmic domain(s) through phosphorylation of one or more of the 
receptor components. We have shown that the fi rst three members of the SERK family can 
heterodimerize with each other (Russinova et al., 2004; Albrecht et al., 2005). In agreement with 
our kinase activity data, SERK1-KD appears to be the most phosphorylated one with at least 24 
phosphorylated residues identifi ed. It was not surprising to fi nd multiple phosphorylation sites 
in the catalytic core of the kinase sub domains I to XI. Only two phosphorylated residues were 
identifi ed in the juxtamembrane region and 4 in the C-terminal tail, which is in contrast with 
BRI1 kinase, where 5 sites were identifi ed in the juxtamembrane region (Wang et al., 2005b). 
85
SERKs phosphorylation status
In the activation loop of the SERK proteins, there are 4 conserved threonines representing 
Thr-459, Thr-462, Thr-463 and Thr-468 in SERK1 protein. These residues were identifi ed 
to be phosphorylated also in vivo and are functionally equivalent to Thr-1039, Ser-1042, Ser/
Thr-1044/45 in BRI1 (Wang et al., 2005b). The conserved residues within the activation loop 
of SERK 1, 2, 3, 5 and perhaps SERK4 (where, due to fast degradation we could not detect 
phosphorylation sites, nevertheless low autophosphorylation activity could be detected) were 
found to be autophosphorylated, similar to what was shown previously for BRI1 (Wang et 
al., 2005b). Phosphorylation of one to three residues in the kinase activation loop was shown 
to be a common mechanism of general kinase activation and in some cases also affects 
binding of kinase substrates (Shah et al., 2001a; Adams, 2003). For example residue Thr-462 
in SERK1, corresponding to BRI1 Ser-1042, was found to affect substrate phosphorylation 
more than autophosphorylation in vitro (Shah et al., 2001a), which was also observed for the 
BRI1T1039A mutant (Wang et al., 2005b). These data are also in agreement with our fi nding 
that Thr-462 in SERK1-KD is trans-phosphorylated by BRI1-KD in vitro. Mutation of Thr-
462 completely abolishes the ability of the mutant protein to trans-phosphorylate artifi cial 
substrates (Shah et al., 2001a).  Substitution in BRI1 of Ser-1044 and/or Thr-1045 and Thr-
1049 by alanine strongly affected autophosphorylation, peptide substrate phosphorylation, 
and in planta BRI1 signaling and suggests an important role for these activation loop residues 
in BRI1 kinase function (Wang et al., 2005b). The equivalent of the BRI1T1049A mutation in 
SERK1-KDT468E  has a similar effect on SERK1 kinase activity in vitro (Shah et al., 2001a). 
The SYMRK receptor was shown by LC-MS/MS to be autophosphorylated in vitro on the 
corresponding residue (Thr-760), and the SYMRKT760A substitution signifi cantly reduced 
kinase activity (Yoshida and Parniske, 2005). Another activation loop residue, Ser-754, was 
also phosphorylated in vitro in SYMRK, and this residue aligns with Ser-1044 in BRI1 and 
with Thr-463 in SERK1. Autophosphorylation of juxtamembrane and C-terminal regions, that 
both show less sequence conservation is believed to generate docking sites for specifi c kinase 
substrates rather than a more general response to kinase activation (Pawson, 2004; Wang et 
al., 2005b). From the SERK family only for SERK1-KD and SERK2-KD the residues Ser-291 
and Ser-299 (corresponding to Thr-302 in SERK2) were found to be phosphorylated in the 
juxtamembrane region and the Thr-606, Ser-612, Thr-613 and Ser-622 residue in SERK1-
KD corresponding to Ser-604, Thr-616 and Ser-625 in SERK2-KD and Thr-589 or Ser-595, 
Ser-602 and Ser-612 for SERK3 in the C-terminal tail (Table 1). Autophosphorylation may 
be important not only as a modulator of trans-phosphorylation kinase activity but also as a 
means of altering protein binding that can affect macromolecular complex formation (Ikeda 
et al., 2000; Merkle et al., 2002). In SERK1-KD protein three phosphorylated tyrosines were 
found, that are unlikely to be the product of trans-phosphorylation by kinases in E. coli , 
because they are not found in the SERK1-KDK330E  mutant protein.  This is in line with the 
fact that SERK1-KD was found to trans-phosphorylate artifi cial substrates such as casein and 
MBP on both serine/threonine as well as tyrosine (Shah et al., 2001a). These fi ndings confi rm 
that SERK1 is a dual specifi city-type receptor kinase. 
Different biological functions were found for the members of the SERK family. SERK1 
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was found to act redundantly with SERK2 in tapetum specifi cation and male sterility. 
The serk1-1 allele misses the last 90 amino acids of the protein. To test the function of the 
identifi ed phosphorylated residues in this region that include kinase subdomains X and 
XI we created mutant proteins. The substitution Ser-562-Ala nearly abolished the kinase 
activity of SERK1-KD in vitro, where Thr-541-Ala/Ser-570-Ala only in double combination 
reduced the autophosphorylation activity. All the residues in kinase subdomain I, II, III 
and IX, X, XI, found to be phosphorylated in wild type SERK1-KD were not found to be 
phosphorylated in the SERK1-KDS562A mutant protein. Interestingly, 3 threonines in the 
activation loop remained phosphorylated, including Thr-462, a residue essential for the full 
autophosphorylation activity (Shah et al., 2001a). The Thr-468 residue shown to be the most 
important residue for autophosphorylation in the activation loop was no longer phosphorylated 
in the SERK1-KDS562A mutant protein. These data, in combination with the phosphorylation 
profi le of the SERK1-KDS562A protein shows the importance of this region and the Ser-562 
residue for a positive regulation of the kinase function of SERK1. The identifi cation of in vivo 
phosphorylation sites of SERK1 receptor confi rms our in vitro identifi ed phosphorylated sites 
and the important role of the activation loop phosphorylation for kinase activity. 
Other members of the SERK family, SERK3 and SERK4 (BKK1) were also shown to have 
multiple functions. Our in vitro autophosphorylation data showed that with the conditions 
used, SERK4 and SERK5 are active kinases, but with lower activity compared to the other 
members of the family. These differences in autophosphorylation activity could be also due 
to expression and purifi cation of the kinase domains in this in vitro system. Like in case of 
SERK4 protein the lower autophosphorylation activity could be a result of the rapid degradation 
of the SERK4 protein observed. He et al, (He et al., 2007) showed that SERK4 functions 
redundantly with SERK3 in negatively regulating a BR-independent cell death pathway. Also 
BR treatment increased phosphorylation levels on threonine residues in SERK3 and SERK4 
(He et al., 2007). Similar induction of phosphorylation status was observed for SERK1 after 
stimulation with BR in vivo. This observation is most probably due to trans-phosphorylation 
upon BR treatment from the main co-receptor BRI1, which is in line with the proposed model 
for signaling of BRI1 upon ligand stimulation (Karlova and de Vries, 2006). These data also 
fi t with our observation that upon BR stimulation phosphorylation in the C-terminal tail is 
detected in vivo. Receptor homo and heterodimerization occurs in the SERK family. SERK1 
was found to form dimers at the plasma membrane of Arabidopsis protoplasts with SERK3 as 
well as with BRI1 (Russinova et al., 2004). SERK1 was also found in a complex with SERK3 
and BRI1 in vivo, suggesting the formation of tetrameric complexes in analogy with animal 
TGF-β receptors that consist of heterotetramers of the receptor pairs Tβ-RI and Tβ-RII. Tβ-RII 
homodimerizes in the absence of ligand and exhibit constitutive autophosphorylation. TGF-β 
binding by Tβ-RII induces the formation of heterotetramer and results in phosphorylation of 
Tβ-RI by Tβ-RII on residues in the juxtamembrane domain (Wagner et al., 1998; Huse et al., 
2001) while activated Tβ-RI is responsible for downstream signaling. It was shown that BRI1 
and BAK1 can trans-phosphorylate each other (Li et al., 2002; Nam and Li, 2002). Our data 
showed that the same is true for BRI1 and SERK1. The current model for BRI1 activation is 
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that binding of BR to the extracellular domain of BRI1 (Kinoshita et al., 2005) activates BRI1 
by phosphorylation of Thr-1049 and Ser-1044 and induces a conformational change in the BRI1 
homodimer. After dissociation from the BKI1 protein (Wang et., 2006) a negative regulator of 
BR signalling, the activated BRI1 then interacts with BAK1 via the kinase domains (Wang et 
al., 2005b; Wang et al., 2005a). Our data showed that SERK1 can also interact with the in vitro 
produced kinase domain of catalytically inactive BRI1 (BRI1-KDK911E) protein, suggesting a 
possibility for heterodimerization in the absence of BR, similar to what was shown in vitro 
for BAK1 (Li et al., 2002). Since in vitro produced BRI1-KDK911E protein was used in the pull 
down the observed interactions could differ from the in vivo situation where the BKI1 (Wang 
et al., 2006) protein bound to BRI1 could prevent the heterodimerization of kinase-inactive 
BRI1 with SERK1. SERK1 and BAK1 co-immunoprecipitate in vivo with BRI1 and BR 
treatment can increase the amount of BAK1-GFP associated with BRI1-Flag (Wang et al., 
2005b; Karlova et al., 2006). Our data support this model and indicate that SERK1 and BRI1 
can both trans-phosphorylate each other. The SERK1 Thr-462 residue, trans-phosphorylated 
by BRI1-KD, was shown to play an important role in auto- and trans-phosphorylation activity 
(Shah et al., 2001a). The BRI1 activation model also involves inhibition of kinase activity 
by its C-terminal tail, which is relieved upon ligand binding to the extracellular domain. 
After activation BRI1 can trans-phosphorylate the SERK1 kinase domain on Thr-462, that 
subsequently leads to activation and increased kinase activity, including phosphorylation of 
the C-terminally located Ser-562. Our data therefore suggest a complex pattern of both intra- 
and intermolecular control of SERK1 kinase activity. 
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Abstract
Cell fate in plant cells is highly fl exible and even differentiated cells can assume a different 
fate. One dramatic example of such a fate change is the ability of fully differentiated cells in 
tissue cultures to revert back to the totipotent state upon appropriate stimulation with plant 
growth regulators such as auxin and cytokinin. The molecular mechanism underlying this 
fate change is poorly understood. Here we show that the plant steroid hormone brassinolide 
(BL) is instrumental to change the differentiated cell fate towards totipotency in Arabidop-
sis explants. The BL-dependent cell fate change is mediated by the BR-perceiving receptor 
BRI1 and one of its co-receptors SERK1. We found that BRI1/SERK1 phosphorylate directly 
the transcriptional regulator AGL15. Upon BL induction, AGL15 protein translocates to the 
nucleus, where directly controls BRI1/SERK1 gene expression, thereby completing a novel 
positive feedback control loop in BR signaling pathway.
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Introduction
Single somatic plant cells in culture can be induced to shift their fate towards totipotency 
or embryogenic competence by application of exogenous auxins (Mordhorst et al., 1998). 
The SOMATIC EMBRYOGENESIS RECEPTOR LIKE KINASE (SERK) gene was fi rst 
identifi ed in carrot as a marker for single cells competent to form somatic embryos (SE) 
(Schmidt et al., 1997). In Arabidopsis ectopic expression of SERK1 increases somatic 
embryogenesis in culture (Hecht et al., 2001), suggesting that SERK1 mediated signaling 
is required for acquisition of embryogenic competence in somatic cells. Cells acquiring 
embryogenic competence in Arabidopsis are derived from procambium cells in the vascular 
tissue that express the SERK1 gene (Kwaaitaal and de Vries, 2007). The AGAMOUS-like 15 
(AGL15) (Harding et al., 2003) also results in enhanced somatic embryogenesis upon ectopic 
over-expression, while loss-of-function mutants of AGL15 exhibit decreased ability to form 
somatic embryos (Thakare et al., 2008). Previously we identifi ed AGL15 as a component of 
the SERK1 protein complex (Karlova et al., 2006), suggesting a direct link in the form of a 
very short signal transduction chain between both. SERK1 is a member of a small family of 
fi ve related RLKs, all of which have fi ve LRRs and a typical Ser-Pro-rich extracellular region 
missing in related LRR-RLKs (Hecht et al., 2001). The SERK1 protein complex also contains 
the main brassinosteroid receptor BRI1 (Li and Chory, 1997) as well as its co-receptor 
SERK3, also known as BAK1 (Li et al., 2002; Nam and Li, 2002) suggesting that SERK1 
also mediates BR signaling (Karlova et al., 2006). BR signaling commences with the ligand 
binding to the main receptor BRI1 (Kinoshita et al., 2005), followed by a conformational 
change and phosphorylation of BRI1 (Wang et al., 2005a) resulting in dissociation of the 
inhibitor BKI1 (Wang and Chory, 2006) and the heterodimerization with BAK1 (Wang et 
al., 2005b) Via a so far unknown mechanism, BRI1 activation then leads to inactivation of 
the kinase BIN2 (Li et al., 2001) resulting in dephosphorylation of the nuclear proteins BES1 
and BZR1 (Mora-Garcia et al., 2004; Vert and Chory, 2006). Dephosphorylated BES1 and 
BZR1 than homodimerized and bind to DNA to regulate BR-responsive genes. Recently it 
was shown that BR signaling also involves a member of the family of 14-3-3 proteins serving 
as a cytoplasmic retention signal of phosphorylated BZR1 (Gampala et al., 2007; Ryu et al., 
2007).   
BRs regulate cellular expansion, differentiation and proliferation and are involved in diverse 
processes, such as stem elongation, vascular differentiation, male fertility, timing of senescence 
and fl owering and leaf development (Li and Chory, 1997; Clouse and Sasse, 1998; Altmann, 
1999), but to date have not been implicated in the acquisition of embryogenic competence. 
In this study we provide evidence that the main BRI1-mediated BR signaling pathway is 
required for the acquisition of embryogenic competence. Both exogenous application of 
BRs and overexpression of BRI1 enhances somatic embryogenesis while bri1 strong mutant 
alleles and the BR biosynthesis mutant det2 show strongly reduced embryogenic competence. 
In det2 but not in the perception mutant bri1-201 somatic embryogenesis can be rescued 
by exogenous BRs application. The loss-of-function alleles serk1 alone or in combination 
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with agl15-4 signifi cantly impair somatic embryogenesis. agl15 also aggravates general 
phenotypes of a weak bri1-301 mutant allele suggesting that it acts as a positive regulator in BR 
signaling. By using Fluorescence Lifetime Imaging Microscopy (FLIM) to determine Förster 
Resonance Energy Transfer (FRET) between fl uorescently tagged proteins we found that 
AGL15 interacts via 14-3-3ν at the plasma membrane with SERK1. Translocation of AGL15 
to the nucleus appears to be dependent on BRs. This suggests that the SERK1 co-receptor 
and its direct target AGL15 represent a novel short positive feedback loop in BR signaling 
reminiscent of the SMAD pathway in TGFß signaling in animals (Feng and Derynck, 1997).
Materials and Methods
Plant materials and growth conditions
Arabidopsis thaliana ecotype Columbia was used as the wild type plant, loss-of-function 
mutants (serk1-1, agl15-4, serk1-1 agl15-4, det2, bri1-201, bri1-301, bri1-116 all in Col) and 
transgenic seeds were surface sterilized and sown on MS media (½ Murashige and Skoog 
(MS) salt and vitamins (Duchefa, Haarlem, The Netherlands) supplemented with 0.8 % (w/v) 
agar (Daishin) and 2 % (w/v) sucrose. Seeds were kept for 2 days at 4oC and then transferred 
to a growth chamber where the seedlings were grown at 22oC under 16 h light/ 8 h dark 
periods. Arabidopsis plants expressing the SERK1 receptor fused to cyan fl uorescent protein 
(CFP) under its native promoter was described previously (Kwaaitaal et al., 2005). The BRI1-
GFP transgenic plants used for SE cultures was described before (Russinova et al., 2004).
The Arabidopsis Somatic Embryo System
The embryo culture system were initiated and maintained using the seedling assay as 
described previously (Mordhorst et al., 1998). Briefl y seeds were surface sterilized and  about 
30 seeds were incubated in 20ml of liquid MS medium, containing 2 % (w/v) sucrose, 4.5μM 
2,4-dichlorophenoxyacetic acid (2,4-D) and 10mM 2-(N –morpholino)-ethanesulfonic acid 
(MES), pH 5.8. After two days at 4 oC the cultures were transferred to 22 oC in the light 
(16h light/8h dark photoperiod). After 2 weeks of culture, and subsequently every week 
after, the medium was replaced with fresh one. For bri1-116 and bri1-201 after 2 weeks, 
homozygous seedlings were discriminated based on their smaller size and anthocyanin 
accumulation and were subcultured separately. After 5 weeks of culturing, the percentage of 
calli containing green embryonic clusters was determined and this percentage was used as 
a measure for embryogenic competence of the culture. The signifi cance of the difference in 
the mean embryogenic competence values compared to wild type or mutants was assessed 
using student-T test; p values equal or lower than 0.05 were regarded as signifi cant. The det2 
mutant was previously described by Chory et al (2001) as well as the bri1-201 and bri1-116 
(Li and Chory, 1997; Bouquin et al., 2001). For the AGL15 overexpression lines, the coding 
region (cDNA) of AGL15 under 35S promoter was used (the construct was kindly provided by 
Stefan de Folter and Gerco Angenent, Plant Research International, Bornsesteeg 65, 6708PD, 
Wageningen).   
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Generation of agl15-4 bri1-301 and agl15-4 serk1-1 double mutants
The bri1-301mutant, ecotype Columbia was kindly provided by Jianming Li (Department of 
Molecular, Cellular, and Developmental Biology, university of Michigan) and was previously 
described by Li and Nam, 2002 (Li and Nam, 2002). AGL15 and SERK1 knockout lines, 
agl15-4 and  serk1-1 were obtained from the SALK insertional mutant population (Alonso et 
al., 2003) as insertion lines SALK_076234 and SALK_544330, respectively, described before 
by Lenti-Shiu et al., (2005) (Lehti-Shiu et al., 2005) , Albrecht et al., (2005) (Albrecht et al., 
2005) in Columbia background. bri1-301 agl15-4 mutant line was generated by crossing bri1-
301 with agl15-4, agl15-4 serk1-1 was generated by crossing agl15-4 with serk1-1. In each 
case, the F1 was allowed to self-fertilize, and candidate double F2 plants were genotyped 
phenotypically and by PCR. 
Construction of the CFP/YFP and GST tagged proteins
PCR fragments containing the coding sequence (cDNA) of AGL15 (At5g13790) and 14-3-
3υ (At3g02520) were digested with NcoI for AGL15 or BglII/NcoI for 14-3-3υ and were C-
terminally linked to CFP or YFP in pMON999 plasmid (van Bokhoven et al., 1993). For the 
expression of the protein with GST tag, pGEX4T1 vector was used and the PCR fragments of 
AGL15 and 14-3-3υ were digested with EcoRI/XhoI in both cases and inserted into pGEX4T1 
for N-terminal fusion with GST. All constructs were checked by restriction analysis and were 
verifi ed by sequencing. Protoplast isolation and transfection were performed as described 
before (Aker et al., 2006). FRET-FLIM was measured 16h after transfections as described 
previously (Karlova et al., 2006; Aker et al., 2007). 
Confocal laser scaning microscopy.  
The CFP and YFP fl uorescence in protoplast was imaged using a confocal laser scanning 
microscope 510 (Carl Zeiss, Jena, Germany) excited using the 458 nm and 514 nm laser lines. 
The fl uorescence was detected using a band-pass fi lter (CFP: 470-500 nm, YFP:  535-590 nm). 
Chlorophyll fl uorescence was detected using a 650 nm long pass fi lter.
Fluorescence Lifetime Imaging Microscopy
FLIM was performed using a Biorad Radiance 2100 MP system in combination with a Nikon 
TE 300 inverted microscope as described before (Russinova et al., 2004). From the intensity 
images obtained, complete fl uorescence lifetime decays were calculated per pixel and fi tted 
using a double exponential decay model.
In vitro trans-phosphorylation and LC-MS/MS analysis
Protein expression and GST purifi cation were performed as described before (Shah et al., 
2001). For the in vitro trans-phosphorylation reaction 1μg SERK1-KD was added to 1μg of 
AGL15 or 14-3-3υ with (γ-32P) ATP as described previously by Shah et al (Shah et al., 2001). 
After incubation for 30 minutes at 30 oC, the reaction was stopped by adding Laemmli SDS-
94
Chapter 5
PAGE sample buffer, boiled at 95oC for 5 minutes and separated on 10% SDS-PAGE. The gel 
was stained with Coomassie Brilliant Blue (CBB) to verify equal loading and then dried. The 
radioactive signal was quantifi ed using ImageQuant program of the PhosphoImager scanner 
(Molecular Dynamics). In vitro phosphorylation for MS analysis was performed as described 
above except that 3 μg of each kinase protein was used and (γ-32P) ATP was replaced by 3 
mM of cold ATP. In-gel digestion was performed as described by Shevchenko et al. (ref) and 
Aker et al. Ref and the tandem mass spectrometric analysis and data analysis were done as 
described before (Aker et al., 2007). 
Chromatin immunoprecipitation of AGL15-DNA complex
AGL-15 specifi c antibodies and pre-imune sera were used as a negative control and were 
kindly provided by Sharyn Perry (University of Kentucky, Department of Plant and Soil 
Sciences, Lexington, USA). The chromatin immuno precipitation (ChIP) was performed 
with wild type plant extract from 5 days old seedlings as described before by Wang et al 
(Wang et al., 2002). Co-precipitated DNA was amplifi ed by PCR using the following primers: 
BRI1PF1: CAATCGCACTCACCTCCATGA  and BRI1PR1:TGTAACTATCTATCG- 
CAAGTG  and BRI1P2F: CATCTCGTACAGTGTACTACA and BRI1P2R: AGAATA-
CTATATTGGTACAAG, and SERK1P1F:TATGAGAACACACTGGTAGAT and SERK1P1R:
GATAATATCCTAGTGCAAGTG and SERK1P2F:GTGCATAGCCTTAAGAGCTT, 
and SERK1P2R:CTACGTGAAGTAATAATAAC. Typically 35 to 40 cycles of PCR were 
performed. 
Gel retardation assays
The binding reactions for the gel retardation assays were performed as described 
by (Winter et al., 2002). 120 ng of protein were used per binding reaction. A CArG 
box sequence from the second intron of AGAMOUS was used as DNA probe (5’-
GAAATTTAATTATATTCCAAATAAGGAAAGTATGGAACGTT-3’) (Gomez-Mena et 
al., 2005). The 5’ ends of the double-stranded DNA probes were biotinylated, and 13 fmol 
of probe was used per lane. For competition experiments, unlabelled CArG-box-containing 
DNA, or unlabelled DNA with randomized sequence was added to the binding reaction in 100-
fold molar excess. After native polyacrylamide gel electrophoresis, the DNA was blotted to 
positively charged nylon membranes (Hybond N+, Amersham) and signal detection was done 
using the chemiluminescent nucleic acid detection module (Pierce, Rockford, IL, USA). 
 
Immunoprecipitation and protein detection.
Immunoprecipitation was done as described before (Karlova et al., 2006). For immno 
detection, the proteins were eluted from the beads by adding SDS sample buffer and boiling for 
5 min at 95oC. The proteins were separated on 10% SDS-polyacrylamide gel (Laemmli, 1970) 
and transferred onto nitrocellulose (Schleicher & Schuell) by wet electroblotting (Bio-Rad). 
Bound primary anti-GFP antibodies (produced by Invitrogen) were detected with horseradish 
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peroxidase-conjugated IgG purifi ed donkey anti-rabbit secondary antibodies at 10,000 x 
dilution (Rockland Laboratories) and visualized using reagents for chemiluminiscence 
detection (ECL Plus reagent; Amersham Biosciences).       
Results
BRI1 dependent BR signaling is required for embryogenic competence
To investigate the role of BRs and BRI1 in embryogenic competence, somatic cultures were 
initiated by exposure to 2,4-dichlorophenoxy acetic acid (2,4-D) from wild type, bri1-116 (Li 
and Chory, 1997), bri1-201 (Bouquin et al., 2001) and BRI1-GFP over-expressors (Russinova 
et al., 2004; Geldner et al., 2007) according to the seedling assay (Mordhorst et al., 1998).
Figure 1. BRI1 and BRs are involved in somatic embryogenesis signaling. A. The percentages of 
calli with green embryonic structures after 5 weeks of culture were accounted. Mean and standard error 
of mean are shown. B. Images are representative of the development of callus and green embryonic 
structures (arrowhead) in wild type Col, bri1-201 and det2 mutants. 
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Figure 2. BRs are involved in somatic embryogenesis signaling. A. The percentages of calli with 
green embryonic structures after 5 weeks of culture were accounted. Mean and standard error of mean 
are shown. BR0, Brassinosteroids were added from day 0 of the culturing. BR2, Brassinosteroids were 
added after 2 weeks of culturing. 
After fi ve weeks, the seedling-derived calli that showed green embryonic masses (Figure 1B) 
were counted. As shown in Figure 2, exogenous application of only 2.5 nM of BL (biosynthetic 
BR) at the beginning of the cultures effectively inhibited somatic embryogenesis while 
application of only 2.5 nM of BL after 2 weeks increased somatic embryogenesis about two-
fold (Figure 1 and Table 1). Therefore in all further analyses BL was added after 2 weeks. 
Over-expression of BRI1 also resulted in a clear increase in somatic embryogenesis, while the 
BRI1 alleles bri1-201 and bri1-116 had a very strong reduction in embryogenic competence 
compared to wild type (Figure 1 and Table 1). Both mutants not only suffered from impaired 
embryogenic competence, but also failed to develop a normal proliferating callus as the wild 
type (Figure 1B). Surprisingly, the weak bri1-301 mutant did not show any reduction but 
rather an increase in embryogenic competence comparable to that of an over-expressor line. 
The bri1-301 allele contains a 989G to I mutation in the kinase domain of BRI1. bri1-301 
plants developed smaller, compact rosettes and have less reduced stature compared to severe 
bri1 alleles (Figure 4A) while maintaining full insensitivity to BR of the roots (Li et al., 2002). 
Embryogenic callus typically originates from the vascular procambial tissue close to the shoot 
apical meristem in seedlings (Kwaaitaal and de Vries, 2007) and bri1-301 mutants typically 
have increased procambial cell layers, which might explain the response in embryogenic 
culture. However this increase was not observed in the bri1-116 mutant which is in agreement 
with the strong reduction in the embryogenic competence (data not shown). For comparison 
with the BR perception mutants, homozygous seed stocks of the brassinosteroid biosynthetic 
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mutant (de-etiolated) det2-1 (Chory et al., 1991) were included. The DET2 protein is a 5α-
reductase in the second step of brassinolide biosynthesis and det2-1 mutant plants accumulate 
less then 10% of wild type level brassinosteroids (Fujioka et al., 1997). The biosynthetic 
mutant det2-1 showed a strong reduction in embryogenic competence (Figure 1 and Table 
1) but did produce normal proliferating callus (Figure 1B). As expected, det2 cultures could 
fully be restored by exogenous application of BL, while the perception mutants failed to 
respond, completely in line with what is observed in plant-based assays (Fujioka et al., 1997; 
Li and Chory, 1997) for det2 and bri1 mutants respectively (Figure 1). These results suggest 
that optimized BR signaling mediated by the BRI1 receptor is required for the acquisition of 
2,4-D induced embryogenic competence in Arabidopsis explants.
Table 1 Percentage of seedlings developing embryonic clusters out of SAM upon germination in liquid 
2,4-D containing media of wild type (WT), WT induced with BL, bri1-116, bri1-201, BRI1-GFP, det-2, 
det-2 induced with BL, bri1-301. 
   
SERK1 and AGL15 are involved in BR-induced acquisition of embryogenic 
competence 
Having established a clear link between the acquisition of embryogenic competence and 
BRI1-mediated BR signaling, our next question was whether SERK1 and AGL15 played a 
similar role in this signaling process. SERK1 and AGL15 showed an overlapping expression 
pattern starting from the mature unfertilized ovule, during embryo development as well as 
throughout the vascular system and shoot apical meristem in seedlings (Perry et al., 1996; 
Hecht et al., 2001; Adamczyk et al., 2007; Kwaaitaal and de Vries, 2007). Previously we 
reported that over-expression of SERK1 increased embryogenic competence (Hecht et 
al., 2001), and a similar phenotype was shown for AGL15 (Harding et al., 2003), while an 
agl15 mutant exhibited mildly reduced embryogenic competence (Thakare et al., 2008). As 
   Genotype      Total Na of seedlings         Percentage of EC b      TTEST-p
                                       tested                                                       
   WT                  1080                                33% 
   WT+BL           270                                  60% p≥0.01
 bri1-201          450                                  2.7% p≥0.0000001
bri1-116       270                                  4%  p≥0.000002
BRI1-GFP 180                                  54% p≥0.0001
det2  450                                  13% p≥0.00008
det2+BL  270                                  36% p≥0.0009
bri1-301 270                                   50.6 p≥0.003  
aN, number 
bEC, embryogenic clusters. 
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shown in Figure 3, over-expression of either SERK1 or AGL15 resulted in enhanced somatic 
embryogenesis in the Columbia ecotype, confi rming previous observations made in other 
ecotypes (Figure 3 and Table 2). The SERK1-YFP line used in these experiments showed only 
approximately two-fold over-expression of the SERK1 gene (data not shown) compared to 
WT. Only the serk1-1 (Albrecht et al., 2005) allele exhibits reduced embryogenic competence 
(Figure 3). None of the other serk mutants tested gave a signifi cant reduction in somatic 
embryogenesis while none of the double mutant combinations with a serk1 allele present 
showed more reduction (data not shown). This suggests a specifi c role of the SERK1 receptor 
in the acquisition of embryogenic competence. In contrast to what was observed for the bri1-
201 mutant (Figure 1), application of exogenous BL to the serk1-1 somatic cultures restored 
embryogenic competence to slightly more then untreated WT level, possibly the result of 
enhanced signaling via the main BRI1 receptor as was seen in the WT and independent from 
the presence of one of its co-receptors. This appears to fi t into the more general scheme for 
BRI1 mediated BR signaling, where it is observed that the BR-related phenotypes observed 
in serk mutants are always less severe when compared to those of BRI1 itself (Li et al., 2002; 
Nam and Li, 2002; Karlova et al., 2006; Albrecht et al., 2008); confi rming that BRI1 can 
also perceive and transduce the BR signal in the absence of the co-receptors (Wang et al., 
2005a). 
Table 2 Percentage of seedlings developing embryonic clusters out of SAM upon germination 
in liquid 2,4-D containing media of SERK1-YFP, 35S-AGL15, serk1-1, serk1-1+35SAGL15, 
serk1-1 induced with BL, agl15-4, agl15-4 serk1-1, agl15-4 bri1-301, bri1-301. 
 
  Genotype      Total Na of seedlings         Percentage of ECb      TTEST-p
                             tested                                                          
 SERK1-YFP 450  60 p≥0.00001    
 35S-AGL15 270                              70 p≥0.00002
 serk1-1 900                              23             p≥0.01
serk1-1+ 270  34
 35SAGL15  
 serk1-1+BL 180  39.7 p≥0.03
agl15-4 450  30.5 p≥0.45
agl15-4 serk1-1 540  17.7 p≥0.006
agl15-4 bri1-301 180   399 p≥0.17
aN, number 
bEC, embryogenic clusters.
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Figure 3. The effect of SERK1, and AGL15 on embryogenic potential of seedlings. A. Percentage 
of seedlings that showed somatic embryo development from the SAM, when seeds of the indicated 
genotypes were allowed to germinate for 5 weeks in liquid media containing 2,4-D. Mean and standard 
deviations are shown. B. Double mutant agl15-4 serk1-1 has shorter hypocotyls when seedlings were 
grown on dark for 7 days. At least 20 seedlings were measured.
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We next tested the agl15-4 mutant (Lehti-Shiu et al., 2005), but could not confi rm the previously 
reported mild reduction (Thakare et al., 2008) in somatic embryogenesis for this allele (Figure 
3 A) probably due to the different light conditions used. However, the agl15-4 serk1-1 double 
mutant did show a signifi cant reduction compared to single serk1-1 or agl15-4 (Figure 3 and 
Table 2) mutants, suggesting a synergistic interaction between both genes. Next question was 
if the double agl15-4 serk1-1 mutant has impaired BR signaling. First the root insensitivity 
to BRs was examined. The double mutant was as sensitive as the serk1-1 alone (data not 
shown), which is consistent with the fact that AGL15 is not expressed in roots (Adamczyk et 
al., 2007). Second the double mutant had no stature phenotype different from the wild type, 
but, analyzing the hypocotyls length as an assay for impaired BR signaling, agl15-4 serk1-
1 double mutant showed a signifi cant reduction in hypocotyls length, when grown in the 
dark (Figure 3 B, p≤ 0.01). Next the agl15-4 bri1-301 double mutant was compared with its 
respective parents. The agl15-4 mutation clearly enhanced the BRI1-associated phenotypes 
such as a reduction in the size of the rosette and the infl orescence length (Figure 4A and B). 
No effect was observed on the root insensitivity or the hypocotyls length probably due to 
the fact, that bri1-301 mutant itself is already insensitive to the high concentrations of BL. 
Embryogenic competence was also determined in the agl15-4 bri1-301 double mutant (Figure 
3 A). The results showed a reduction of bri1-301 embryogenesis to a level intermediate of 
both single mutants, confi rming that similar to the double mutant agl15-4 serk1-1, also agl15 
mutation can infl uence the embryogenic competence of the weak bri1-301 allele. This is in 
agreement with the observed enhancement of the stature phenotype. These fi ndings indicate 
that the MADS box transcription factor AGL15 is involved as a novel positive regulator in 
general aspects of BR signaling besides embryogenic competence. Over-expression of AGL15 
restored the observed limited reduction in embryogenic competence in serk1-1 mutant calli 
to wild type level. Surprisingly the strong over-expression phenotype of AGL15 in WT is 
lost in the serk1-1 mutant background, indicating that AGL15 is not only a direct target of 
BRI1 and SERK1 signaling, but also acts as a regulator of SERK1 expression. This is in line 
with the fact that AGL15 over-expression can enhance SERK1 expression in SE cultures 
(Harding et al., 2003). To verify whether AGL15 can directly bind to the promoter of SERK1, 
chromatin immuno precipitation using AGL15 specifi c antibodies (kindly provided by Sharyn 
Perry, University of Kentucky, Department of Plant and Soil Sciences, Lexington, USA) was 
performed. Five days old seedlings were used and immuno precipitation was performed as 
described by Wang et al., (Wang et al., 2002). The SERK1 and BRI1 genomic sequences were 
analyzed for precise canonical CArG motifs as putative MADS box transcriptional regulator 
targets (Tang and Perry, 2003). Four primer pairs were designed near the identifi ed motifs 
for measurement of DNA enrichment by PCR. As shown in Figure 5 A, for both SERK1 and 
BRI1 promoter elements enrichment was observed, suggesting that AGL15 indeed is able to 
bind directly to these sites in vivo and could indeed be a regulator of SERK1 as well as BRI1 
expression. The specifi c binding of in vitro produced GST-AGL15 protein to the CArG box 
sequence is shown on Figure 5 B. All three bands visible are specifi c since there are no longer 
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present after incubation with the unlabeled CArG box containing DNA (Figure 5 B and C). 
Figure 4. AGL15 function in brassinosteroid signaling. agl15-4 mutation enhances the weak bri1-
301 mutation. A, 5 weeks old plants are shown. B, Reduction of the infl orescence length and the rosette 
width of the double agl15-4 bri1-301 mutant. At least 10 plants were measured. 
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Figure 5. A. Chromatin immunoprecipitation. Enrichment of the SERK1 and BRI1 promoter 
fragments. No enrichment was observed using preimmune serum as a negative control- C-. B and C, 
Gel retardation experiments with biotinylated DNA probes and with GST-AGL15 and/or GST-14-3-3ν, 
GST-SERK1 and GST-SERK1L330E   proteins in vitro purifi ed. 
BL induces nuclear localization of AGL15  
Recently, it was shown that BR induces rapid nuclear trans-location of BZR1, a transcription 
factor involved in brassinosteroid signaling (Gampala et al., 2007; Ryu et al., 2007). To clarify 
whether BR regulates nuclear localization of AGL15, the transcription factor was coupled 
to either a cyan or yellow fl uorescent protein (AGL15- YFP or AGL15-CFP) and analyzed 
in absence and presence of BR. When AGL15-CFP/YFP was transiently expressed in Col-0 
Arabidopsis leaf protoplasts the labeled protein was localized both in the nucleus and in the 
cytoplasm (Figure 6A). In the det2 (BR biosynthesis mutant) protoplasts, AGL15-CFP was 
completely absent from the nucleus in 70% of the transfected cells (Figure 6B). A similar result 
was observed when Col-0 protoplasts expressing AGL15-CFP were treated with brassinazole 
(BRZ), an inhibitor of BR biosynthesis (data not shown). To confi rm wheteher the nuclear 
localization of AGL15-CFP is BL dependent, det2 protoplasts expressing AGL15-CFP, were 
treated with BL. As shown in Figure 6C, AGL15-CFP clearly appeared in the nucleus after 
3h of BL application. In contrast, in untreated cells AGL15-CFP remained in the cytoplasm 
(Figure 6D).
Interaction between SERK1 and AGL15 occurs at the plasma membrane and requires 
14-3-3ν
Molecular interactions between SERK1 and AGL15 was demonstrated by applying Förster 
Resonance Energy Transfer (FRET) detected by Fluorescence Lifetime Imaging Microscopy 
(FLIM) in a transient protoplast assay (Russinova et al., 2004). In these experiments SERK1-
CFP was used as a donor and the AGL15-YFP as acceptor fl uorescent proteins. By comparing 
the donor fl uorescence lifetimes in absence and presence of acceptor will be a read-out for 
monitoring molecular interactions spatially resolved. In fi gure 7A I confocal images show that 
SERK1-YFP and AGL15-CFP are localized at the PM however FRET-FLIM measurements 
showed no reduction of the donor lifetimes and no FRET was observed (Figure 7B IV). 
Therefore we asked whether the 14-3-3ν protein (Karlova et al., 2006) could be a mediator 
between both, perhaps in analogy to what was shown for 14-3-3λ in case of BZR1/BES1 
(Gampala et al., 2007). As shown in Figure 7A II , SERK1 co-localizes with 14-3-3ν at the 
plasma membrane while AGL15-CFP and 14-3-3ν-YFP co-localize at the plasma membrane, 
in the cytoplasm as well as in the nucleus (Figure 7A III and IV). Subsequently FRET 
between the three proteins was determined in all 6 possible combinations (only 3 donor-
acceptor combinations are shown in Figure 7 B). The mean fl uorescence lifetime of the donor 
molecules in cells expressing AGL15-CFP alone was determined at the PM (Figure 7B I) and 
in the nucleus (Figure 7B II). The average lifetime of 14-3-3ν-CFP alone was also recorded at 
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the PM and found to be identical with a value of 2.5 ns (Figure 7B III and Table3). The results 
presented in Figure 7B IV show that AGL15-CFP and SERK1-YFP do not interact directly at 
the plasma membrane, since no reduction of the fl uorescence lifetime compared to the τ of the 
donor molecules was observed in any of the 29 cells tested.
Figure 6. Brassinosteroids are essential for the nuclear localization of AGL15. Arabidopsis leaf 
protoplasts of wild type Col (A) or det2 mutant plants (B, C and D) were transfected with AGL15-CFP 
alone (A)  or co-transfected with AGL15-CFP and CDC48C-YFP (nuclear marker), (B, C and D). After 
incubation for 16h the transformed protoplasts were pictured on CLSM (B) or after 18h (D), or treated 
with 100μ epi-brassinolide for 3h (C).
A similar result was obtained when the CFP and the YFP tags were changed between both 
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proteins (data not shown). In contrast, AGL15-CFP and 14-3-3υ-YFP did show an interaction 
at the plasma membrane and exhibited a signifi cant reduction in the average lifetime (τ) from 
2.5 to 2.03 ns of the donor AGL15-CFP molecule (Figure 7B VII). This reduction was not 
equally distributed over the membrane and exhibited a typical punctuate pattern that was 
also observed previously when comparing the direct interaction between receptor molecules 
(Russinova et al., 2004) and between the receptors and CDC48 proteins (Aker et al., 2006). 
A similar phenomenon was observed in the nucleus, where AGL15-CFP and 14-3-3υ-YFP 
co-localize and interact in a spotted pattern (Figure 7B V and Table 3). Such spotted patterns 
are routinely observed when determining interaction properties between other members of 
the MADS box transcription factors family (Tonaco et al., 2006) and are not the result of 
over-expression of the proteins in the protoplasts. These results show that in the physiological 
conditions of the protoplasts, a subset of the AGL15-CFP protein is in a complex with 14-3-
3υ-YFP. SERK1-YFP interacts with 14-3-3υ-CFP at the plasma membrane (Figure 7B VI), as 
evidenced by an average lifetime reduction of 2.00 ns for the donor (14-3-3υ-CFP). However, 
there appear to be less areas of strong interaction when compared to AGL15-CFP/14-3-3 υ-
YFP. These data suggests that a subset of the SERK1 receptors reside in a protein complex at 
the PM with a subset of AGL15 molecules most probably by employing the adaptor or scaffold 
protein 14-3-3. To confi rm that the observed subset of AGL15-CFP proteins interacting 
with 14-3-3υ-YFP is the same subset of SERK1-YFP interacting with 14-3-3υ-CFP, a co-
immunoprecipitation experiment was performed using AGL15 specifi c antibodies (Wang et 
al., 2002) to detect AGL15 in transgenic seedlings expressing SERK1-CFP. The precipitated 
proteins were analyzed by immunobloting procedure using anti-GFP antibodies. A band with 
the expected mobility of SERK1-CFP was detected (Figure 7C a) which was not present in 
the negative control, precipitated with rabbit preimmune serum (Figure 7C b). These data 
confi rm the presence of AGL15 in the SERK1 receptor complex in planta while previously 
the presence of 14-3-3 proteins in the SERK1 complex was established (Rienties et al., 2005; 
Karlova et al., 2006).
Protein τ PM 
  ns 
FRET Eff. 
      % 
τ N 
ns 
FRET Eff. 
      % 
Number of 
cells 
A-C 2.44 ± 0.03    -                            2.5 - 5 
A-C/S-Y 2.44 ± 0.04 - - - 29 
A-C/14-Y 2.03 ± 0.06 17 2.23 ± 0.10 11 30 
14-C  2.45 ± 0.02 - - - 5 
14-C/S-Y 2.00 ± 0.09 18 - - 11 
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Table 3. FRET-FLIM analysis. Lifetime τ is determined as described in “Materials and Methods”. 
PM is plasma membrane, N is nucleus. FRET Eff. Is FRET effi ciency. A-C is AGL15-CFP, S-Y is 
SERK1-YFP, 14-Y is 14-3-3υ-YFP, 14-C is 14-3-3υ-CFP, A-C/S-Y is AGL15-CFP/SERK1-YFP, A-
C/14-Y is AGL15-CFP/14-3-3υ-YFP, 14-C/S-Y is 14-3-3υ-CFP/SERK1-YFP.  
Figure 7. A, I. Co-localization of SERK1-YFP with AGL15-CFP in transfected protoplast on the 
plasma membrane. II. Co-localization of SERK1-CFP with 14-3-3υ-YFP on the plasma membrane. 
III. Co-localization of AGL15-CFP and 14-3-3υ-YFP on the plasma membrane. IV. Co-localization of 
AGL15-CFP and 14-3-3υ-YFP in the nucleus. B. FRET between SERK1, AGL15 and 14-3-3υ imaged 
by FLIM on Arabidopsis protoplast transiently expressing AGL15-CFP (I and II) or 14-3-3υ-CFP (III) 
alone, AGL15-CFP/SERK1-YFP (IV), AGL15-CFP/14-3-3υ-YFP (V), 14-3-3-CFP/SERK1-YFP (VI) or 
AGL15-CFP/14-3-3υ-YFP (VII) for 16h. Mean fl uorescence lifetime values (τ) and lifetime distribution 
for the images I to VII are presented as pseudo color images. The arrow heads point to an area with 
a short lifetime, indicative of FRET. Note the color bar, where dark blue is used to show a τ of 2.5 ns 
(no interactions) and light green or yellow is used to show a τ of 2 ns (interactions). C, protein extract 
from SERK1-CFP transgenic seedlings was precipitated with anti-AGL15 antibodies (a). As a negative 
control a protein extract was precipitated with preimune serum (b). D. In vitro trans-phosphorylation 
of AGL15 and 14-3-3υ by SERK1 kinase domain protein. Left, Phospho image of AGL15 (lane 2) 
and 14-3-3υ (lane 3) trans-phosphorylated by SERK1. Lane 1 shows autophosphorylation activity of 
SERK1 alone. Right panel, Equal loading and size control of GST-SERK1-KD (lane 1), GST-SERK1-
KD together with GST-AGL15 (lane 2), GST-SERK1-KD and GST-14-3-3υ (lane 3).
AGL15 and 14-3-3υ are substrates of the SERK1 kinase domain
Having established that AGL15 and 14-3-3υ are part of the PM-located SERK1 receptor 
complex we next aimed to determine whether the SERK1 kinase domain (KD) (Shah et al., 
2001) can trans-phosphorylate AGL15. The SERK1-KD, AGL15 and, the 14-3-3υ proteins 
were expressed in E. coli as N-terminal GST fusion proteins and purifi ed on glutathione resins. 
Phosphorylation assays were performed by incubating the AGL15 or 14-3-3υ with SERK1-
KD in presence of radioactive γP32 –ATP. As shown on Figure 7D, lane 1, SERK1 is heavily 
autophosphorylated and can trans-phosphorylate both AGL15 and 14-3-3υ proteins (Figure 
7D, lane 2 and 3). In case of the 14-3-3υ protein these results confi rmed previous work using 
the 14-3-3λ protein as a target of SERK1 (Rienties et al., 2005). To identify the phosphorylated 
sites, liquid chromatography (LC)-tandem mass spectrometry (MS/MS) was employed. The 
50 kD GST-AGL15 and GST-14-3-3υ proteins were in gel digested with trypsin, and the 
peptides were measured using an LCQ. More than 75% sequence recovery of the proteins was 
achieved and phosphorylated residues in AGL15 or 14-3-3υ proteins were only identifi ed after 
incubation with active SERK1 protein. For 14-3-3υ two threonines (T-34 and T-211) were 
found to be phosphorylated and for AGL15, three sites were found to be phosphorylated by 
SERK1 in a part of the protein that is rich on serines and threonines. As a result, we could not 
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precisely determine the trans-phosphorylated (S-58, S-59 or T-60, S-173 or T175, and T-209 
or T-210) residues. 14-3-3 proteins are known to bind to specifi c phosphorylated sequences. 
A potential although not perfect 14-3-3 binding site sequence was identifi ed in AGL15 at 
amino acids 168-175 (RSFLPSF), where S-173 was found to be phosphorylated by SERK1, 
corresponding to S-173 in the 14-3-3 binding site of BZR1 transphosphorylated by BIN2 (Ryu 
et al., 2007). Having determined that AGL15 can be trans-phosphorylated by SERK1, we 
examined now if the phosphorylation is affecting the binding of the transcription factor to the 
CArG box DNA sequence. As shown on Figure 5 B and C performing the binding reaction in 
presence of kinase buffer (KB) and ATP already inhibit the reaction. Addition of 14-3-3 does 
not change the binding capacity of AGL15 as well as SERK1-mediated phosphorylation, since 
the binding of AGL15 is the same in presence of an active SERK1 kinase or of  the mutated 
SERK1K330E kinase, which has no auto and transphosphorylation activities (Shah et al., 2001) 
(Figure 5 C). Apparently AGL15 phosphorylation does not affect its transcriptional activity, 
in contrast to BIN2-mediated phosphorylation of BES1, which resulted in a complete loss of 
its DNA-binding activity (Vert and Chory, 2006).      
      
Discussion
In this study we aimed to investigate the role of SERK1, AGL15 and BRI1 in the somatic 
embryo formation from SAM. SERK1 and AGL15 previously were shown to play a role in 
this signaling pathway (Hecht et al., 2001; Harding et al., 2003; Thakare et al., 2008). Our data 
shows that loss of function of SERK1 alone or in combination with loss-of function of AGL15 
signifi cantly decreases somatic embryogenic competence in culture. Furthermore to extend 
our previous observation that SERK1, AGL15 and BRI1 are found to be present in one protein 
complex (Karlova et al., 2006) we examined the role of BRI1 in the acquisition of embryonic 
competence. Both BRs and BRI1 were found to be essential for this process. The loss of 
function allele of AGL15 was found to enhance aspects of defective brassinosteroid signaling 
in combination with a weak serk1-1 or bri1-301 alleles, suggesting that it is a positive regulator 
in both somatic embryogenesis and BR signaling. The nuclear localization of AGL15 was BR 
dependent and using FRET by FLIM we proposed that AGL15 interacts via 14-3-3ν with 
SERK1 at the plasma membrane. 
Somatic embryogenesis and BR signaling mediated trough BRI1, SERK1 and AGL15 
Plant stem cells, contained in specialized structures called meristems, have amazing 
regenerative powers. They enable plants to grow and produce new organs throughout lifetimes, 
that can span hundreds of years (Weigel and Jurgens, 2002). Plant cells can undergo an 
alternative form of embryo formation called somatic embryogenesis, a process that does not 
require formation of a zygote by fertilization (Mordhorst et al., 1998). Thus in contrast with 
the mammals a single differentiated plant cell in culture can be induced to shift their fate 
towards stem cell fate by application of exogenous auxins. Understanding how the process of 
differentiation can be reversed in plant cells could contribute to stem-cell biology in other 
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systems as well. In Arabidopsis SERK1 ectopic expression increases somatic embryo 
formation in culture (Hecht et al., 2001) and in several plant species, homologs of SERK gene 
were discovered, where the gene was also found to be a marker for embryogenic potential like 
sunfl ower  (Thomas et al., 2004) and rice (Hu et al., 2005). Another gene that was shown to 
increase SE formation, when over-expressed is the MADS box transcription factor, AGL15 
(Harding et al., 2003). Recently AGL15 was shown to act redundantly with its homolog, 
AGL18 in two processes: somatic embryogenesis (Thakare et al., 2008) and in the control of 
fl owering time (Adamczyk et al., 2007). Interestingly BRI1 and BRs were found to 
predominantly functioned as a fl owering-time enhancer (Domagalska et al., 2007). AGL15 
together with BRI1 and SERK3 have been identifi ed as a components of SERK1 protein 
complex (Karlova et al., 2006). Relevant to this fi nding in this study we could confi rm a 
synergistic interaction between both AGL15 and SERK1 genes. Although SERK1 (Karlova 
et al., 2006; Albrecht et al., 2008) was shown to be in a complex with SERK3 and both 
proteins can participate in brassinosteroid signaling by being co-receptors of BRI1 (Li et al., 
2002; Nam and Li, 2002; Karlova et al., 2006), only SERK1 and none of the other members 
of the SERK family was found to have a role in somatic embryogenesis. Somatic embryogenesis 
can be induced in addition of over-expression of specifi c genes by use of specifi c hormone 
treatments. Both SERK1 and AGL15 are expressed in response to auxin treatment (Hecht et 
al., 2001; Zhu and Perry, 2005; Kwaaitaal and de Vries, 2007). In Arabidopsis, AGL15 was 
shown to act via control of gibberillin (GA) metabolism. Chromatin immunoprecipitation 
(ChIP) analysis showed that a GA2-oxidase (AtGA2ox6) is a downstream target of AGL15. 
GA2-oxidase converts biologically active GA to inactive forms. A decrease in biologically 
active GA caused an increased in SE, whereas addition of active GA led to a decrease in SE 
production (Wang et al., 2004). Using the same ChIP method we found that AGL15 can bind 
specifi cally to the promoter elements of SERK1 and BRI1, and probably as shown before for 
the embryogenic callus (Harding et al., 2003) to positively regulate their expression. Since 
BRI1 was found in the SERK1 protein complex and BRI1 can bind directly BRs (Kinoshita 
et al., 2005) we fi rst investigated the role of  brassinosteroids in the process of somatic 
embryogenesis. BRs were shown to regulate cellular expansion, differentiation and 
proliferation and are involved in diverse processes (Karlova and de Vries, 2006), but were 
never shown to play a role in somatic embryogenesis. Our data showed that BRs can enhance 
the somatic embryo competence in liquid culture in presence of auxin, which points to a 
synergetic effect of the two hormones in agreement to the cross talks observed before 
(Nakamura et al., 2003). Both BRs and auxin signaling pathways were shown to activate the 
transcription of IAA biosynthesis and auxin-responsive genes (Nakamura et al., 2003). 
Moreover, BRs were shown to stimulate polar auxin transport and to modify the distribution 
of endogenous auxin (Li et al., 2005). Interestingly our data suggests that BRs can enhance as 
well as inhibit the somatic embryogenesis and more specifi cally the proliferation, depending 
on the time of the application. When BRs are applied from the begging of the liquid culture 
no proliferation and formation of somatic embryos was observed (Figure 2) and even more the 
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wild type seedlings in these cultures were mimicking the phenotype of the strong homozygous 
bri1-201 seedlings, when grown in liquid. Moreover the BR biosynthetic mutant det2 (Chory 
et al., 1991) showed strong reduction in the embryogenic competence, which could be rescued 
by exogenous application of BL. BRI1 is the receptor perceiving and transducing the BR 
signaling (Li and Chory, 1997; Kinoshita et al., 2005). In this study we determined a new role 
of BRI1 receptor in acquisition of embryogenic competence in somatic cells. BRI1 over-
expression in analogy to SERK1 and AGL15 and addition of BRs can enhance, while bri1 
strong mutant alleles showed very limited embryogenic competence. An exception of these 
fi ndings was the weak bri1-301 mutant, which did not show any reduction, but instead an 
increased embryogenic competence. In Arabidipsis the property to form embryogenic cells in 
tissue culture is restricted to the vascular (pro-cambium) stem cell or transit amplifying (TA) 
cell and is not shared with the stem cells in the apical meristem, because mutants lacking a 
functional SAM like shoot meristemless, wuschel and zwille/pinhead did not show a reduction 
in embryogenic competence (Mordhorst et al., 2002). Therefore we analyzed further the 
infl orescence stem vascular organization of bri1-301 mutant and found out that bri1-301 
mutant had increased number of procambial cell layers, which might explain the increased 
embryogenic competence. Unlike det2, which embryogenic competence was fully rescued by 
exogenous application of BL, strong bri1 mutants failed to respond, in line with their 
insensitivity to the BRs on hypocotyls, root and plant level (Clouse et al., 1996; Fujioka et al., 
1997; Li and Chory, 1997). In this study we could establish also a direct link between the 
three proteins identifi ed in the SERK1 receptor complex, which participate in the process of 
somatic embryogenesis. Previously SERK1 was identifi ed to participate in BR signaling as a 
co-receptor of the main receptor, BRI1 (Karlova et al., 2006). The SERK1 mutant allele serk1-
1 was found to enhance the phenotype of the weak BRI1 allele bri1-119. Moreover recent data 
of Albrecht et al., (Albrecht et al., 2008) showed that from the SERK family only serk1 but not 
serk2, serk4 or serk5 mutant alleles enhance the BR insensitivity of serk3-1 mutant roots and 
hypocotyls. It was shown that the interaction between SERK3 and BRI is enhanced upon BR 
stimulation (Wang et al., 2005b). Although our data suggest that the interaction of BRI1 and 
SERK1 is not dependent on the kinase activity of BRI1, the phosphorylation status of SERK1 
is also brassinosteroid-dependent (Karlova et al., 2008 in press). Auto- or trans phosphorylation 
of the C- terminus of BRI1 was shown to be instrumental in enhancing the kinase activity of 
BRI1, as well as promoting its affi nity for the co-receptor BAK1 (Wang et al., 2005b; Wang 
et al., 2005a). After hetero-oligomerization, BAK1 accelerated internalization by endocytosis 
of BRI1 (Russinova et al., 2004). SERK1, is also able to interact with BRI1 and appears to 
modulate BRI1 signaling in a manner similar to that observed for BAK1 (Karlova et al., 2006; 
Albrecht et al., 2008). Although the precise stoichiometry is not yet known, the emerging 
picture suggests that SERK and BRI receptors exist as homodimers in the absence of ligands 
and form ligand-induced tetrameric complexes, analogous to the receptor complexes of 
mammalian transforming growth factor–β (TGF-β) receptors. At the cell surface, the ligand 
binds a complex of transmembrane receptor serine/threonine kinases (types I and II) and 
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induces trans phosphorylation in the type I receptor by the type II receptor kinases. The 
consequently activated type I receptor phosphorylate selected Smads at C-terminal serines. 
Activated Smad (R-Smad) complexes translocate into the nucleus, where they regulate 
transcription of target genes. R-Smads shuttle between nucleus and cytoplasm (Derynck and 
Zhang, 2003). In analogy to this model BRI1 in Arabidopsis could be the mechanistic 
counterpart to the type II receptor, and SERK3 or SERK1 have a role similar to the type I 
receptor. Then upon activation by BRI1 (type II), SERK1 is activated and phosphorylate 
AGL15 (R-Smad) at the C-terminus as shown by our trans-phosphorylation data. This 
activation of AGL15 leads to its translocation from the cytosol to the nucleus, which is 
dependent in analogy to the Smad protein on the presence of the ligand, in our case BRs. In 
agreement with our data, AGL15 is a positive regulator of somatic embryogenesis as well as 
BRs signaling. The AGL15 mutant allele agl15-4 was found to enhance the phenotype of the 
weak BRI1 allele bri1-301 as well as serk1-1. Moreover we show that the nuclear translocation 
of AGL15 is dependent on the presence of BRs and that AGL15 interacts with SERK1 at the 
plasma membrane via the 14-3-3ν protein.       
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Most biological processes are governed by multiprotein complexes rather than individual 
proteins. Identifi cation of protein complexes therefore is becoming increasingly important to 
gain a molecular understanding of cells and organisms. Receptors for example represent an 
abundant class of integral membrane proteins that transmit information on various types of 
signals within the cell. Receptor signaling and regulation can be characterized as a dynamic 
process that is dependent on direct as well as indirect coupling between receptors and their 
interacting partners (Kabbani, 2008). Besides that the receptors are distributed throughout 
the cell at different subcellular localization at different time points. This translocation also 
requires different interacting partners and assembly of different complexes. Therefore the 
capture of receptor complexes in their full integrity and in suffi cient purity and quantity 
remains a primary challenge. Several methods have been developed to identify receptor 
complexes in cells. The most common method used is immunoprecipitation, which makes 
use of specifi c antibodies to isolate target proteins out of complex sample mixtures. The 
immunoprecipitation is often followed by 1- or 2-D electrophoresis for separating the isolated 
protein complexes followed again by, nano HPLC mass spectrometric analysis to identify 
proteins. In this thesis an approach was establish for isolating complexes of transmembrane 
plant receptors (chapter 2 and 3) based on single step purifi cation using GFP as a bait protein 
fused to the protein of interest in our case SERK1, SERK3 and BRI1 receptors. Quite often 
tandem affi nity purifi cation (TAP) is used for protein complex isolation. The fi rst TAP tag 
used consisted of three components: a calmodulin-binding peptide, a TEV protease cleavage 
site, and Protein A as a Ig-binding domain. TAP of protein complexes was fi rst demonstrated 
in yeast (Rigaut et al., 1999). Because proteins are present in a high dynamic range, varying 
from only 10-100 copies to more then 107 copies per cell (Van Leene et al., 2008), and because 
they cannot be amplifi ed like polinucleotides by PCR, the success rate of TAP and single 
tags purifi cation depends on the amount of protein complexes purifi ed and the sensitivity of 
the MS as well as the amount of the background proteins binding. In general, using tandem 
affi nity purifi cation will reduce the amount of the background proteins but also the less 
abundant and/or stable interacting partners will be lost. From the other hand the single tag 
purifi cation (for example GFP used in this thesis) is a quicker method (which will benefi t the 
purifi cation of less stable interactors) but also more “dirty” then the TAP method and will 
result in more background proteins which subsequently will reduce the number of the identifi ed 
proteins. Actually for unraveling the entire composition of receptor protein complexes the 
combination of methods is required as well as combination of different mass spectrometers 
which use different ionization methods. In any case the identifi ed interacting partners then 
should be validated by other methods like western blotting, co-localization of the receptor 
and the putative binding protein within the cells, FLIM etc. One of the best studied plant 
receptors is BRI1. BRI1 can bind directly to its ligand, brassinosteroids and regulate cellular 
expansion, differentiation and proliferation (Li and Chory, 1997; Clouse and Sasse, 1998; 
Altmann, 1999). On the basis of genetic screens, a second LRR-RLK, a member of the SERK 
family, BAK1 (SERK3) was identifi ed as interacting partner of BRI1. Another receptor from 
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the SERK family, SERK1 was found to function redundantly with SERK2 in male sterility 
(Albrecht et al., 2005). Because of protein redundancy and high sequence homology in the 
SERK family we developed an alternative to the genetic screens approach to determine the 
functions of a protein by identifying its interacting partners as described in chapter 2 and 3. 
The Immunoprecipitation of the membrane receptors with specifi c antibodies was followed 
by mass spectrometry and identifi cation of the protein present in the receptor complex. This 
method identifi ed not only specifi c partners for SERK1, which help to unravel the function of 
this receptor for example in the brassinosteroid signaling (chapter 2), but also for SERK3 and 
BRI1 (chapter 3). As described in chapter 2, two other receptors were identifi ed to be present 
in SERK1 protein complex, BRI1 and SERK3 and further genetic analysis showed that indeed 
the SERK1 mutant allele serk1-1 could enhance the phenotype of the weak BRI1 allele bri1-119. 
Furthermore, using Blue Native Gel Electrophoresis we showed that SERK1 and SERK3 are 
part of BRI1 containing multiple protein complexes with a relative mass between 300 and 500 
kDa and in contrast to the co-receptors, only a small percentage of the BRI1 protein is present 
in high order complex(es) and most of it is present as a homo or heterodimer (chapter 2). In 
agreement with these data recent studies of Albrecht et al., (Albrecht et al., 2008), showed that 
from the fi ve SERK family members indeed only SERK1 and SERK3 are involved in the BRs 
signaling pathway. SERK3 was also shown to be differentially phosphorylated upon treatment 
with BRs, which also enhanced its affi nity to interact with BRI1 (Wang et al., 2005b). Similar 
to these data in chapter 4 we showed that BRs could enhance the phosphorylation status also 
of SERK1 and that the kinase activity of BRI1 is not necessary for their dimerization. Other 
interacting partners were identifi ed to be present in SERK1 as well as in SERK3 receptor 
complexes like CDC48A and 14-3-3s proteins. Interestingly we identifi ed the BAG1 (Bcl-2-
associated athanogene) protein in SERK3 receptor complex. BAG proteins are distinguished 
by a common conserved region located near the C terminus termed the BAG domain (BD) 
involved in interaction with Hsp70 proteins. Some of them, like AtBAG1, contain a ubiquitin-
like domain at the N terminus (Doukhanina et al., 2006). The plant BAG proteins were also 
shown to have a function in cell protection under stress and inhibition of plant programmed 
cell death that shares features associated with apoptosis. This observation is in line with the 
postulated function of SERK3 to play a role in negative regulation of a cell death pathway 
independent of its role in brassinosteroid signaling (He et al., 2007). Further analyses are 
needed in order to understand how this signaling pathway is regulated. It was shown that 
after hetero-oligomerization, SERK3 accelerated internalization by endocytosis of BRI1 
(Russinova et al., 2004), although the localization and turnover of BRI1 are independent of 
ligand (Russinova et al., 2004; Geldner et al., 2007). In line with the observed presence of the 
two receptors in endosomal compartments we identifi ed members of the small Ras related 
GTPases in both SERK3 and BRI1 complexes, which could indicate that there are similar 
mechanisms in the vesicle traffi cking for both BRI1 and SERK3 receptors (chapter 3). 
Activation of many kinases is a key regulator in their signaling. For example auto-or 
transphosphorylation of the C-terminus of BRI1 was shown to be important for enhancing 
116
Chapter 6
the kinase activity of BRI1, as well as promoting its affi nity for the co-receptor BAK1 (Wang 
et al., 2005b; Wang et al., 2005a). Only for a few plant receptors, including BRI1 and BAK1, 
the autophosphorylation sites have been identifi ed (Oh et al., 2000; Wang et al., 2005b). After 
BR treatment the BRI1 receptor autorphosphorylates at least 6 residues that were identifi ed in 
vivo and corresponded to the same residues as previously identifi ed from the in vitro produced 
BRI1 protein. To test if the in vivo phosphorylation level of SERK1 was also regulated by 
exogenously applied brassinosteroids (BR) we identifi ed the in vivo phosphorylation sites 
in SERK1 receptor. Interestingly and in contrast with BRI1 most of the sites were already 
phosphorylated in SERK1 in vivo and only one site in the C-terminal tail was observed to be 
differentially phosphorylated after BRs stimulation (chapter 4). Since members of the SERK 
family were found to participate in different signaling pathways we compared in chapter 4 
the kinase activity and identifi ed the auto-phosphorylation sites in all 5 members in order to 
investigate if there is a link between the different kinase activity and functions. Surprisingly 
although SERK1 and SERK2 were found to have redundant function, SERK1 was found to 
be more active than SERK2 with 22 compared to 7 sites phosphorylated in vitro respectively. 
For SERK3, 8 phosphorylated sites were identifi ed, which were similar to the one identifi ed 
in SERK1 and SERK2, especially the sites in the activation loop, which point to the similar 
mechanism of activation of all the members of the family. Low autophosphorylation activity 
was observed for SERK4 and SERK5, where protein stability problems were observed for 
SERK4. Using mutagenesis in the SERK1 kinase domain, residue Ser-562 was found to 
control the full autophosphorylation activity. As shown before, SERK1 (chapter 2) and BAK1 
(Wang et al., 2005b) co-immunoprecipitate in vivo with BRI1 and BL treatment can increase 
the amount of BAK1-GFP associated with BRI1-Flag. Our data from chapter 4 support this 
model and indicate that SERK1 and BRI1 can both trans-phosphorylate each other. Also the 
SERK1 Thr-462 residue, that was found to be trans-phosphorylated by BRI1-KD in chapter 
4, was shown to play an important role in auto- and trans-phosphorylation activity before 
(Shah et al., 2001). The BRI1 activation model involves inhibition of the kinase activity 
by its C-terminal tail, which is relieved upon ligand binding to the extracellular domain. 
After activation, BRI1 can trans-phosphorylate the SERK1 kinase domain on Thr-462, that 
subsequently leads to activation and increased kinase activity, including phosphorylation of 
the C-terminally located Ser-562 as found in chapter4. Our data therefore suggest a complex 
pattern of both intra- and intermolecular control of SERK1 kinase activity and point to a 
tetrameric active complex formation of SERKs with BRI1 in analogy to the TGF-β family 
in animals. SERK1 was also shown to increases somatic embryogenesis in culture, when 
overexpressed (Hecht et al., 2001), suggesting that SERK1 mediated signaling is required for 
acquisition of embryogenic competence in somatic cells. Plant cells can undergo an alternative 
form of embryo formation called somatic embryogenesis upon appropriate stimulation with 
plant growth regulators such as auxin and cytokinin. This reveals the underlying totipotent 
character of a plant cell, but the question of how fully differentiated plant cells become 
stem cells again remains. In chapter 5 we aimed to answer this question by investigating the 
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signaling pathway required for acquisition of the embryogenic competence in somatic cells. 
These cells in Arabidopsis are derived from procambium cells in the vascular tissue and were 
shown to express the SERK1 gene (Kwaaitaal and de Vries, 2007). Another protein, which 
overexpression result in enhanced somatic embryogenesis is AGAMOUS-like 15 (AGL15) 
(Harding et al., 2003). A loss-of-function mutants of AGL15 exhibits decreased ability to 
form somatic embryos (Thakare et al., 2008). We identifi ed AGL15 as a component of the 
SERK1 protein complex (chapter 2), suggesting a direct link in the form of a very short signal 
transduction chain between both. In chapter 5 the functional involvements in the somatic 
embryogenesis and BR signaling of the proteins found to be present in the SERK1 receptor 
complex was investigated. The loss-of-function alleles serk1 alone or in combination with 
agl15-4 signifi cantly impair somatic embryogenesis. Furthermore AGL15 mutant allele 
agl15-4 also aggravated general phenotypes of a weak bri1-301 and serk1-1 mutant alleles, 
suggesting that it acts as a positive regulator in BR signaling. Moreover in this study (chapter 
5) for the fi rst time we provided evidence that the main BRI1-mediated BR signaling pathway 
is required for the acquisition of embryogenic competence. Both exogenous application of 
BRs and overexpression of BRI1 enhances somatic embryogenesis while bri1 strong mutant 
alleles and the BR biosynthesis mutant det2 show strongly reduced embryogenic competence. 
In det2, but not in the perception mutant bri1-201, somatic embryogenesis can be rescued 
by exogenous BRs application. The physical interaction of all the proteins found in the 
SERK1 receptor complex was investigated by using fl uorescent lifetime imaging microscopy 
to determine FRET between fl uorescently tagged proteins. Using this technique we fond 
that AGL15 interacts via 14-3-3nu at the plasma membrane with SERK1 (chapter 5). 14-3-3 
proteins are scaffold proteins that are highly conserved in all eukaryotes. They participate 
in various signal transduction and regulatory processes by interacting with diverse target 
proteins in a sequence-specifi c and phosphorylation-dependent manner (Ferl, 1996; Fulgosi 
et al., 2002). Recently it was show that 14-3-3s participate also in BR signaling by interacting 
with the BZR1 protein that has been phosphorylated by BIN2 (Gampala et al., 2007; Ryu et al., 
2007). Our data from the complex isolation of the BRI1 receptor showed that 14-3-3 is a part 
of this complex in vivo (chapter 3). Brassinosteroids were also shown to regulate the nuclear 
localization of BZR1 and BZR2 proteins. In chapter 5 we observed similar effect of BRs on 
AGL15 nuclear translocation. Moreover using chromatin immunoprecipitation AGL15 was 
found to specifi cally bind to the promoter elements of SERK1 and BRI1, thus forming a novel 
positive feedback control loop in their signaling. 
The research described in this thesis provides a new powerful technique for transmembrane 
protein complex isolation as well as advance in our understanding of brassinosteroid signaling 
and stem cell fate in Arabidopsis.   
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Summary
Summary
Receptors represent an abundant class of integral membrane proteins that transmit information 
on various types of signals within the cell. Since receptor signaling and regulation can be 
characterized as a dynamic process that is dependent on direct as well as indirect coupling 
between receptors and their interacting partners immunoprecipitation based on single GFP 
tag purifi cation technique was employed in chapter 2 to identifi ed interacting partners of 
plant trans-membrane receptor SERK1. SERK1 is a member of small family of 5 receptors. 
Two other receptors were identifi ed to be present in SERK1 protein complex, BRI1 and 
SERK3 and further genetic analysis showed that indeed the SERK1 mutant allele serk1-1 
could enhance the phenotype of the weak BRI1 allele bri1-119. Other interacting partners 
were identifi ed to be present in SERK1 as well as in SERK3 receptor complexes (chapter 
3) like CDC48A and 14-3-3s proteins and a MADS-box transcription factor AGL15 in case 
only of SERK1 receptor. Furthermore, using Blue Native Gel Electrophoresis we showed that 
SERK1 and SERK3 are part of BRI1 containing multiple protein complexes with a relative 
mass between 300 and 500 kDa and in contrast to the co-receptors, only a small percentage 
of the BRI1 protein is present in high order complex(es) and most of it is present as a homo 
or heterodimer (chapter 2). These data help to unravel the function of SERK1 receptor in 
the brassinosteroid signaling. Brassinosteroids are plant steroid hormones, which regulates 
cellular expansion, differentiation, and proliferation. BRI1 is the plant receptor that can bind 
directly to brassinosteroids. In chapter 3 using the same immunoprecipitation technique the 
protein complexes of BRI1 and its co-receptor SERK3 were investigated. Interestingly we 
identifi ed the BAG1 (Bcl-2-associated athanogene) protein in SERK3 receptor complex. The 
plant BAG proteins were also shown to have a function in cell protection under stress and 
inhibition of plant programmed cell death that shares features associated with apoptosis. 
This observation is in line with the postulated function of SERK3 to play a role in negative 
regulation of a cell death pathway independent of its role in brassinosteroid signaling (He 
et al., 2007). BRI1 as well as its co-receptor SERK1 and SERK3 are found to be present in 
endosomal compartments and we identifi ed members of the small Ras related GTPases in 
both SERK3 and BRI1 complexes, which could indicate that there are similar mechanisms in 
the vesicle traffi cking for both BRI1 and SERK3 receptors (chapter 3). The SERK receptors 
as well as BRI1 have functional kinase domains which activities were compared in chapter 
4. Furthermore the phosphorylated residues were identifi ed by LC-MS/MS. The in vivo 
phosphorylation level of SERK1 was regulated by exogenously applied brassinosteroids 
(BR), like it was shown before for SERK3 and the in vivo phosphorylation sites in SERK1 
receptor were identifi ed. Different members of the SERK family were found to have different 
autophosphorylation activity and SERK1 and BRI1 were found to transphosphorylate each 
other as well as to interact independent of the kinase activity of BRI1. In chapter 5 the role 
of the SERK1 interacting partners AGL15, 14-3-3ν and BRI1 in the somatic embryogenesis 
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was investigated. In this chapter we provided evidence that the main BRI1-mediated BR 
signaling pathway is required for the acquisition of embryogenic competence. Both exogenous 
application of BRs and overexpression of BRI1 enhance somatic embryogenesis while bri1 
strong mutant alleles and the BR biosynthesis mutant det2 show strongly reduced embryogenic 
competence. AGL15 is also involved in this process and was found to be a positive regulator 
of both somatic embryogenesis and brassinosteroid signaling. Upon BL-dependent nuclear 
translocation, mediated by the adaptor protein 14-3-3ν, the AGL15 protein is able to bind to 
the promoter elements of the BRI1 and SERK1 genes and probably is a positive regulator.      
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Nederlandse samenvatting
Samenvatting
Een belangrijke klasse integrale membraaneiwitten zijn de receptoren. Deze receptoren ver-
zorgen signaal overdracht van verschillende signaal typen in de cel. Zowel de regulatie van 
deze receptor aktiviteit als de afgegeven signaal intensiteit kan worden gezien als een dyna-
misch proces dat afhankelijk is van zowel direkte als indirekte koppeling tussen receptoren 
en hun interactoren. Immunoprecipitatie met behulp van een enkelvoudige GFP additie was 
gebruikt in hoofstuk 2, om interacterende partners van de planten trans membraan receptor 
SERK1 te identifi ceren. SERK1 behoort tot een kleine klasse met 5 receptoren. Twee an-
dere receptoren (BRI1 en SERK3) zijn geidentifi ceerd in een SERK1 eiwitcomplex. Verdere 
genetische analyse toonde aan dat de SERK1 mutant versie serk1-1 het fenotype van het 
zwakke BRI1 versie bri1-119 kon versterken. Andere interakterende partners zoals CDC48A 
en 14-3-3-s eiwitten zijn aangetoond in zowel SERK1 als SERK3 receptor complexen (hoofd-
stuk 3). In het geval van de SERK1 receptor is ook nog een MADS box transcritie faktor 
aangetoond. Met behulp van natieve gel electroforese (Blue Native Gel Electroforese) toonden 
wij aan dat SERK1 en SERK3 onderdeel zijn van een meervoudig BRI1 eiwitcomplex met 
een massa tussen 300 en 500 kDalton. In tegenstelling tot de co-receptoren, is alleen een klein 
percentage BRI1 aanwezig in hogere orde complexen, terwijl het grootste deel voorkomt als 
homo- of heterodimeer (hoofdstuk 2). Deze data helpen om de functie van de SERK1 receptor 
in de Brassinosteroide signalering te ontrafelen. Brassinosteroiden zijn planten steroid hor-
monen die de celgroei, diferentiatie en ontwikkeling reguleren. BRI1 is de planten receptor 
die direct brassinosteroiden kan binden. In hoofdstuk 3 werd dezelfde immunoprecipitatie 
techniek gebruikt om de eiwit komplexen van BRI1 en zijn co-receptor SERK3 te onder-
zoeken. We identifi ceerden BAG1 (Bcl-2-associated athanogene) eiwit in SERK3 receptor 
complexen. Voor de planten BAG eiwitten is aangetoond dat ze een beschermende funktie 
hebben  onder stres condities en dat ze de geprogrammeerde planten cel dood (welke veel 
overeenkomsten vertoond met apopotose) remmen. Deze observering past in de voorgestelde 
functie van SERK3, namelijk dat SERK3 een rol speelt bij de (negatieve) regulering van een 
cel dood proces onafhankelijk van zijn rol in brassinosteroid signalering (He en anderen, 
2007). Zowel BRI1 als zijn co-receptoren SERK1 en SERK3 zijn aanwezig in endosomale 
compartimenten en voor zowel SERK3 als voor BRI1 komplexen hebben we onderdelen van 
kleine Ras gerelateerde GTPases geïdentifi ceert. Dit zou er op kunnen duiden dat transport 
van zowel BRI1 als SERK receptoren via vergelijkbare mechanismen plaats vinden (hoofd-
stuk 3). SERK receptoren en BRI1 hebben functionele kinase domeinen en de kinase aktiv-
iteiten hiervan zijn vergeleken in hoofdstuk 4. De gefosforyleerde aminozuren zijn geïden-
tifi ceert met behulp van LC-MSMS. Het nivo van de in vivo fosforylering van SERK1 was 
gereguleerd door exogeen aangeboden brassinosteroiden (BR), zoals eerder gevonden voor 
SERK3. De in vivo gefosforyleerde aminozuren van SERK1 receptor werden geïdentifi ceert 
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door middel van LC-MSMS. Voor verschillende kinases behorende tot de SERK familie is 
aangetoond dat ze een verschillende autofosforylerings aktiviteit bezitten en SERK1 en BRI1 
transfosforyleren en interakteren met elkaar onafhankelijk van de kinase aktiviteit van BRI1. 
In hoofdstuk 5 wordt de rol van SERK1 z’n interakterende partners AGL15, 14-3-3v en BRI1 
in de somatische endogenese onderzocht. In dit hoofdstuk verstrekken wij  bewijs dat de door 
BRI1 beinvloedde BR signaleringsroute nodig is voor de competentie om embryo’s te kun-
nen vormen. Zowel exogene toevoeging van brassinosteroiden als overexpressie van BRI1 
versterken de somatische embryogenese.  Sterke bri1 mutanten als ook de BR biosyntese 
mutant det2 daarentegen, laten een sterk gereduceerde embryogene competentie zien. Voor 
AGL15, welke ook betrokken is bij dit proces, is aangetoond dat deze een positieve regulator 
is van zowel somatische embryogenese als brassinosteroid signalering. Bij BL afhankelijke 
kern translocatie of AGL15,  zoals verzorgt door het transport eiwit 14-3-3v, kan het AGL15 
eiwit binden aan promotor delen van BRI1 en SERK1 genen en is hierdoor waarschijnlijk een 
positieve regulator.
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